https://cavendishglobal.com/services-gallery daily 0.75 2019-08-19 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484689112039-US7E5YIZFBN7MF1HB0IA/CIC_LogoGood.png Services - Cavendish Impact Capital https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484689112039-US7E5YIZFBN7MF1HB0IA/CIC_LogoGood.png Services - Cavendish Impact Capital https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484685355919-TOEZQGEN6S5TW0UVJGSU/IQ_Logo2.png Services - Cavendish IQ https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484688427118-8K429XL6QQFHTE64JXC5/CIC_Logo2.png Services https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484687916018-TUOXC90DM4N33WL8HOEH/CIF_Logo4.png Services - The Cavendish Impact Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423858468188-CPJ71LDO17PQKU1YET0A/20140505_4773.jpg Services - Impact Forums https://cavendishglobal.com/impact-forum-slideshow daily 0.75 2017-03-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423860801615-X4JSP4PLIMJUFLAJJTJP/image-asset.jpeg Impact Forum Slideshow - Dinner at the 2014 United Nations Forum https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423860801615-X4JSP4PLIMJUFLAJJTJP/image-asset.jpeg Impact Forum Slideshow - Dinner at the 2014 United Nations Forum https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490217945291-I58HY03XGXBVXH7HY25I/MC_3.jpg Impact Forum Slideshow https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423860829962-X0YCRH8C0UQ0DYCJGFDU/20140505_3693.jpg Impact Forum Slideshow - Innovation Partner presentations at the 2014 United Nations Forum https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423860857819-TVYBBLKQIV31V6POSPD7/20140505_3481.jpg Impact Forum Slideshow - Dinner at the 2014 United Nations Forum https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423860861863-JFA5UZLBUELKA46PQ8BY/20140505_4829.jpg Impact Forum Slideshow - Innovation Partner presentation at the 2014 United Nations Forum https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1481218374160-VVL5TIDQC5PUHYH8NHET/_DM21339.JPG Impact Forum Slideshow - Networking at the 2016 Palm Beach Forum https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1481218381480-B936H55M3NTT3CAT61ST/8J5A5245.JPG Impact Forum Slideshow - Cocktail Reception at the 2016 La Jolla Forum https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1481218396355-J4QVKQPUI3HRAQQEYRYT/8J5A5517.JPG Impact Forum Slideshow - 2016 Phoenix Forum https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490217981947-IRFG4DMFEUJ4OYCNG1OF/MC_1.jpg Impact Forum Slideshow https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1481218403255-CSMJY8TEBQRUN987QEL4/8J5A5719.JPG Impact Forum Slideshow - Cavendish Tours of the University of Arizona College of Medicine, 2016 Phoenix Forum https://cavendishglobal.com/la-jolla-social daily 0.75 2015-06-29 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1435590582423-GLTG7MS0MEHS534V42AQ/social2.JPG La Jolla Social https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1435590582423-GLTG7MS0MEHS534V42AQ/social2.JPG La Jolla Social https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1435590610381-C133C9L7H9594PO2ZM89/social.JPG La Jolla Social https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1435590631919-ARF4GZEJ94WBM9D5SDQB/social3.JPG La Jolla Social https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1435590671877-ZRT2MQWXKNLC54ZDPCEE/social5.JPG La Jolla Social https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1435590651481-NKLNN4YLP3VNWBTLB6Y4/social4.JPG La Jolla Social https://cavendishglobal.com/clevelandfeaturedspeakers daily 0.75 2015-08-06 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1438807278451-T3POHTE0TSTZ4VX4GA9Y/image-asset.jpeg Cleveland_featured_speakers - Bruce Broussard Chief Executive Officer & President, Humana, Inc. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1438807278451-T3POHTE0TSTZ4VX4GA9Y/image-asset.jpeg Cleveland_featured_speakers - Bruce Broussard Chief Executive Officer & President, Humana, Inc. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1435592969630-A3UUZT6FVG1F2YBBHF46/delow_cosgrove.png Cleveland_featured_speakers - Delos Cosgrove, MD President and Chief Executive Officer of Cleveland Clinic, Cleveland, Ohio https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1435592971464-3HOPE59SWFXWL8QMDQ6V/joe_cunningham.png Cleveland_featured_speakers - Joe Cunningham Managing Director, Sante Ventures https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1438807307364-UJRXC0SKBZYNZUY2PUI3/image-asset.jpeg Cleveland_featured_speakers - Geno Germano Group President, Global Innovative Pharma Business, Pfizer. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1438809151046-G5FZP549HIREYH30YUE8/Neil-Jordan-Microsoft.jpg Cleveland_featured_speakers - Neil Jordan General Manager of Health Worldwide, Microsoft https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1438808853083-JXCIKE6QEGLSE7LTJ0BX/Kevin-A.-Lobo-Stryker-Corporation.jpg Cleveland_featured_speakers - Kevin A. Lobo Chairman and Chief Executive Officer, Stryker Corporation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1438809049762-1MPRSOI81CQ7XCYJQJ7K/Claudia-Fan-Munce-IBM-Corporate-Strategy.jpg Cleveland_featured_speakers - Claudia Fan Munce Managing Director, IBM Venture Capital Group Vice President, IBM Corporate Strategy. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1435592972909-0E0ADET7PXCSU7KMY6G9/scott_para.png Cleveland_featured_speakers - Scott Parazynski, M.D. Astronaut – Everest Climber – Physician – Pilot – Inventor – Keynote Speaker https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1438809458204-296USQ5R35NXTYZ9Q9XP/Christi-Shaw-Novartis.jpg Cleveland_featured_speakers - Christi Shaw US Country Head & President, Novartis Corporation. https://cavendishglobal.com/nyu-kind daily 0.75 2017-03-21 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490132868308-XN7VIY2RGCKPV846IKKM/James_Rosebush_031417.jpg NYU KIND THE HONORABLE JAMES ROSEBUSH Founder and CEO, GrowthStrategy Mr. Rosebush is a pioneer in the field of impact philanthropy and investing. Beginning in the early 1970s, he became an advocate of employing robust investment-like management practices to measure the effectiveness of charitable giving. He also became a proponent of using program-related investment funds (PRIs), as well as corporate social responsibility (CSR) programs to make a positive impact in the community. Mr. Rosebush held leadership roles in private and corporate foundations at a time when the Sullivan Principles were being applied to management practices and board governance. In response to this new movement, he was involved in the creation of collaborative industry impact groups such as Grantmakers in Health, which sought to increase the effectiveness of every contributive dollar in the field of health. His philanthropic work has included helping to found four schools including the first school without walls, a school for youthful offenders, and the Challenger Memorial Center for Space Science Education. He integrated corporate engagement with public investment in K-12 education, seeking measurable, documentable, advances in competency. This was the focus of his work as the CEO of the Fairfax Education Foundation — the first public school education foundation in the US, and as founder and CEO of Technology Transforming Education Compact, Inc. — an industry-led effort to turn around the public schools in our Nation’s Capital. Mr. Rosebush was appointed to create and manage the first White House office focused on impact philanthropy and investing for President Reagan. This initiative became the president’s favorite domestic policy program and was a pattern for successive administrations. As a senior advisor to the President, he was an advocate for the integration of corporate, investment, and philanthropic initiatives to be combined and focused on societal issues for maximum impact. He also became the longest servicing Chief of Staff to the First Lady and managed her philanthropic program, as well as establishing the Nancy Reagan Foundation. Following his White House years, he has been an advisor to many investment firms, family offices, and philanthropies. Among these are: Tudor Investment Corporation, JP Morgan, Bankers, Trust, Alex. Brown and Sons, Columbia Capital, The Carlyle Group, Stargazer Funds, Hillview Capital, CapitalSource, The American Stock Exchange, and Bessemer Trust, as well as, The Martin Luther King Memorial Foundation, The Museum of the International Red Cross, The Urban Monuments Foundation, The Impact Incubator at Children’s Hospital Los Angeles, World Healers Network. He is a designated philanthropy advisor to Fidelity Investments and UBS. In addition to serving on various boards, Mr. Rosebush has taught corporate social responsibility in the McDonough School of Business at Georgetown University; the history of philanthropy at The George Washington University; and a course entitled Crisis in the Classroom at Principia College, his undergraduate alma mater. His graduate degree is in public affairs from Boston University. Among numerous awards he was selected as was a Woodrow Wilson Scholar at Princeton University and was nominated by President Reagan to serve as Ambassador to UNESCO. His most recent book, a best seller, is TRUE REAGAN, What Made Ronald Reagan Great and Why It Matters. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490132868308-XN7VIY2RGCKPV846IKKM/James_Rosebush_031417.jpg NYU KIND THE HONORABLE JAMES ROSEBUSH Founder and CEO, GrowthStrategy Mr. Rosebush is a pioneer in the field of impact philanthropy and investing. Beginning in the early 1970s, he became an advocate of employing robust investment-like management practices to measure the effectiveness of charitable giving. He also became a proponent of using program-related investment funds (PRIs), as well as corporate social responsibility (CSR) programs to make a positive impact in the community. Mr. Rosebush held leadership roles in private and corporate foundations at a time when the Sullivan Principles were being applied to management practices and board governance. In response to this new movement, he was involved in the creation of collaborative industry impact groups such as Grantmakers in Health, which sought to increase the effectiveness of every contributive dollar in the field of health. His philanthropic work has included helping to found four schools including the first school without walls, a school for youthful offenders, and the Challenger Memorial Center for Space Science Education. He integrated corporate engagement with public investment in K-12 education, seeking measurable, documentable, advances in competency. This was the focus of his work as the CEO of the Fairfax Education Foundation — the first public school education foundation in the US, and as founder and CEO of Technology Transforming Education Compact, Inc. — an industry-led effort to turn around the public schools in our Nation’s Capital. Mr. Rosebush was appointed to create and manage the first White House office focused on impact philanthropy and investing for President Reagan. This initiative became the president’s favorite domestic policy program and was a pattern for successive administrations. As a senior advisor to the President, he was an advocate for the integration of corporate, investment, and philanthropic initiatives to be combined and focused on societal issues for maximum impact. He also became the longest servicing Chief of Staff to the First Lady and managed her philanthropic program, as well as establishing the Nancy Reagan Foundation. Following his White House years, he has been an advisor to many investment firms, family offices, and philanthropies. Among these are: Tudor Investment Corporation, JP Morgan, Bankers, Trust, Alex. Brown and Sons, Columbia Capital, The Carlyle Group, Stargazer Funds, Hillview Capital, CapitalSource, The American Stock Exchange, and Bessemer Trust, as well as, The Martin Luther King Memorial Foundation, The Museum of the International Red Cross, The Urban Monuments Foundation, The Impact Incubator at Children’s Hospital Los Angeles, World Healers Network. He is a designated philanthropy advisor to Fidelity Investments and UBS. In addition to serving on various boards, Mr. Rosebush has taught corporate social responsibility in the McDonough School of Business at Georgetown University; the history of philanthropy at The George Washington University; and a course entitled Crisis in the Classroom at Principia College, his undergraduate alma mater. His graduate degree is in public affairs from Boston University. Among numerous awards he was selected as was a Woodrow Wilson Scholar at Princeton University and was nominated by President Reagan to serve as Ambassador to UNESCO. His most recent book, a best seller, is TRUE REAGAN, What Made Ronald Reagan Great and Why It Matters. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490132762016-1I6SYBPA4GMNK26J9T6C/James_Rosebush_031417.jpg NYU KIND https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1445528363088-6WUFZBNS9YT1YWRE5GUB/lubetzky.jpg NYU KIND DANIEL LUBETZKY Founder & CEO, KIND Daniel Lubetzky, founder and CEO of KIND, is on a mission to make the world a little kinder one snack and act at a time. Maker of nutritious and delicious snack foods, KIND is the fastest-growing U.S. snack company, and through the KIND Movement has inspired more than one million kind acts since the company’s inception in 2004. A pioneering social entrepreneur working to build bridges between people through innovative models, Daniel is also the founder of PeaceWorks Inc., a business that fosters cooperative ventures among neighbors in the Middle East, and co-creator of Maiyet, a fashion brand that partners with artisans to promote entrepreneurship in developing economies. Additionally, he co-founded the OneVoice Movement, an international grassroots effort that amplifies the voices of moderate Israelis and Palestinians seeking to end the conflict. His commitment to creating economically sustainable and socially impactful business has been lauded by BusinessWeek, Time, Advertising Age and Entrepreneur. Daniel has also been recognized by the World Economic Forum and the Skoll Foundation, and in 2015 President Barack Obama and Commerce Secretary Penny Pritzker named him a Presidential Ambassador for Global Entrepreneurship (PAGE). He is also the author of the New York Times bestseller Do the KIND Thing. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1445528368599-PYCRX1O5AKDEIPKIHSSF/vandermey.jpg NYU KIND ANNE VANDERMEY Associate Editor, Fortune Magazine Anne VanderMey is an associate editor at Fortune where she runs Macro, the first section of the magazine. For the past five years she's written, assigned and edited business stories on a range of topics for Fortune and its website. Previously, she was on staff at BusinessWeek and The Hartford Courant newspaper in Connecticut. She is a Michigan native and lives in Brooklyn. https://cavendishglobal.com/palm-beach daily 0.75 2016-12-08 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1449770301590-Y290WW5VIWH4WFBUH5E5/Breakers.JPG Palm Beach - The Breakers, Palm Beach https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1449770301590-Y290WW5VIWH4WFBUH5E5/Breakers.JPG Palm Beach - The Breakers, Palm Beach https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1449770312085-1HQ8ST8CUPWTNAIJ9U9X/Breakers+pool.jpg Palm Beach - Poolside at The Breakers https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1481217610289-WULIAVXT6IG7R0FE3IUZ/_DM21341.JPG Palm Beach - McLaren Automotive offered community members the 'ultimate driving experience' https://cavendishglobal.com/education-summit-speakers daily 0.75 2016-04-04 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1459174655641-ZQLQI7Q5C2XVUAW6XJB6/DSC_1373-1-1-1.jpg Education Summit Speakers - Pearl Johnson Biedron - Founder, The Willow School Pearl holds a B.A. in English and American literature from Brown University, and a M.S. in Communication Sciences and Disorders from the Institute of Health Professions at Massachusetts General Hospital. She taught at the Pennington School in New Jersey and at the Charles Armstrong School in Belmont, California. Gretchen has also worked as a private tutor, specializing in language and learning disabilities. Prior to enrolling at Brown, she attended Far Hills Country Day School in Far Hills, The Peck School in Morristown, and The Hotchkiss School in Lakeville, Connecticut. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1459174655641-ZQLQI7Q5C2XVUAW6XJB6/DSC_1373-1-1-1.jpg Education Summit Speakers - Pearl Johnson Biedron - Founder, The Willow School Pearl holds a B.A. in English and American literature from Brown University, and a M.S. in Communication Sciences and Disorders from the Institute of Health Professions at Massachusetts General Hospital. She taught at the Pennington School in New Jersey and at the Charles Armstrong School in Belmont, California. Gretchen has also worked as a private tutor, specializing in language and learning disabilities. Prior to enrolling at Brown, she attended Far Hills Country Day School in Far Hills, The Peck School in Morristown, and The Hotchkiss School in Lakeville, Connecticut. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1459696552238-IJEA2807AZSBY53OSVNP/unnamed-1.jpg Education Summit Speakers - Gabriel Brodbar - Founder and Executive Director, NYU Program in Social Entrepreneurship Gabriel Brodbar is the founding Executive Director of the New York University Program in Social Entrepreneurship, a leading and pioneering approach to finding and catalyzing extraordinary social change agents. Prior to NYU, Gabriel served as the founding Director of Dartington-i New York and as the founding Director of the Office of Housing Policy and Development at the NYC Administration for Children’s Services, both of which focused on performance contracting systems and social impact bonds, supportive housing development, and data-based policy analysis. He has developed and operated award-winning dropout prevention and college preparatory programs for at-risk youth, is a founding member of the Child Welfare League of America’s National Homelessness Advisory Panel, and is a Teach For America alumnus. His published work on the intersections of foster care and homelessness, community-based needs assessment tools and social entrepreneurship can be found in Child Welfare, The Social Service Review, and Beyond Profit. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458246836198-LI3LYVTOGKB62N30GZBY/Carvalho_Portrait_.jpg Education Summit Speakers - Alberto Carvalho - Superintendent of Miami-Dade County Public Schools Alberto M. Carvalho has served as Superintendent of Miami-Dade County Public Schools, the nation’s fourth largest school system, since September 2008. He is a nationally recognized expert on education transformation, finance, and leadership development. During his tenure, M-DCPS has become one of the nation’s highest-performing urban school systems receiving systemwide accreditation from AdvancEd in 2014. The District has also been named as the 2014 College Board Advanced Placement Equity and Excellence District of the Year, as well as the 2012 winner of the Broad Prize for Urban Education. As a staunch believer in school choice, he has expanded choice options in Miami-Dade to include over 500 offerings including programs in fine and performing arts, biotechnology, engineering, robotics, aviation, forensic sciences, and many others. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458247407328-3JZXVLQGVCRKVP771JY8/kevin_c+%281%29.png Education Summit Speakers - Kevin P. Chavous - Author, Attorney, and National Eduction Reformer As a former member of the Council of the District of Columbia and Chair of the Council's Education Committee, Mr. Chavous was at the forefront of promoting change within the District public school system. His efforts led to more than $500 million new dollars being made available to educate children in D.C. A leading national advocate for educational choice, Mr. Chavous helped to shepherd the charter school movement into the nation's capital. Under his education committee chairmanship, the D.C. charter school movement became the most prolific charter school jurisdiction in the country, with now nearly half of D.C.'s public school children attending charter schools. In recent years, Mr. Chavous has worked to advance charter school and parental choice programs in a host of jurisdictions around the country, most notably in Louisiana and Indiana. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458245639381-CNUDOE7PSC36TBE1VWTO/David_Coleman_9980_web+%281%29.jpg Education Summit Speakers - David Coleman - CEO, College Board With a team of educators, David founded the Grow Network, an organization committed to making assessment results truly useful for teachers, parents and students. McGraw-Hill acquired the Grow Network in 2005. PreviouslyIn 2007, David left McGraw-Hill and cofounded Student Achievement Partners, a nonprofit that assembles educators and researchers to design actions based on evidence to improve student outcomes. Student Achievement Partners played a leading role in developing the Common Core State Standards in math and literacy. David left Student Achievement Partners in the fall of 2012 to become president of the College Board. David was named to the 2013 Time 100, the magazine’s annual list of the 100 most influential people in the world. He has been recognized as one of the POLITICO 50 for 2014, Time magazine’s “11 Education Activists for 2011”, and was one of the NewSchools Venture Fund Change Agents of the Year for 2012. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458246229949-CJECGR6JSROLA6E5D1JN/David+A.+Dik.+Photo.jpeg Education Summit Speakers - David Dik - National Executive Director, Young Audiences David A. Dik was appointed National Executive Director of Young Audiences Arts for Learning in July 2010, the nation’s largest arts in education network. Prior to this position, he served as the Managing Director of the Metropolitan Opera Guild, having also served as the Guild’s Director of Education. David serves on the Leadership Team of the National Coalition for Core Arts Standards, Board of Directors for the Music-in-Education National Consortium, the Advisory Committee of the Arts Education Partnership (AEP), a trustee of the Potsdam College Foundation and a member of the Harvard Graduate School of Education Arts in Education Advisory Council. David’s career began as a certified school music educator. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1459696789290-291A796LAMRA3G5SMOD0/unnamed.jpg Education Summit Speakers - Jeff Ervine - President & Founder, Bridg-it Jeffrey J. Ervine is Founder and President of Bridg-it LLC. Mr. Ervine spent the first two decades of his professional life on wall street in financial services. His career began in public accounting (as a CPA for Deloitte), and later he became an investment banker and finally he specialized in asset management focussing in the hedge fund and private equity industry. After being defamed online in 2008 and spending several years defending his name in court, eventually winning a mult-million dollar verdict for cyber defamation, Mr. Ervine developed an expertise and passion for helping victims of online defamation. Mr. Ervine created Bridg-it to provide school communities with the first sustainable solution to bullying, cyberbully and harassment. Mr. Ervine is a graduate of The Pennsylvania State University B.S. in Accounting and has an MBA in Finance from Columbia Business School. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458848925407-CZEAP988I9RKQRCLP3UK/Will+Ethridge.jpg Education Summit Speakers - William Ethridge - Former CEO, Pearson Education Will Ethridge is active in the education sector as an investor, a board member of several companies, and as the Principal of Ethridge Advisors, where he provides advisory services to education companies, educational institutions, policy makers and private equity companies. From 2008 through 2014, Mr. Ethridge was CEO of Pearson North America and also served on Pearson’s board of directors. From March 2003 to 2008 Mr. Ethridge served as Chief Executive Officer of Pearson’s Higher Education, International and Professional Publishing Groups. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1459173863054-ZT5J0XVS9M5CF3ZZRXBO/31534d8a-a8b7-47f2-84dc-21d6ee1b9005.png Education Summit Speakers - Emily Grad - Founder and CEO, Edhesive Emily Grad is the founder and CEO of Edhesive. She incubated the business while at Amplify where she served as the Executive Director of Program Management of its Innovation Lab. Prior to Amplify, Emily served as the Director of Production for The Daily, News Corp's mobile news app, and the Global Creative Producer for AOL. Before moving to New York, Emily worked at various design agencies in Seattle. While in college, Emily worked as a substitute teacher for a local middle school. She has a deep passion for using technology to make advanced curriculum accessible to all students. Emily herself benefited advanced curriculum. Through the AP coursework she completed in high school, Emily was able to skip her freshman year and start college as a sophomore. Emily holds a B.A. with honors from the University of Washington. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458245956775-KYB3M625EB03NAWG0XV9/Alan+Photo.PNG Education Summit Speakers - Alan Hilburg - President/CEO, Hilburg Associates Alan Hilburg, President and CEO of HilburgAssociates, is an award-winning author of two NY Times bestsellers on leadership, a filmmaker (with an Academy Award nomination) and a senior advisor, counselor and strategist to more than 200 international leadership teams, CEOS, country presidents on institutional branding and organization transitions. He also describes himself as an "edupreneur and education missionary" which demands that we tireless believe that education innovation is defined in how we share our life's career successes and experiences with the next generation of leaders. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458848370647-9Y6DVK58RTOSEG5SEANE/Eric+Jones.png Education Summit Speakers - Eric Jones - Founder and CEO, EdGems Eric served as an Executive Vice President of Pearson plc. in London, working with all three of the company’s divisions, Pearson Education, Penguin Publishing and The Financial Times. He also served as Executive Vice President of the Penguin Television Group, and Executive Vice President Worldwide of Pearson Broadband Ltd. He designed, launched and ran the original Channel One News— a daily program serving millions of students—during its first five years. During that company’s last five years, Eric was brought back in to serve as the Senior Vice President and Founder of Channel One 2.0, responsible for transitioning the original television news service to an Internet Protocol delivery with the inclusion of daily interactive lessons. Channel One was sold to Houghton Mifflin in May of 2014. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1459171536059-FO8RQ0THRHGP6BHYO5Y3/Gary1.jpg Education Summit Speakers - Gary June - Founding Partner, Hatch Group Gary June is a media and education professional with high level results and talent generation expertise in education, trade publishing, content technology, sales, marketing, business development and strategy. He is also active in the education venture circuit and an angel investor in several media and ed-tech companies. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458246341390-7ZTMRGUKXJLN11U4HQ32/Kathy_Lemay.jpg Education Summit Speakers - Kathy LeMay - CEO, Raising Change Kathy LeMay is an internationally-recognized public speaker, philanthropic advisor, global social change fundraiser and published author whose purpose-driven life centers on lifting up the voices, stories, leadership and influence of women and girls around the world. Kathy speaks about the transformative life; of shifting from success to significance, and putting humanity back into modern philanthropy. She coaches social change innovators and global donors to boldly and unapologetically create the world we know is possible. Kathy's book The Generosity Plan, released by Simon & Schuster and Beyond Words in 2010, aims to put philanthropic power into the hands of regular individuals, families, and communities. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458246079872-EWXUQSSL18LRZ72OH7QM/Madan_Vineet_-43.jpg Education Summit Speakers - Vineet Madan - Founder, Junction Education Vineet Madan is the Founder & CEO of Junction Education, a company focused on scaling affordable, engaging and effective courseware for colleges and universities. In just 18 months post-launch, Junction has saved students over $300,000 on course materials while delivering a learning experience that 82% of students prefer to alternatives. A frequent speaker and writer on the digital transformation of education, his perspectives have been widely covered including in the Wall Street Journal, Fortune, CNN, Mashable, The Huffington Post, The Verge, Crain’s, Fox News and The New York Times. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1459176532035-ZXJH4AOHYWEKTY12FI4Q/molly-melching-+headshot.jpg Education Summit Speakers - Molly Melching - Founder and CEO, Tostan Molly Melching has lived and worked in Senegal, West Africa since 1974 and has dedicated her life to the empowerment of communities at grassroots levels. Molly’s early experiences working with children in Dakar and living in a rural village enforced her beliefs that many development efforts were not addressing the true needs and realities of African communities. In collaboration with community members, Molly began to develop a new type of learning program that actively involved both adults and adolescents by using African languages and traditional methods of learning. Their efforts grew throughout the 1980s, leading Molly to found Tostan in 1991. Tostan is an organization whose innovative grassroots education model—the Community Empowerment Program (CEP)—engages communities for three years in cross-cutting themes of democracy, human rights, problem-solving, hygiene, health, literacy, project management skills and parental education. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458849011780-8YO7VPMP20GIRFD4YOJD/Daniel+Meyer-BioResume-March2016.jpg Education Summit Speakers - Daniel Meyer - CEO, Academica Virtual Education Academica Virtual Education is one of the fastest growing digital learning organizations in the world (from seven enrollments in 2010 to 40,000+ in 2016) with students throughout the US, Europe, Latin America, the Caribbean, and soon the Middle East, North Africa, and Asia. In addition to his management duties, Daniel provides digital consulting to over 140 K-12 schools and college settings within the Academica network of schools. He also regularly consults with external investors and accelerators to evaluate the viability of education, technology, and business ventures. He previously served as the Chief Learning Officer for Academica. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458848745901-LL6WV2CY1Y0G2O82O1UA/Eva2%5B1%5D.jpg Education Summit Speakers - Eva Moskowitz - Founder and CEO, Success Academy Charter Schools Eva Moskowitz founded Success Academy Charter Schools in 2006 to tackle the monumental crisis in public education in the most prominent city in the United States. Over the past ten years, Success has become the largest network of public charter schools in New York City – one of the fastest-growing and highest-performing in the country and a beacon for educators searching for innovation and inspiration in the classroom. With 41 dynamic schools (as of August), from elementary to high school, the network’s goal is to prepare every scholar to go college. Success has proved many times over that, regardless of neighborhood, racial, ethnic, and socio-economic lines, children can attain the highest academic standards. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1459696692788-L6KH2WYS7D97LD6FJG64/Pitbull_Playboy_0266_final+CROP+250x275+GooglePlus.jpg Education Summit Speakers - Armando Pérez - Rap Artist, Founder of SLAM Armando Christian Perez—globally known as Pitbull—is everywhere. His relentless work ethic transformed him into a Grammy-winning international superstar, visionary entrepreneur, fashion maven, and successful actor. His social media presence speaks to nearly 90 million people daily, matching some television networks. It’s almost impossible to think the Miami native born to Cuban-American expatriates, “turned a negative into a positive” and became one of the world’s greatest entertainers and businessmen, but that’s exactly what he accomplished. Continuously giving back and cultivating success among the next generation, he serves as the brand ambassador for Sports, Leadership and Management Academy (SLAM!)—part of the Academica charter school network with locations in Little Havana, Miami and Las Vegas, Nevada. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1459194015705-DP5THJJJXJ1R1EOM8SD3/IMG_0879.JPG Education Summit Speakers - Neesha Rahim - Co-Founder, Level Up Village Neesha Rahim co-founded Level Up Village with a conviction that applying global collaboration and STEAM learning to real-life problems will transform the world of education and not only equip young people for the jobs of the future, but also prepare them to lead successful, happy lives. Her Masters Degree in Social Work and International Affairs from Columbia University, along with her extensive work with youth development and conflict resolution organizations all over the world, power her passion for wide-scale impact in education. In the early years of her career, Neesha spent time at UNICEF and then at a small school in Harlem, NY, serving at-risk children, followed by work in youth conflict resolution at Seeds of Peace. Neesha later moved to management and development consulting with organizations around the world, helping them meet their ambitious goals and expand their impact. As an active member of the PTA, Neesha also worked to bring innovative programs to her children’s after-school program. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458245604085-NX8IZ2ZENM8SX0MCT1SJ/PeterSamuelson.jpg Education Summit Speakers - Peter Samuelson - Founder, Starlight Children's Foundation Peter Samuelson is an accomplished film producer and in parallel, a serial pro-socialentrepreneur. Films produced by Peter Samuelson have been nominated for multiple Academy Awards. In 1999 his strong passion for children’s advocacy led him to co-found First Star, a DC based nonprofit dedicated to improving the lives of America’s abused and neglected children. In1982, Peter co-founded the Starlight Children’s Foundation—an international charity dedicated togranting wishes for seriously ill children. In 1990 Peter founded with Steven Spielberg and GeneralNorman Schwarzkopf Starbright World, an online social network to educate, encourage andempower children to cope with the medical, emotional and social challenges of their illness. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458247171626-MRTEMJ10F54BYMP7A47P/Shoshana_Vernick.jpg Education Summit Speakers - Shoshana Vernick - Managing Director, Education Opportunity Fund, Sterling Partners Shoshana Vernick joined Sterling Partners in 2003 and is currently a Managing Director of the Education Opportunity Fund. As Managing Director of the Education Opportunity fund, Shoshana guides the fund’s investment strategy and governance processes. The fund’s focus is on technology-relevant, growth stage companies that align with the following themes: enabling the globalization of education, partnering with colleges and universities, utilizing advanced analytics to improve education services, reshaping the student experience and enabling successful outcomes, implementing technology to improve how students learn and teachers teach, and addressing relevant skill gaps and promoting workforce opportunities. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458848939533-OFGTCYQKFOH89WWQYHYS/3aaa2ccc-8107-4555-9ef0-5969f6d79197.jpg Education Summit Speakers - Fernando Zulueta - President, Academica Fernando Zulueta is the president of Academica Corporation, one of the nation's largest and most successful charter school service and support organizations. Academica serves more than 150 charter schools in Florida, California, Utah, Nevada, DC, and Texas. He is a Board Member of The National Alliance for Public Charter Schools, past Chairman of the Florida Charter School Review Panel, and founding Board Member of the Florida Consortium of Charter Schools. https://cavendishglobal.com/san-diego daily 0.75 2016-04-12 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460487545738-GCAFIRN6W0ZO573A7J27/booth-31.jpg San Diego - La Jolla and Torrey Pines https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460487545738-GCAFIRN6W0ZO573A7J27/booth-31.jpg San Diego - La Jolla and Torrey Pines https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460487594111-B1SRH1MODRV09USCPSYB/bg-fs-legendary-services.jpg San Diego - The Lodge at Torrey Pines https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460487654009-DTO73FVU7OA78Q4FM9JI/room-image1%402x1.jpg San Diego - Illumina Theater, The Alexandria at Torrey Pines https://cavendishglobal.com/previous-forums-gallery daily 0.75 2019-05-09 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557425983425-G2IUTHLGTDBW9BD1RQVI/nyc.jpg Previous Forums - New York | April 2019 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557425983425-G2IUTHLGTDBW9BD1RQVI/nyc.jpg Previous Forums - New York | April 2019 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557425425829-26CT9FBJQSY04RAHXMF5/sfo.jpg Previous Forums - San Francisco | February 2019 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557425175794-CMHCZLVF8KGM36HC4ZE1/seattle.jpg Previous Forums - Seattle &amp; Bellevue | October 2018 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557425024256-1UB7JOO6I78CY6N3O97T/sralab.jpg Previous Forums - Chicago | July 2018 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557424695639-4H3OUZYIJ4GHDZ0SK14R/BG2.jpeg Previous Forums - Boca Grande | March 2018 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1518804523627-81KK4TOVZYRZY1SFMGCN/16dd4997170b55e63fb40a57a4d1f8ef.jpg Previous Forums - San Diego | February 2018 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1518804450022-3JJYQOGCLTUX3HQT3PUQ/AdobeStock_60595305.jpeg Previous Forums - New York | October 2017 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1504800248263-9N85Y3B840CGDB7X0MCF/AdobeStock_70577112+%281%29.jpeg Previous Forums - Chicago | July 2017 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497541747117-ULSH2ODJAZKM97P4ZPI0/AdobeStock_52628626+%281%29.jpeg Previous Forums - Washington, DC | May 2017 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488470259089-DBOPWL987TG7JXVKPDH4/sdbanner.png Previous Forums - San Diego | February 2017 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1475181052979-04E1CLH19ARNS73GY2Z4/phoenix.jpeg Previous Forums - Phoenix | September 2016 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1475181203043-XELWLE08P1FOZWG69U48/lajolla_beach.jpg Previous Forums - San Diego | June 2016 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460489099795-M10B7558LLR5PEVHRGIX/Breakers.JPG Previous Forums - Palm Beach | February 2016 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460488935752-8FE4CN5J8KLM4I5NPPL7/pClevelandClinic_50024_web_lrg.jpg Previous Forums - Cleveland Clinic | October 2015 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460489248992-9MLDF51UIAN3PR22V5PG/Scripps+Forum.jpg Previous Forums - San Diego | May 2015 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460488923110-PBQEZ4VBJU03EYRPLEVE/909C9957.MOV.22_16_12_13.Still001.jpg Previous Forums - Oxford, UK | November 2014 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460488645046-K5DSVK1045LMIGJDIYSV/Breakers.JPG Previous Forums https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460488902419-623DOXCNKGLVESMS198V/20140505_3693.jpg Previous Forums - United Nations | May 2014 https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/570d4984859fd09b9e22f8ba/5cd469c16e9a7f557cd6d06d/1557424577504/ Previous Forums https://cavendishglobal.com/previous-summits daily 0.75 2018-02-16 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460490155293-83SA8Q1O91D8UQMW7DL7/static1.squarespace.jpg Previous Summits - Boca Grande | April 2016 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460490155293-83SA8Q1O91D8UQMW7DL7/static1.squarespace.jpg Previous Summits - Boca Grande | April 2016 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460490244868-JJ10IV33OCRP9TO0O7DL/uat_025817.jpg Previous Summits - New York University | November 2015 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460490080273-IYTMTABJ8MB3S4DHCX5T/sanrst-omni-la-costa-resort-sunrise-gallery.jpg Previous Summits - Chopra Center for Wellbeing | October 2015 https://cavendishglobal.com/san-diego-2016-featured-speakers daily 0.75 2016-06-16 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466082534282-63V0DLZPVMXTZ3RN84N0/Venter-high.jpg San Diego 2016 Featured Speakers - J. Craig Venter, PhD. Co-Founder, Executive Chairman, CEO, Human Longevity, Inc. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466082498815-I3D6SNDCZONV036CTT5A/Venter-high.jpg San Diego 2016 Featured Speakers https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466082534282-63V0DLZPVMXTZ3RN84N0/Venter-high.jpg San Diego 2016 Featured Speakers - J. Craig Venter, PhD. Co-Founder, Executive Chairman, CEO, Human Longevity, Inc. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464892614349-MVLSUFAJ6FYJRVEUB0D5/Headshot_RainHenderson.jpg San Diego 2016 Featured Speakers - Rain Henderson CEO, Clinton Health Matter Initiative, The Clinton Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464892597946-349JD0SYMNLNFAXJRORS/Headshot_AnthonyZolezzi.jpg San Diego 2016 Featured Speakers - Anthony Zolezzi Entrepreneur, Partner, Pegasus Capital Advisors LP https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464892612050-286ZSWVHMXKIN6TCO584/Headshot_MartyTenenbaum.jpg San Diego 2016 Featured Speakers - Marty Tenenbaum, PhD CEO, Cancer Commons https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464892599254-4T0A4BJDRVMO1U9I53J0/Headshot_BarryDidato.jpg San Diego 2016 Featured Speakers - Barry Didato Chief Investment Officer, The Innovation Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464892603952-OVEL9AG42UV57AQJLOPN/Headshot_HarryGruber.jpg San Diego 2016 Featured Speakers - Harry Gruber, MD CEO, Tocagen, Inc. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464893387279-Y52LBS457KZ5CBEQQNS5/DA_2-e1443195723918.jpg San Diego 2016 Featured Speakers - D.A. Wallach Recording Artist; Songwriter; Essayist; Investor in Health and Biotechnology https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464892616957-KX8NSLS7DEUZXN4RKJ6X/Headshot_SaralynMark.png San Diego 2016 Featured Speakers - Saralyn Mark, MD President, SolaMed Solutions https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464892605777-IDQZSVPD5HCCMU75ZB03/Headshot_LarrySmarr.jpg San Diego 2016 Featured Speakers - Larry Smarr, PhD UCSD; Calit2 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464892603689-6M784EEMIZWYX2QGILVO/Headshot_ADWallach.png San Diego 2016 Featured Speakers https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464893679974-WFA9LC0GNAV24I7M6HWK/Headshot_MalinBurnham.jpg San Diego 2016 Featured Speakers - Malin Burnham Chair of the Sanford Consortium for Regenerative Medicine https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464892638329-QNLWHM2AZYNEWJAK7WPU/Headshot_JamieLynnSiegler.jpg San Diego 2016 Featured Speakers - Jamie-Lynn Sigler Actress, Singer, Writer https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1464892615361-QTQJSH77YA5C7A5ZR90P/Headshot_RobinSmith.jpg San Diego 2016 Featured Speakers - Robin Smith, MD, MBA Chairman and President, Stem For Life Foundation https://cavendishglobal.com/phoenix-2016-featured-speakers daily 0.75 2016-09-01 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1471273823051-11FPFB8F4067XVE0XRZ8/fishburne_015_b_0.jpg Phoenix 2016 Featured Speakers - Lindy Fishburne SVP Investments, Theil Foundation & Breakout Labs; Managing Partner, Breakout Ventures https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1471273823051-11FPFB8F4067XVE0XRZ8/fishburne_015_b_0.jpg Phoenix 2016 Featured Speakers - Lindy Fishburne SVP Investments, Theil Foundation & Breakout Labs; Managing Partner, Breakout Ventures https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466611072599-GBS48G71HTYM6KJHWZ8U/Jack_Jewett.png Phoenix 2016 Featured Speakers - Jack Jewett President & CEO, Flinn Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466611212591-W0GZ6BAZ771KLL7NNFR3/Richard_Mallery.png Phoenix 2016 Featured Speakers - Richard Mallery, Esq. Founding Chairman and CEO International Genomics Consortium https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1470773755363-LSFXMRFRF3O15ERQIB6Z/Mara-Aspinall.jpg Phoenix 2016 Featured Speakers - Mara Aspinall President and CEO of HealthCatalysts and Executive Chairman of GenePeeks https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1472741482950-IATOOXAHU7RKWUYL1IO4/isaac_blech.jpg Phoenix 2016 Featured Speakers - Isaac Blech Chairman, 21st Century Investors https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466611318898-CA50QCF6RR7ZLB5YIE1I/Untitled.png Phoenix 2016 Featured Speakers - Jeffrey Trent, PhD President and Research Director Translational Genomics Research Institute (TGen)   https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466611400492-G39GVZ7VBLI0OQBT15VN/Aleksander_Sekullc.png Phoenix 2016 Featured Speakers - Aleksandar Sekulic, MD, PhD Mayo Clinic and TGen https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466611524098-KX81NO06SIKJ8QXAYMO8/Carolyn_Compton.png Phoenix 2016 Featured Speakers - Carolyn Compton, MD, PhD Chief Medical Officer National Biomarker Development Alliance (NBDA)   https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466611619191-9QNG9AZ82D5Q7HVCLTK2/Eric_Reiman.png Phoenix 2016 Featured Speakers - Eric Reiman, MD Executive Director, Banner Alzheimer’s Institute (BAI) Chief Executive Officer, Banner Research, Clinical Director of the Neurogenomics Division at the Translational Genomics Research Institute (TGen) Professor of Psychiatry, University of Arizona Director, Arizona Alzheimer’s Consortium   https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466611762415-0S8DIVWLTMH4YDQBBKXF/Lukas.png Phoenix 2016 Featured Speakers - Ronald J. Lukas, PhD Vice President of Research and Senior Staff Scientist Barrow Neurological Institute and St. Joseph's Hospital and Medical Center https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1472572343197-NVZ70RG3AVYKAE97MU0K/carol+barnes_UA.jpg Phoenix 2016 Featured Speakers - Dr. Carol Barnes Director, Evelyn F. McKnight Brain Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466611830685-KARMT8U3JP2ZTME7XDOH/Javier_Cardenas.png Phoenix 2016 Featured Speakers - Javier Cárdenas, MD Barrow Neurological Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1472572423792-A2YBLFB9H006OR0H5FVE/ceo-susan-pepin.jpg Phoenix 2016 Featured Speakers - Dr. Susan Pepin President and CEO of the Virginia G. Piper Charitable Trust https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466611901980-GXUA56FPLDZQDWRKN1GO/Robert_Bowser.png Phoenix 2016 Featured Speakers - Robert P. Bowser, PhD Director, Gregory W. Fulton ALS and Neuromuscular Research Center at the Barrow Neurological Institute Chairman, Neurobiology Professor, Neurology and Neurobiology   https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1470773394903-I9LC6R0ZC5H9A55NRI22/Matt.jpg Phoenix 2016 Featured Speakers - Matthew Huentelman, PhD Professor, Neurogenomics Division, and Co-Director, Center for Rare Childhood Disorders, TGen https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1470773428494-7XW7TQWCUPDGQJTIMGAL/Kendall+Van+Keuren-Jensen.jpg Phoenix 2016 Featured Speakers - Kendall Van Keuren-Jensen, PhD Associate Professor, Neurogenomics Division, and Co-Director, Center for Noninvasive Diagnostics, TGen https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1470773610638-VIIMVUBVUY8CJG7QXZRV/Adelson+PD.jpg Phoenix 2016 Featured Speakers - Dr. P. David Adelson Director, Barrow Neurological Institute at Phoenix Children’s Hospital Chief of Neurosurgery, and Co-Director, Concussion/Neurotrauma Program https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1472133059496-7R38BD2BRPR4TW9V73QP/Dr.+Penny+photo+2012.jpeg Phoenix 2016 Featured Speakers - Dr. Robert Penny Co-founder and Chief Medical Officer of The International Genomics Consortium (IGC)   https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1470773799387-HIG0FRWAOQRBHU6I7FNL/marie+wesselhoft.JPG Phoenix 2016 Featured Speakers - Marie Wesselhoft President and Co-Founder, MsDx https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1470773828668-3AJNUF2L24WK68HZUKBX/slater_mark_LAP_9545.jpg Phoenix 2016 Featured Speakers - Dr. Mark Slater VP Research HonorHealth and Chair of the Arizona Bioscience Roadmap Steering Committee https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1470773878124-TV0VZWCTLC8E4OJ9KUBR/Vinodh-Narayanan-TGen-MD.jpg Phoenix 2016 Featured Speakers - Dr. Vinodh Narayanan TGen - Translational Genomics Research Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466611265479-KJONOX56FLYHB219OB2H/Joan+KW.png Phoenix 2016 Featured Speakers - Joan Koerber-Walker President & CEO Arizona Bioindustry Association (AZBio) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1471273598397-VS5IDV0JFFKYXC6XXY26/Hirsch1.jpg Phoenix 2016 Featured Speakers - Hirsch Handmaker, MD Chairman and CEO The CACTIS Foundation https://cavendishglobal.com/san-diego-2017-featured-speakers daily 0.75 2017-02-05 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1486326856175-Y21L3WRO5X74ABRHBBCO/EH_JamieMetzl-1.jpeg San Diego 2017 Featured Speakers - Jamie Metzl Senior Fellow at the Atlantic Council; Syndicated Columnist; Media Commentator; and novelist https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1486326794329-0T9FFI5GVU69ZHPH3SIR/EH_JamieMetzl-1.jpeg San Diego 2017 Featured Speakers https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1486326856175-Y21L3WRO5X74ABRHBBCO/EH_JamieMetzl-1.jpeg San Diego 2017 Featured Speakers - Jamie Metzl Senior Fellow at the Atlantic Council; Syndicated Columnist; Media Commentator; and novelist https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484669784625-XYH2ALQRJL2B1ELMLR1U/SD3_GregSimon.jpeg San Diego 2017 Featured Speakers - Gregory C. Simon Executive Director, White House Cancer Moonshot Task Force https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484669805829-TPS1SVXJ46O3Q9M2UOFP/SD3_MalinBurnham.jpg San Diego 2017 Featured Speakers - Malin Burnham Philanthropist; Chairman, Sanford Consortium for Regenerative Medicine   https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484669829926-MC49HQ0TF528QDNGG66I/SD3_LarrySmarr.jpg San Diego 2017 Featured Speakers - Larry Smarr, PhD UCSD; Calit2 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484669875418-4ZKYR4E4U32FVMDK71EK/SD3_RobinSmith.jpg San Diego 2017 Featured Speakers - Robin Smith, MD, MBA Chairman and President, Stem For Life Foundation   https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484669926313-LQWLWW43V1F1YVIM1S4Q/SD3_RobKnight.jpg San Diego 2017 Featured Speakers - Rob Knight, PhD UCSD, Principle Investigator, Knight Lab; Co-Founder, American Gut Project https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484669951508-JA5B2HXE60WFXK0AARPS/SD3_SalGonzalez.jpg San Diego 2017 Featured Speakers - Sal Gonzalez Wounded Warrior Project; Purple Heart Recipient; Singer and Songwriter; and Semi-Finalist, America’s Got Talent     https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484669983798-X5FQGZGDI91B0LDS73JZ/SD3_SteveWestly.jpg San Diego 2017 Featured Speakers - Steve Westly Founder and Managing Partner, Westly Group; Impact Investor https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484670011674-2Y1WVQJ0B5J2V44GDOIL/SD3_WendyTaylor.jpg San Diego 2017 Featured Speakers - Wendy Taylor Director, Center for Accelerating Innovation and Impact, USAID https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484670038208-41XB9RMB34PW2GZFFEG8/SD3_SherryCagan.jpg San Diego 2017 Featured Speakers - Sherry Cagan Co-Founder and President, Stand4Lyme Foundation   https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484770886589-GZHSTHPOSUEUW8D1SBRC/JRD+Pic+%281%29.jpg San Diego 2017 Featured Speakers - James R. Doty, MD Founder and Director, Center for Compassion and Altruism Research and Education, Stanford University https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484842320099-TFPT4API1JGVNB8QW60L/guptonweb.jpg San Diego 2017 Featured Speakers - B. Frank Gupton, PhD Virginia Commonwealth University, Chemistry, and Chemical and Life Science Engineering https://cavendishglobal.com/san-diego-2017-slideshow daily 0.75 2017-02-15 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678415367-C2AWBM5FABM64U28TF20/entrance.jpeg San Diego 2017 Slideshow - Fairmont Grand Del Mar, Main Entrance https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678415367-C2AWBM5FABM64U28TF20/entrance.jpeg San Diego 2017 Slideshow - Fairmont Grand Del Mar, Main Entrance https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678437555-F9WME4PW9FZISF5HF46F/479139_high.jpg San Diego 2017 Slideshow - Aria Lawn at the Fairmont Grand Del Mar https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484755665651-OA2QUZSFHEYMIWMWW15A/1380228209GCS_7739.JPG San Diego 2017 Slideshow - <i>USS Midway</i> On Monday night, Cavendish hosted cocktails, dinner and entertainment aboard the famed ship in the beautiful San Diego Bay https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678458404-XZIAL5VYIWXUVGRGNCTB/479257_high.jpg San Diego 2017 Slideshow - Manchester Salon https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678489905-SNYUKS0ZSYIC1L2NZFFS/479264_high.jpg San Diego 2017 Slideshow - The ultimate venue for Innovation Partner presentations https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678466314-0R6HZRSKGLV9T4HUD9TK/479259_high.jpg San Diego 2017 Slideshow - Forum attendees gathered for special cocktail receptions at the end of the day https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678480447-OXZ9NGKZ6NMND8T5UR6F/479042_high.jpg San Diego 2017 Slideshow - Fairmont Grand Del Mar https://cavendishglobal.com/san-diego-ip-videos daily 0.75 2017-04-06 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488226422073-IHJQ1LCMAHWOD6WJK4BE/image-asset.jpeg SD3 IP Videos - Agile Sciences - Malcolm Thomas https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488226422073-IHJQ1LCMAHWOD6WJK4BE/image-asset.jpeg SD3 IP Videos - Agile Sciences - Malcolm Thomas https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488227500724-PQFOD70DSGKS8PQU7M4K/image-asset.jpeg SD3 IP Videos - Akashi Therapeutics - Marc Blaustein https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488225753021-XYHS3EN2EZNUVYYDR3IE/image-asset.jpeg SD3 IP Videos - Agile Sciences - Malcolm Thomas https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228664223-U3I7RXXM3FBL6E3154A3/image-asset.jpeg SD3 IP Videos - Autotelic - Falguni Trieu https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1491516842604-J0IG366UTVBXZJZY9WVY/image-asset.jpeg SD3 IP Videos - BlackBox Biometrics - David Borkholder https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488227603354-210JBWRVY7Q0NZ3VKUFW/image-asset.jpeg SD3 IP Videos - Centrexion Therapeutics - Jeffrey Kindler https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488230164358-9IXLZXKFLWMNFL7OZWUN/image-asset.jpeg SD3 IP Videos - CK Sciences - Tracy Ryan https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488294199290-XHF0HACFK0AZDLX42YH5/image-asset.jpeg SD3 IP Videos - DigiSight - Doug Foster https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488378895574-PVRMMK22KM1O59M7HFLF/image-asset.jpeg SD3 IP Videos - DiscGenics - Robert Wynalek https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228058325-BAAD284SQCIBPLCF9V22/image-asset.jpeg SD3 IP Videos - Dthera Sciences - Edward Cox https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228144195-BJY3CDS57ZLCJT1YCP4X/image-asset.jpeg SD3 IP Videos - Gamida Cell - Einet Galamidi https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488402940108-YI8DU7ZK4DMW953OFF5Z/image-asset.jpeg SD3 IP Videos - HaemaLogiX - Bryce Carmine https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488227859421-DDFXYDQHBEMOLBIWD2V0/image-asset.jpeg SD3 IP Videos - i2 Pharmaceuticals - Bruce Eaton https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488230121677-SJNOGAOSULOKJEHY1GXB/image-asset.jpeg SD3 IP Videos - Infiniti-Blue, Inc. - Rocky Nordquist https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488379049892-D108TGIK7F71TFXUZJ4W/image-asset.jpeg SD3 IP Videos - Leading BioSciences - Thomas Hallam https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488227724266-78S5WQAID2XDSOS2GMJP/image-asset.jpeg SD3 IP Videos - Mesa Biotech - Hong Cai https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488227952918-KT1PYUZT4IBI39L54SG2/image-asset.jpeg SD3 IP Videos - Methylation Sciences - Dave MacDonald https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/58b485a66b8f5bc3d7086992/58b488765a730f7d941b0b4a/1488226414724/ SD3 IP Videos - Agile Sciences - Malcolm Thomas https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488227779247-PIZ99CTM0ULSS1ZZMQS6/image-asset.jpeg SD3 IP Videos - MitoGenetics - Marcia Hendrickson https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228117092-HJRUB5J4LHQ4WAMLYL05/image-asset.jpeg SD3 IP Videos - Numerate - Guido Lanza https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228406489-WFKPXPWZQJ48AYY355Y6/image-asset.jpeg SD3 IP Videos - OneOme - Troy Kopischke https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488379159409-3VE7VSOWYF0FAWVCGWB6/image-asset.jpeg SD3 IP Videos - Oryzon Genomics - Carlos Buesa https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228228912-B0RY4NDQXUZA8LCFVK4R/image-asset.jpeg SD3 IP Videos - Prevencio - Rhonda Rhyne https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228174676-K65E39PLM4Q7V8LQ1ORV/image-asset.jpeg SD3 IP Videos - ProLung - Steven Eror https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228449528-AZOPHY4DX8N1IYK4GPQD/image-asset.jpeg SD3 IP Videos - QurAlis - Kasper Roet https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228465832-55X3WJ0O32LXJ8SJGBXL/image-asset.jpeg SD3 IP Videos - Safe H20 - Dan Morrow https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/58b485a66b8f5bc3d7086992/58b485d891b186b8c7d814cb/1488225725078/ SD3 IP Videos https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228356123-8AGTY9IKDPK7ETDSGAAW/image-asset.jpeg SD3 IP Videos - Spark - Nancy Anne Federspiel https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228303844-2P5PXN1IBRF8MZDFPT1R/image-asset.jpeg SD3 IP Videos - Turner Imaging Systems - Clark Turner https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228016489-XKP9DGX66BA2PUGOD9V9/image-asset.jpeg SD3 IP Videos - Valley Fever Solutions, Inc. - David Larwood https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488294417382-O772754L8AS1XCCWKISI/image-asset.jpeg SD3 IP Videos - WiseWear - Jerry Wilmink https://cavendishglobal.com/sd3-panels-and-keynotes daily 0.75 2017-03-01 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228924259-YJPAXQZF4CCIYJYSQCGF/image-asset.jpeg SD3 Panels and Keynotes Videos - Deborah Szekely - 6 Years on the Front Line of the Health and Wellness Revolution https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488228924259-YJPAXQZF4CCIYJYSQCGF/image-asset.jpeg SD3 Panels and Keynotes Videos - Deborah Szekely - 6 Years on the Front Line of the Health and Wellness Revolution https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488230491029-M4G3S5D2WAGYX0EXYLJH/image-asset.jpeg SD3 Panels and Keynotes Videos - Gregory Simon - The White House Cancer Moonshot: The Accomplishments and Challenges that lie Ahead https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/58b48a9c5016e17f471c4e0a/58b4922b9c03e0155df44bb7/1488228901461/ SD3 Panels and Keynotes Videos https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488229130932-8NBV8QM7NFYWJ27O3UGI/image-asset.jpeg SD3 Panels and Keynotes Videos - Lyme Disease: The Challenges in Diagnosis and Treatment of a Devastating Illness https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/58b48a9c5016e17f471c4e0a/58b4923c05b037165f2d7009/1488228907982/ SD3 Panels and Keynotes Videos https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488229554598-X8ZZAXULTPIQ7FFCPAWM/image-asset.jpeg SD3 Panels and Keynotes Videos - Jamie Metzl - Homo Sapiens 2.0: Genetic Enhancement and the Future of Humanity https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488292178809-M3DJBDCDQYQT331XX334/image-asset.jpeg SD3 Panels and Keynotes Videos - Steve Westly - Impact Investing: Investing in Companies that Change the World https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488229639624-5HE115CG3G7X4R164FI2/image-asset.jpeg SD3 Panels and Keynotes Videos - New Technology Trends in Behavioral Health https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488292208165-HRNPIHODWMEX25064YQG/image-asset.jpeg SD3 Panels and Keynotes Videos - Frank Gupton - Reinventing Pharmaceutical Manufacturing: The Medicines for All Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488300843131-L299885JYUGJ5L35BVQD/image-asset.jpeg SD3 Panels and Keynotes Videos - James Doty - A Neuroscientist's View of Compassion, Altruism and Happiness https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488325437806-8O9F1NP6OAP1S3FP1Q0G/image-asset.jpeg SD3 Panels and Keynotes Videos - Brad Perkins - The Science of Aging: Extending the Healthy Human Lifespan https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488379326635-0YMU839L59XXGK79CPGH/image-asset.jpeg SD3 Panels and Keynotes Videos - A Market-Based Approach for Curing the World's Ills https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488379455272-9B5EC5494TST0CPNB2UH/image-asset.jpeg SD3 Panels and Keynotes Videos - Women in Biotech: Building Companies and Careers https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488379570621-GDOQI6PYP6ZRJ6BQR4AT/image-asset.jpeg SD3 Panels and Keynotes Videos - The Microbiome and its Effects on Health and Disease https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488379792349-DQZVKHLGKYFZJSRDGNPD/image-asset.jpeg SD3 Panels and Keynotes Videos - UC San Diego Office of Innovation and Commercialization https://cavendishglobal.com/sd3-cav-advisors daily 0.75 2017-03-01 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488380395609-U0N9BW0Z0ZLJKBF1KBNP/image-asset.jpeg SD3 Cav Advisors - Clinical trials and tribulations https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/58b6e1d61b631b8f01161d17/58b6e1eb365ffa1f2a103971/1488380395233/ SD3 Cav Advisors https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488380395609-U0N9BW0Z0ZLJKBF1KBNP/image-asset.jpeg SD3 Cav Advisors - Clinical trials and tribulations https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488380609721-RHF47RIPU1J1RHWQ58QS/image-asset.jpeg SD3 Cav Advisors - The regulated environment; the right and wrong ways https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488380798695-QWB2355ADZ46RUNV0EPE/image-asset.jpeg SD3 Cav Advisors - Intellectual property https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1488397055094-7CBQJ4RCN9UJZ3WIWRVM/image-asset.jpeg SD3 Cav Advisors - What is your product, who will buy it and for how much? https://cavendishglobal.com/new-gallery daily 0.75 2017-03-23 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490219930244-03CVQ2WQYBECXD6OULZQ/IMG_3269-2.jpg DC 2017 Photos - Forum attendees will stay at the historic Willard InterContinental https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490219930244-03CVQ2WQYBECXD6OULZQ/IMG_3269-2.jpg DC 2017 Photos - Forum attendees will stay at the historic Willard InterContinental https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490219905696-CZ1WAX624Y1GM6CO5QS0/Meeting_Room_Willard.jpg DC 2017 Photos - Rehearsals and Cavendish Advisors will be hosted at the Willard InterContinental https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490219911773-R1NMQTIL43NZ879AT30N/Round+Robin+Bar_1.jpg DC 2017 Photos - Round Robin Bar at the Willard InterContinental — it is said the term "lobbying" was first coined here https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490219935692-DYUYN96EC7WQ7T4QRP8T/Rounds4.jpg DC 2017 Photos - The Forum will convene at the Ronald Reagan Building for presentations, keynotes, panels and more https://cavendishglobal.com/dc-featured-speakers daily 0.75 2017-05-08 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1493675759196-P2ZHUN7J5PS33SYCO7CS/Governor-McAuliffe.jpg DC Featured Speakers - Governor Terry McAuliffe 72nd Governor of Virginia https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1493675759196-P2ZHUN7J5PS33SYCO7CS/Governor-McAuliffe.jpg DC Featured Speakers - Governor Terry McAuliffe 72nd Governor of Virginia https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1491920428965-9R5U7MC03Q183LJ9QOJH/AlexandraGivens2.jpeg DC Featured Speakers - Alexandra Reeve Givens Board of Directors, Christopher and Dana Reeve Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490894970015-EH52K2CUMPYQUFTTT7G2/James_Rosebush_031417.jpg DC Featured Speakers - The Honorable James Rosebush CEO, Growth Strategy, Inc.; Reagan White House Official; Best Selling Author https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490975827139-09ZBUW165XSBGVBVBUMR/RS.jpg DC Featured Speakers - Richard P. Shannon, MD Executive Vice President, Health Affairs, University of Virginia https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1492110701486-GQQ2D4TMM8TPBXFMJVK9/Summar%2C+Marshall1.jpg DC Featured Speakers - Marshall L. Summar, MD Director, Rare Disease Institute, Children's National Medical Center https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490901208130-VUBX95A2XV4LFD247BAH/Tom_Miller.png DC Featured Speakers - Tom Miller Founder and Managing Partner, GreyBird Ventures https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1492631503432-NQ9PUPOLLSIHKHEC5XEO/Closing-Bell-819x1024-1.jpg DC Featured Speakers - Barbara Newhouse President and CEO, The ALS Association https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1493307468596-P922AR9RILZAT5124QXU/Jennifer+Lee.jpg DC Featured Speakers - Jennifer Lee, MD Deputy Undersecretary for Health for Policy and Services, U.S. Veterans Administration https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490975058544-AWLQKG3QLCZPRX83D0RS/cache.096961.D._Tyler_McQuade.jpg DC Featured Speakers - D. Tyler McQuade, PhD Deputy Director, Defense Sciences Office, DARPA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1493308345403-NNHY2HCNCYT0WRAWAKSV/RachelRamoni.jpg DC Featured Speakers - Rachel B. Ramoni, DMD, ScD Chief Research and Development Officer, Veterans Health Administration https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490975792438-036KS49QJES1WEFXBKCW/Gallagher+Portrait+2015.JPG DC Featured Speakers - Jeff Gallagher CEO, Virginia Biotechnology Association (VirginiaBio) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490988836102-AR2SAPPOBBKE9LFXCGII/Laura_Thrall.jpg DC Featured Speakers - Laura S. Thrall President and CEO, CureSearch https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1492704694238-49J3IWCU5CABO3NW7ZID/Barb.jpeg DC Featured Speakers - Barbara Newhouse President and CEO, The ALS Association https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1491414461486-7BH01RU63QZNWGARAIYN/Mike_Friedlander_2.jpg.200x0_q90_crop-scale.jpg DC Featured Speakers - Michael J. Friedlander, PhD Vice President for Health Sciences and Technology, Virginia Tech; Executive Director of the Virginia Tech Carilion Research Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1491939015075-QP6GA7MN2TV911Q01TDG/peter+samuelson+oscar+headshot+2012.jpeg DC Featured Speakers - Peter Samuelson President and Co-Founder, First Star https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1491414444964-31W78JANNOE89JIS35XO/Moeller.jpg DC Featured Speakers - F. Gerard Moeller, MD Director, C. Kenneth and Dianne Wright Center for Clinical and Translational Research; Associate Vice President for Clinical Research and Director, Institute for Drug and Alcohol Studies, Virginia Commonwealth University https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1491414127848-28LVE80F8K12PF943IRR/unspecified.png DC Featured Speakers - Mike Grisham President and CEO, Virginia Biosciences Health Research Corporation ("The Catalyst") https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1491414548265-O3DEDS1PUYP7SYA1HS0V/Warren_Bickel_Fhpb6Pv.JPG.200x0_q90_crop-scale.jpg DC Featured Speakers - Warren K. Bickel, PhD Director, Addiction Recovery Research Center, Virginia Tech https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1494168931887-7TEGIKG2EJPXCP5Z1O6X/ken-headshot-269x402.jpg DC Featured Speakers - Ken Schaner Schaner & Lubitz, PLLC https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1492704670712-ZHP6GJX78ZPN7I5PLOYW/Barb.jpeg DC Featured Speakers - Barbara Newhouse President and CEO, The ALS Association https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1494249394000-BKPR6B02KBGGWBK9UOBT/Pasternack-Gary-Headshot-April+17.jpg DC Featured Speakers - Gary R. Pasternack, MD, PhD CEO, Asklepion Pharmaceuticals https://cavendishglobal.com/washington-dc-videos1 daily 0.75 2017-07-25 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497623525757-O88WEVBYAW0K9DNBSAKH/image-asset.jpeg Washington DC Videos - ADial Pharmaceuticals - William Stilley https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497623525757-O88WEVBYAW0K9DNBSAKH/image-asset.jpeg Washington DC Videos - ADial Pharmaceuticals - William Stilley https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/594198c2cd0f685f04006690/594198fdc534a5ae2869405a/1497471229974/ Washington DC Videos https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471255174-TWENYOMKSXJ5TD31L8V6/image-asset.jpeg Washington DC Videos - Aperiomics - Crystal Icenhour https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471288830-GYIPLNZY3AAMB9L0PDX0/image-asset.jpeg Washington DC Videos - AptomiR - Marc Thibonnier https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471320235-KPODDPE8KIOFX7DAGQAP/image-asset.jpeg Washington DC Videos - Arcturus - Joe Payne https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497966242266-HMDEAG1CGMA1G940S5AA/image-asset.jpeg Washington DC Videos - BioAegis - Susan Levinson https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471704525-PH0O78W0L2IUL1GEQZY4/image-asset.jpeg Washington DC Videos - Cellphire - Thomas Dann https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471545090-ZTGJIDLJW8DO7UKS4LON/image-asset.jpeg Washington DC Videos - Chronic Care Advocates - Nicholas Garofolo & Stuart Williams https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471369021-VC78HWN5S2JI3SJBDEND/image-asset.jpeg Washington DC Videos - CK Sciences - Tracy Ryan https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471386007-MVKZI8WP7BETIXJ0U6T4/image-asset.jpeg Washington DC Videos - DiscGenics - Flagg Flanagan https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471645440-MMFPGGZ2DX8488JHMIBB/image-asset.jpeg Washington DC Videos - Embody - Jeff Conroy https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497472530743-CASL9THBJX5I91ZDU6IO/Epibiome.01_00_51_29.Still001.jpg Washington DC Videos - EpiBiome - Nick Conley https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471402082-VB6196X4YAL03HZCAD0J/image-asset.jpeg Washington DC Videos - Exactus - Philip Young https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1498762277606-ITYJUN1D78NTFBQ12BR9/image-asset.jpeg Washington DC Videos - Gobiquity - Andrew Burns https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497623732120-BNLJ8TYGP4L016PX1NR1/image-asset.jpeg Washington DC Videos - Melinta Therapeutics - Eugene Sun https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471419971-8EIU8QTEM882AOGGKE6Q/image-asset.jpeg Washington DC Videos - OncoCyte - William Annett https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471581406-VUPDKY495I55W6IGZJTV/image-asset.jpeg Washington DC Videos - ProLung - Steven Eror https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471601055-1U7A0IWX30EAFC51F9UK/image-asset.jpeg Washington DC Videos - QurAlis - Kasper Roet https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471617472-IXFSTHJH7QZAF7F4MZZH/image-asset.jpeg Washington DC Videos - RXi Pharmaceuticals - Alexey Eliseev https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497472556319-UCFQHYWG7UFW910AXH28/SageMedic.00_01_25_29.Still001.jpg Washington DC Videos - SageMedic - Chris Apfel https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471471802-SC7U0EKWHB4JSA05FIZS/image-asset.jpeg Washington DC Videos - TearSolutions - Tom Gadek https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497472503126-RLXGES01DZLC59ZLFDEW/valleyfever.jpg Washington DC Videos - Valley Fever Solutions - David Larwood https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497471720106-CDHZSS0HWDHOSB0UNOIG/image-asset.jpeg Washington DC Videos - VoltMed - Chris Arena https://cavendishglobal.com/new-gallery-1 daily 0.75 2017-12-08 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1512670703153-HF65WG198SN2G1AKBWTD/bulb_hp.jpg Member Icons - Innovators Curated early and development-stage innovators and entrepreneurs launching conspicuous concepts and innovations addressing critical areas of unmet need. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1512670703153-HF65WG198SN2G1AKBWTD/bulb_hp.jpg Member Icons - Innovators Curated early and development-stage innovators and entrepreneurs launching conspicuous concepts and innovations addressing critical areas of unmet need. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1512673958898-32E0RL01LU3FFERE8XB6/bank_hp.jpg Member Icons - Impact Investors Pre-qualified, active investors with a demonstrated interest in advancing impactful innovations; comprising of single and multi-family offices, foundations, private equity, venture capital, angel investors, and independent philanthropists. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1512674641527-2569GDYIRER2SYK6GW2E/lightning_hp.jpg Member Icons - Strategic Partners Individuals, organizations, and institutions that catalyze and inspire our community's shared goal of amplifying the most impactful innovations. Many of our strategic partners participate as speakers. https://cavendishglobal.com/san-diego-2018-speakers daily 0.75 2018-04-19 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1516399923991-285X451J3GSPLPFMYACS/MV-Headshot_300_300_70_c1.jpg San Diego 2018 Speakers - Maurizio Vecchione Maurizio Vecchione Executive Vice President, Global Good & Research, Intellectual Ventures Managing Partner, Global Good Fund, a collaboration by Bill Gates and Intellectual Ventures https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1516399923991-285X451J3GSPLPFMYACS/MV-Headshot_300_300_70_c1.jpg San Diego 2018 Speakers - Maurizio Vecchione Maurizio Vecchione Executive Vice President, Global Good & Research, Intellectual Ventures Managing Partner, Global Good Fund, a collaboration by Bill Gates and Intellectual Ventures https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1514561973928-SSUUP3YVLWVZL5FGK9SI/SSB+headshot+large.jpg San Diego 2018 Speakers - Sheri Sobrato Brisson Sheri Sobrato Brisson Trustee, The Sobrato Organization, and Sobrato Philanthropies Founder, The Digging Deep Project https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519505935170-4SQBLIRHSBVB5N6KWN1B/malin.jpg San Diego 2018 Speakers - Malin Burnham Malin Burnham Former Vice Chairman, Cushman & Wakefield https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1514561844382-ZG8C3GJ65VI1UPGRA9YW/Ed+Holmes+2.jpg San Diego 2018 Speakers - Ed Holmes Edward W. Holmes, MD President and CEO Sanford Consortium for Regenerative Medicine https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1513096855202-7FLLMTCKST6TXVI5IT6C/rosemarie_truman.jpg San Diego 2018 Speakers - Rosemarie Truman Rosemarie Truman Founder, CEO, and Board Member, The Center for Advancing Innovation Founder, Gazelle Futures https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1516399976664-YNT0M4PAO0P6ZKBZ1TPK/gupton-photo.jpg San Diego 2018 Speakers - B. Frank Gupton B. Frank Gupton, PhD Chair, Department of Chemical and Life Science Engineering, Virginia Commonwealth University Medicines for All Project (M4ALL) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1517424458078-T5LOY28O2KF61QIF4CVG/img-team-alex.png San Diego 2018 Speakers - Alex Kopelyan Alex Kopelyan Program Director and Partner IndieBio (backed by SOSV) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1515092671689-43D5YUD8VW7E0NCLNGYX/TimHeadshot+%281%29.jpg San Diego 2018 Speakers - Tim Freundlich Tim Freundlich CEO ImpactAssets https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1513096803268-R50TO65CUT7ZLB66LTNY/rosemarie_truman.jpg San Diego 2018 Speakers https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1515100957465-VGVD6L1JT5A6XDP04JIQ/7319637.jpg San Diego 2018 Speakers - Greg Mech Greg Mech Managing Director The CAPROCK Group https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1516400471963-ZURMKJDSW6F6PZ36E3VB/25653a5.jpg San Diego 2018 Speakers - David A. Levitt David A. Levitt Principal Adler & Colvin https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1513097195555-T4RVIYY2HMQEF7PMIO83/alan-bell-1240x550.jpg San Diego 2018 Speakers - Alan Bell Alan Bell Advocate and Public Health Warrior Author of Amazon #1 Bestseller, Poisoned https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1516656722018-4KU2FAARX2F3WTAGEP0Z/mayhem-atw-090116-1-12.jpg San Diego 2018 Speakers - Michael Fitzpatrick Michael Fitzpatrick Founder and Executive Director, Millenia Music; Music Director, Muhammad Ali Humanitarian Awards; and Founder, Chairman and Artistic Director, Earth's Call https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1513096802727-FEQ8HGNNYUB816Y296L4/alan-bell-1240x550.jpg San Diego 2018 Speakers https://cavendishglobal.com/logo-gallery daily 0.75 2017-12-13 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1513184258944-MUO7LF1YUAYMQV26344U/Cavendish_inline_CMYK_dark.jpg Logo Gallery - Cavendish Global Text here. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1513184258944-MUO7LF1YUAYMQV26344U/Cavendish_inline_CMYK_dark.jpg Logo Gallery - Cavendish Global Text here. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1513184261617-H2WKTAKLZX5MJT0EH7EN/CIF_Logo.png Logo Gallery - Cavendish Impact Foundation Text here. https://cavendishglobal.com/boca-grande-2018-speakers daily 0.75 2018-04-09 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1520447796849-AVBQC8F2D3FPNXMNI28A/GregSimon_Fortune.png Boca Grande 2018 Speakers - Greg Simon Gregory C. Simon President, Biden Cancer Initiative Former Executive Director, White House Cancer Moonshot Task Force (created by President Barack Obama) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1520447796849-AVBQC8F2D3FPNXMNI28A/GregSimon_Fortune.png Boca Grande 2018 Speakers - Greg Simon Gregory C. Simon President, Biden Cancer Initiative Former Executive Director, White House Cancer Moonshot Task Force (created by President Barack Obama) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519242069318-KVMIRITFBIDAIAU42TX2/KennedyApproved1.jpg Boca Grande 2018 Speakers - Brian Kennedy Brian Kennedy, PhD Professor and Researcher; Former President and CEO, Buck Institute for Research on Aging https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519242022759-V1K8QMCQUMMH2NQM0BNX/KennedyApproved1.jpg Boca Grande 2018 Speakers https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519242079138-LE2H5FHRNF0H5CGYX5EU/fiona-crawford.jpg Boca Grande 2018 Speakers - Fiona Crawford Fiona Crawford, PhD President and CEO, The Roskamp Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519242089743-QWC7DU9THXA57BRTB1CG/brian_pollok.400x400.jpg Boca Grande 2018 Speakers - Brian Pollok Brian A. Pollok, PhD Founder, President and CEO, Propagenix https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1522685839462-A0RVGCUMQ3WABASNY3VN/Jeff+Galvin+Portrait+Photo.jpg Boca Grande 2018 Speakers - Jeffrey Galvin Jeffrey A. Galvin Co-Founder and CEO, American Gene Technologies (AGT) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519242046772-E0Z5207KPIFMTDO9KSTW/photo.jpg Boca Grande 2018 Speakers - Mike Mullan Michael Mullan, MD, PhD CEO, Archer Pharmaceuticals https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1520447900287-GWAFJ7PJDHTHTG71LE1O/FAM2l4Dg_400x400.jpg Boca Grande 2018 Speakers - Tony Quinones Tony Quinones Founder, Bright Path Pharmaceuticals https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1520447999391-MTAVA7PJCB8U5K5BLYVM/gupton-photo.jpg Boca Grande 2018 Speakers - Frank Gupton B. Frank Gupton, PhD Chair, Department of Chemical and Life Science Engineering, Virginia Commonwealth University Director, Medicines for All Project (a joint initiative with the Bill and Melinda Gates Foundation) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519242039882-62T2O3C7DWBDATXKM8ZJ/341651b.jpg Boca Grande 2018 Speakers - Sally Boulter Sally Boulter Senior Engagement Officer, ImpactAssets https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1520448198910-KL6UF5MZN6ND81UZGEFN/Headshot+Thomas+Forest+Farb+Thrive+Bio+July+2017.jpg Boca Grande 2018 Speakers - Thomas Forest Farb Thomas Forest Farb Founder and CEO, Thrive Bioscience https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1520448153079-45GZIEM0OKR24KGMF1H1/07a5bb6.jpg Boca Grande 2018 Speakers - Randy Hubbell Randy Hubbell CEO, Carmell Therapeutics https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1520972850790-5GXLBEW76F4GU149ZOAV/Screenshot+2018-03-13+16.26.28_preview.png Boca Grande 2018 Speakers - Elena Medo Elena Medo CEO, Medolac Laboratories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1520972863025-EE7T6N4H6PKUTJ1ZXR5P/60bc304b-72b8-4b21-8a9d-43c05ffe6328.jpg Boca Grande 2018 Speakers - Tracy Milner Tracy Milner Founder and CEO, BrainFx https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519242052352-3UWNVPBZ7S34WCJZQ4MH/1511142805570.jpeg Boca Grande 2018 Speakers - Peter McCrea Peter McCrea President and Director, Cavendish Impact Foundation https://cavendishglobal.com/home daily 1.0 2023-12-06 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1521128869876-XLE3MMQD06US8OV66ZOX/cg_connectivity_2.jpg Home https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1521128829907-SM15EIO8F6N1B93HGW0D/cg_search2.jpg Home https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1521128849551-IVM2AOIBEO8MUII6IMU5/cg_forum2.jpg Home https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1521128738339-B1Y45PW70MU406C27ZIA/c_lightning2.jpg Home https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1521128638537-64RQVHVRPRT0URFFFBC9/c_bank2.jpg Home https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1521128506955-6SUICT3Y9SJIEZBP277I/c_bulb2.jpg Home https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519499763024-VE0Z3B92F3KYQ4RV4JAE/iq_small.jpg Home https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519485588904-HKEGMBA0EOE5K4UQSTJM/20140505_4806.jpg Home https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519486431160-EZYL4P6WVFQTBD76XK8E/cg_members.JPG Home https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519490310650-30H6VLVLRQVGWNK3DXS4/8J5A6296+%282%29.JPG Home https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519485827293-L9WDD66QZ0SL4KR4JQSL/8J5A6515.JPG Home https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519493076914-DBWG1WQ3OH0NYH0S8ZJ0/8J5A5054.JPG Home https://cavendishglobal.com/ch2-schedule-day-1 daily 0.75 2018-06-18 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529334677660-6TT016Z167EE8KKJ3K1N/CH18_Web_Cocktail.jpg CH2 Schedule - Day 1 - Opening Night Cocktail Reception 6:00 PM - 8:00 PM | Shirley Ryan AbilityLab 10th Floor Foyer and the Searle Gathering Garden The opening reception is a member favorite. Join new and returning members for an evening of uninterrupted networking and meeting at the Shirley Ryan AbilityLab. Additionally, the AbilityLab will be providing exclusive tours for attendees, visiting the facility wet labs and research space, highlighting the facility's newest capabilities and work. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529334677660-6TT016Z167EE8KKJ3K1N/CH18_Web_Cocktail.jpg CH2 Schedule - Day 1 - Opening Night Cocktail Reception 6:00 PM - 8:00 PM | Shirley Ryan AbilityLab 10th Floor Foyer and the Searle Gathering Garden The opening reception is a member favorite. Join new and returning members for an evening of uninterrupted networking and meeting at the Shirley Ryan AbilityLab. Additionally, the AbilityLab will be providing exclusive tours for attendees, visiting the facility wet labs and research space, highlighting the facility's newest capabilities and work. https://cavendishglobal.com/ch2-schedule-day-2 daily 0.75 2018-07-10 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529336931145-E949FGYH8SSD23RKNKXY/CG_Web_CH18_4.jpg CH2 Schedule - Day 2 - Continental Breakfast and Registration 7:30 AM - 8:10 AM | Sky Lobby and Foyer on the 10th Floor Registered attendees may stop by the registration desk to collect Forum materials, consult with our Digital Services team on the use of Cavendish IQ for setting partnering meetings, sending messages, profile building, and to grab breakfast, ahead of opening remarks. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529336931145-E949FGYH8SSD23RKNKXY/CG_Web_CH18_4.jpg CH2 Schedule - Day 2 - Continental Breakfast and Registration 7:30 AM - 8:10 AM | Sky Lobby and Foyer on the 10th Floor Registered attendees may stop by the registration desk to collect Forum materials, consult with our Digital Services team on the use of Cavendish IQ for setting partnering meetings, sending messages, profile building, and to grab breakfast, ahead of opening remarks. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529337714074-4KBR7ULKAL2ES00JXEXY/CH18_Web_Placeholder.jpg CH2 Schedule - Day 2 - Welcome from Cavendish 8:10 AM - 8:15 AM | J. Michael Moffat, Chairman, Cavendish Global Cavendish Chairman, Michael Moffat, will open the general session of the Chicago Forum with remarks on the state of the Cavendish network, new announcements from the team and a call for collaboration and impact. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529337961153-SK6QYK8DUKT9YBXEJZLP/CG_Web_CH18_RL.jpg CH2 Schedule - Day 2 - Welcome from the Shirley Ryan AbilityLab and Opening Keynote Address 8:15 AM - 9:00 AM | Richard L. Lieber, PhD, CSO and SVP, Shirley Ryan AbilityLab Details to be announced. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529338646909-N7XLJWJ89UCGYA5IZ0M8/CG_Web_Placeholder2.jpg CH2 Schedule - Day 2 - Groundbreaking Discoveries and Innovations 9:00 AM - 10:00 AM | Cavendish Innovation Partners Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthroughs. Are you interested in presenting at the Chicago Forum? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529338678308-2VCH5O47FEVOKPAH5LY0/CG_Web_Placeholder2.jpg CH2 Schedule - Day 2 - Partnering Meetings and Coffee Break 10:00 AM - 10:45 AM | Foyer and Auditorium on the 10th Floor Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations. Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529435477845-4ZSZ498PJKEUIPHFZ2MD/CH18_Web_Blockchain3.jpg CH2 Schedule - Day 2 - Blockchain in BioHealth 10:45 AM - 11:30 PM | Moderated by Jason Cross, PhD, Agraria Technologies Jason Cross, PhD, together with PwC Director of Pharma R&D, Brian Slizgi; Bright Path Group’s Chief Technology Officer, David Stefanich, will discuss the latest trends around the application of blockchain technology in biohealth, including opportunities and challenges for early-stage companies. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529338162367-HLMKOIQ7NLUDQ78TTJ1Y/CG_Web_CH18_LGV.jpg CH2 Schedule - Day 2 - The Voice of the Patient 11:30 AM - 12:15 PM | Lili Gil Valletta, CEO & Co-Founder, CIEN+ Award-winning entrepreneur, business strategist, Hispanic market expert and media commentator, Lili Gil Valletta, will discuss the latest applications in data collection and interpretation, to understand and address the unmet needs of patients. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529336903548-50AE0W5OM0C8PWPWDP8F/CG_Web_CH18_4.jpg CH2 Schedule - Day 2 - Luncheon in the Sky Lobby 12:15 PM - 1:15 PM | Sky Lobby on the 10th Floor Break bread with fellow Cavendish members over a casual buffet lunch, surrounded by breathtaking views of Streeterville and Lake Michigan. Cavendish luncheons do not feature keynote speakers, leaving attendees uninterrupted to network, meet and dine. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529339012933-E5TNHNWIKGC7IZA704BN/CG_Web_CH18_McCreaBoulter.jpg CH2 Schedule - Day 2 - Impact Investing with Philanthropic Capital 1:15 PM - 1:45 PM | Moderated by Peter McCrea, President, Cavendish Impact Foundation In this third installment of a continuing panel series on impact investing, the Cavendish Impact Foundation's Peter McCrea joins philanthropic partner, ImpactAssets' Senior Engagement Officer, Sally Boulter, to discuss the latest strategies in impact investment using philanthropic capital, and how to approach and participate in transactions from the standpoints of donors and innovators. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1530029967975-17X0HJFLQ8DUTXO95IXY/CH18_Web_PitcairnR.jpg CH2 Schedule - Day 2 - A Family Office Perspective: Achieving Long-Term Investment Success 1:45 - 2:15 PM | Fireside Chat with H. F. “Rick” Pitcairn, CFA, Chief Investment Officer, Pitcairn Drawing on his experience as CIO of one of the leading family offices in the industry, Rick Pitcairn will discuss key components family offices adhere to when crafting investment strategies for multi-generational families: long-term discipline, asset allocation, diversification, and global market trends. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529339149821-JKQQZ7Q40X2X7J09XLP3/CG_Web_Placeholder2.jpg CH2 Schedule - Day 2 - Groundbreaking Discoveries and Innovations 2:15 PM - 3:15 PM | Cavendish Innovation Partners Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthroughs. Are you interested in presenting at the Chicago Forum? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529339158730-8YB5T6T0NZWBFGM9RUI7/CG_Web_Placeholder2.jpg CH2 Schedule - Day 2 - Partnering Meetings and Coffee Break 3:15 PM - 4:00 PM | Foyer and Sky Lobby on the 10th Floor Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations. Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1530229485215-5LJEC58G3A04CTKIPFP8/CH18_Web_SRAPanel2.jpg CH2 Schedule - Day 2 - AbilityLab Innovations Panel 4:00 - 4:45 PM | Moderated by Richard L. Lieber, PhD, CSO & SVP, Shirley Ryan AbilityLab Led by Richard L. Lieber, PhD, and featuring the AbilityLab’s Executive Director for Innovation & Research, David Zembower, PhD; Director of the Regenstein Center for Bionic Medicine, Levi Hargrove, PhD; and VP & Chief of Research Operations, Tim McKula, this panel will highlight the latest innovations emerging out of the AbilityLab and its partner institutions in the region. Panelists will discuss their own journeys in accelerating breakthroughs, while also touching upon their personal successes and challenges in fundraising. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1531247204684-R89HR7KK0VNBVQ8QQKQ0/CH18_Web_McNally.jpg CH2 Schedule - Day 2 - Fireside Chat with McNally Capital 4:45 PM - 5:15 PM | Featuring Beth Rahn, Vice President & Head of Family Capital, McNally Capital; moderated by Steven J. Thayer, JD, Partner, Handler Thayer LLP Forum programming will close with an exclusive fireside chat with McNally Capital VP and Head of Family Capital, Beth Rahn, together with Steven J. Thayer, Partner at Handler Thayer LLP, a leading Chicago law firm dedicated to rendering superior, technologically current, and innovative professional services to affluent families, family offices and privately-held companies. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529944350718-5OZGXUKMT3CV576U9BRB/CH18_Web_Fitzpatrick.jpg CH2 Schedule - Day 2 - Evening Cocktail Reception, Exclusive Performance and Tours 5:15 PM - 8:00 PM | Foyer and the Searle Gathering Garden on the 10th Floor General Session programming will close with an immediate opening of the Evening Cocktail Reception. Cavendish and Forum partners will deliver remarks, repeat the call for greater collaboration, innovation and impact, and highlight the upcoming 2018 Seattle Forum. Please be sure to join us for a special performance from Cavendish member, Michael Fitzpatrick, acclaimed musician, Founder & Chairman of Earth’s Call, Music Director for the Muhammad Ali Humanitarian Awards and recipient of The Prince Charles Award for Oustanding Musicianship. Mr. Fitzpatrick will also update our community on his latest work and efforts with Earth’s Call. Additionally, the AbilityLab will be providing exclusive tours for attendees, visiting the facility wet labs and research space, highlighting the AbilityLab's newest capabilities and work. https://cavendishglobal.com/sea1-schedule-day-1 daily 0.75 2018-09-28 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1533134223177-W4OCKPTXUSICZTGVTMPR/SEA1_Web_1_1.jpg SEA1 Schedule - Day 1 - Registration at Intellectual Ventures Laboratory 2:00 PM - 2:45 PM | Intellectual Ventures Laboratory in Bellevue, Wash. Registration will open for members at the Intellectual Ventures Laboratory in Bellevue. Meet with our Forum Services team to review the Forum schedule, speakers, and work with our Digital Services team to set up your Cavendish IQ profile, schedule one-on-one meetings and more. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1533134223177-W4OCKPTXUSICZTGVTMPR/SEA1_Web_1_1.jpg SEA1 Schedule - Day 1 - Registration at Intellectual Ventures Laboratory 2:00 PM - 2:45 PM | Intellectual Ventures Laboratory in Bellevue, Wash. Registration will open for members at the Intellectual Ventures Laboratory in Bellevue. Meet with our Forum Services team to review the Forum schedule, speakers, and work with our Digital Services team to set up your Cavendish IQ profile, schedule one-on-one meetings and more. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535467043848-71K3N9LSUX6WV7RLWWM9/SEA1_Web_1_3.jpg SEA1 Schedule - Day 1 - Opening Remarks from Cavendish Global 2:45 - 2:50 PM | J. Michael Moffat, Chairman, Cavendish Global Cavendish Global Chairman, J. Michael Moffat, will welcome the audience to the Intellectual Ventures Laboratory and the Seattle Forum. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1533134530572-3KVXS4IZYRUX50GDE3D2/SEA1_Web_1_2.jpg SEA1 Schedule - Day 1 - Welcome to Intellectual Ventures and Opening Keynote 2:50 PM - 3:30 PM | Maurizio Vecchione, Executive Vice President, Global Good and Research, Intellectual Ventures Maurizio Vecchione is executive vice president of Global Good and Research at Intellectual Ventures (IV). In this role, he oversees Global Good, IV’s collaboration with Bill Gates to invent and deploy technology specifically focused on improving life in developing countries, as well as the research and operations of the IV Laboratory and Institute for Disease Modeling. Mr. Vecchione most recently served as CEO of Arrogene, which is commercializing a new nanotechnology platform for cancer-targeted therapeutics and diagnostics, and as CEO of telemedicine pioneer CompuMed. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535467216562-2KOWNI4TPPYOOKUN1FF3/SEA1_Web_1_4_1.jpg SEA1 Schedule - Day 1 - Panel Discussion with the Washington Global Health Alliance 3:30 PM - 4:15 PM | Moderated by Dena Morris, President & CEO, Washington Global Health Alliance Dena Morris will lead a panel discussion with global health leaders from around Seattle and Washington State, on the latest initiatives, trends and discussions taking place in the nation’s leading global health hub, and the implications for key stakeholders. Panelists include: Elizabeth Aylward, PhD, Director, Office of Science-Industry Partnerships at Seattle Children’s Research Insitute Thomas S. Uldrick, MD, Deputy Program Head, Global Oncology Program, Fred Hutchinson Cancer Research Center Scott Maloney, Director of Innovation and Private Sector Research Engagement, College of Veterinary Medicine, Washington State University Rhea Coler, PhD, Senior Vice President, Infectious Disease Research Institute, University of Washington https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535468999781-0YBUSGSI872558FKFLUJ/SEA1_Web_1_4_2.jpg SEA1 Schedule - Day 1 - Keynote Address from Praveen Raja, PhD 4:15 PM - 4:45 PM | Praveen Raja, PhD, Vice President, Technology Development and Introduction, PATH Dr. Raja oversees PATH’s Medical Devices and Tools, Diagnostics, and Global Innovation Hub teams in leveraging technology to improve health outcomes for underserved communities around the world. He has extensive experience in the development and commercialization of innovative medical devices, diagnostics, pharmaceuticals, and digital health tools that have achieved clinical adoption and commercial success globally. Dr. Raja has developed and led teams focused on innovation in start-up environments as well as in multibillion-dollar global companies and franchises. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535468621150-4MD0NQVL2TYXZ3D9PY7W/SEA1_Web_1_6.jpg SEA1 Schedule - Day 1 - Special Performance and Fireside Chat with Dr. Jonathan Sackier 4:45 - 5:15 PM | Featuring renown musicians, former Incubus guitarist, Michael Einziger, together with his wife and acclaimed violinist, Ann Marie Simpson, with a fireside chat moderated by Dr. Jonathan Sackier, Chief Medical Officer and Managing Partner, Cavendish Global Ahead of the Opening Cocktail Reception, guests will be treated to an exclusive musical performance, featuring a unique discussion with Cavendish Global’s Dr. Jonathan Sackier. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1533135325931-58FJHBZ1A8UDOIJOKA45/SEA_Web_1_4.jpg SEA1 Schedule - Day 1 - Cocktails, Entertainment and Tours at the Intellectual Ventures Lab 5:15 PM - 8:00 PM | Intellectual Ventures Laboratory The opening reception is a member favorite. Join new and returning members for an evening of uninterrupted networking and meeting at the Intellectual Ventures Laboratory. The IV Laboratory will be providing members with exclusive tours of their facilities and current projects. This is a can’t-miss evening! https://cavendishglobal.com/sea1-schedule-day-2 daily 0.75 2018-11-14 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1533137378057-9D5GWSKYMY2RFVU8P7MG/SEA1_Web_2_1.jpg SEA1 Schedule - Day 2 - Registration at UW Medicine's South Lake Union Campus 7:30 AM - 8:10 AM | Location at UW Medicine to be announced! Registration will open for members at the UW Medicine South Lake Union Campus in Seattle. Meet with our Forum Services team to review the Forum schedule, speakers, and work with our Digital Services team to set up your Cavendish IQ profile, schedule one-on-one meetings and more. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1533137378057-9D5GWSKYMY2RFVU8P7MG/SEA1_Web_2_1.jpg SEA1 Schedule - Day 2 - Registration at UW Medicine's South Lake Union Campus 7:30 AM - 8:10 AM | Location at UW Medicine to be announced! Registration will open for members at the UW Medicine South Lake Union Campus in Seattle. Meet with our Forum Services team to review the Forum schedule, speakers, and work with our Digital Services team to set up your Cavendish IQ profile, schedule one-on-one meetings and more. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1537294138008-1D1YW3JSJQ65BAMCN5Y5/SEA1_Web_2_2.jpg SEA1 Schedule - Day 2 - Welcome and Opening Remarks from UW Medicine 8:05 AM - 8:15 AM | Carlos A. Pellegrini, MD, Chief Medical Officer, UW Medicine; with an introduction from J. Michael Moffat, Chairman, Cavendish Global UW Medicine’s Chief Medical Officer, Carlos A. Pellegrini, MD, will open the second day of the Seattle Forum on the South Lake Union campus of UW Medicine. Dr. Pellegrini will be introduced by Cavendish Global Chairman, J. Michael Moffat. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535470400088-K58WI0F5M8D6SQ2IGC7D/SEA1_Web_2_3.jpg SEA1 Schedule - Day 2 - Opening Keynote Address from the Institute for Health Metrics and Evaluation (IHME) 8:15 AM - 8:45 AM | Christopher J. L. Murray, MD, DPhil, Professor, IHME; Director and Chair, Department of Health Metrics Sciences Christopher J.L. Murray, MD, DPhil, is the Director of the Institute for Health Metrics and Evaluation (IHME) and Professor of Global Health at the University of Washington. A physician and health economist, Dr. Murray is widely regarded as one of the founders of modern population health measurement, and his work has helped shape public policy in countries around the world. Dr. Murray created the concept of the Global Burden of Disease with Dr. Alan Lopez while working as a professor at the Harvard School of Public Health. Dr. Murray led the coordination of the Global Burden of Disease Study 2010, the most comprehensive assessment to date of levels and trends in health worldwide. He served as the Executive Director of the World Health Organization’s Evidence and Information for Policy Cluster, where he pioneered the groundbreaking World Health Report 2000, in collaboration with Dr. Julio Frenk. Dr. Murray played a key role in the creation of the 1993 World Development Report, considered a touchstone for all subsequent attempts to study the effects of health policy and health investment on health outcomes. He returned to Harvard to help launch the Harvard Initiative for Global Health (now the Harvard Institute for Global Health) as its first director. Dr. Murray’s work has been cited more than 50,000 times by other researchers in published articles. He holds Bachelor of Arts and Science degrees from Harvard University, a DPhil from Oxford University, and a medical degree from Harvard Medical School. Dr. Murray and Dr. Frenk founded IHME in 2007. By measuring health, tracking program performance, finding ways to maximize health system impact, and developing innovative measurement systems, IHME provides a foundation for informed decision-making that ultimately will lead to better health globally. https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/5b61b9d70e2e724a6bebb514/5b61d557562fa7638c69980f/1542207826481/SEA1_Web_2_4_2.jpg SEA1 Schedule - Day 2 - Groundbreaking Discoveries &amp; Innovations 8:45 AM - 9:45 AM | Cavendish Innovation Partners Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthroughs. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1533138497663-JU9K04B98KTNIXCFLZQE/SEA1_Web_1_3.jpg SEA1 Schedule - Day 2 - Partnering Meetings &amp; Coffee Break 9:45 AM - 10:30 AM | Orin Smith Conference Center at UW Medicine Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations. Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535470742076-NFC80ETMCNJEQ324XN4A/SEA1_Web_2_6.jpg SEA1 Schedule - Day 2 - Fireside Chat with Beyond Type 1 10:30 AM - 11:00 AM | Featuring Sarah Lucas, Co-Founder & CEO, Beyond Type 1, interviewed by Rachel Butler, Executive Director, Cavendish Impact Foundation Sarah is the CEO of Beyond Type 1, a nonprofit organization leveraging the power of social media and technology, changing what it means to live with a chronic condition. In just three years, her team has built a powerhouse global brand with the largest digital audience of any diabetes organization in the world. The result is improved health outcomes for millions of people, new opportunities to partner with iconic brands and the ability to consolidate other non-profits for greater impact. Sarah will discuss how venture capital, the tech and design worlds and traditional non-profit practices influenced the building of this new brand of philanthropy. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535471002753-XGULRA1B85OGN201JEDC/SEA1_Web_2_7.jpg SEA1 Schedule - Day 2 - Blockchain in BioHealth 11:00 AM - 11:30 AM | Featuring Brian Slizgi, Director, Pharma R&D Advisory, PwC Brian Slizgi, PwC Director of Pharma R&D Advisory will discuss the latest trends around the application of blockchain technology in biohealth, including opportunities and challenges for early-stage companies. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535471411184-EJXCU70GPAZS38Z0H4NS/SEA1_Web_2_8.jpg SEA1 Schedule - Day 2 - Fireside Chat with Envestnet 11:30 AM - 12:00 PM | Featuring James Lumberg, Co-Founder & EVP, Envestnet, together with James Patrick, Co-Founder & EVP, Envestnet, and Chairman of the Cavendish Impact Foundation Details to be announced! https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535471768362-NBRJXDD5V1R3ZOUWB4K8/SEA1_Web_2_9.jpg SEA1 Schedule - Day 2 - Networking Luncheon at UW Medicine 12:00 PM - 1:15 PM | Orin Smith Conference Center and surrounding lounge areas Break bread with fellow Cavendish members and leaders from the University of Washington over a casual buffet lunch at UW Medicine. Cavendish luncheons do not feature keynote speakers, leaving attendees uninterrupted to network, meet and dine. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535472511808-RRU1HTJXPJOZIHOWXU92/SEA1_Web_2_10.jpg SEA1 Schedule - Day 2 - Impact Investing with Philanthropic Capital 1:15 PM - 1:45 PM | Moderated by Peter McCrea, President, Cavendish Impact Foundation, together with Timothy Freundlich, President, ImpactAssets In this fourth installment of a continuing panel series on impact investing, the Cavendish Impact Foundation's Peter McCrea joins philanthropic partner, ImpactAssets' President, Timothy Freundlich, to discuss the latest strategies in impact investment using philanthropic capital, and how to approach and participate in transactions from the standpoints of donors and innovators. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1537804045357-OWFGBYVXM5SPEQOVNB1B/SEA1_Web_2_11_2.jpg SEA1 Schedule - Day 2 - Keynote from Charles (Chuck) E. Murry, MD, PhD 1:45 PM - 2:15 PM | Charles (Chuck) E. Murry, MD, PhD, Director, UW Institute for Stem Cell and Regenerative Medicine; Co-Director, UW Center for Cardiovascular Biology; Co-Director, UW Medicine Heart Regeneration Program Dr. Murry’s research focuses on stem cell biology, with an emphasis on understanding differentiation of the human cardiovascular system and using these cells to study diseases and to regenerate damaged tissues. His group is a world leader in heart regeneration and is working toward a clinical trial using cardiomyocyte therapy. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535477884982-BMXF726QGLF7OT3RWJSR/SEA1_Web_2_12.jpg SEA1 Schedule - Day 2 - Groundbreaking Discoveries & Innovations 2:15 PM - 3:15 PM | Cavendish Innovation Partners Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthroughs. (Image: David Huizenga, CEO, Moterum Technologies) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1533141179301-OABB85O26OAQG2WIMIM7/SEA1_Web_1_3.jpg SEA1 Schedule - Day 2 - Partnering Meetings & Coffee Break 3:15 PM - 4:00 PM | Orin Smith Conference Center at UW Medicine Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations. Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535474079107-ACS4P83IZBT662QOLJVA/SEA1_Web_2_15.jpg SEA1 Schedule - Day 2 - Keynote Address from One Mind 4:00 PM - 4:30 PM | Featuring Ramona Hicks, PhD, Science and Technology Director, One Mind At One Mind, Dr. Hicks works to facilitate the exchange of scientific knowledge across neuropsychiatric disorders, international borders, and academic and commercial entities to accelerate the development of diagnostic tools, biomarkers, and effective treatments. Projects include developing the One Mind Portal into a user-friendly and useful tool for research collaboration, especially among large, multi-center studies, implementing an evidence-informed screening and management tool for concussion in emergency departments (Screen-Inform-Prevent), and exploring opportunities for a public-private psychosis research initiative. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1537803878618-N28YMBRCL5OBWC7A27WT/SEA1_Web_2_16_2.jpg SEA1 Schedule - Day 2 - Keynote from Heather Mefford, MD, PhD 4:30 PM - 5:00 PM | Heather Mefford, MD, PhD, Director, Mefford Laboratory, Division of Genetic Medicine, University of Washington Dr. Mefford is a physician at Seattle Children’s Hospital and an Associate Professor of Pediatrics at the University of Washington. She directs a research laboratory in the Division of Genetic Medicine that is devoted to gene discovery in pediatric disorders, with a focus on severe pediatric epilepsies. The Mefford Lab has identified numerous new epilepsy genes, which are now tested in the clinical setting. She has also been a key member of international consortium efforts for epilepsy gene discovery. Her clinical interests parallel her research interests and include seeing patients with suspected genetic disorders, pediatric epilepsies and neurocognitive defects of unknown causes. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1533141561208-K5TUQ72RUZHMVX1BVH2H/SEA1_Web_2_15.jpg SEA1 Schedule - Day 2 - Evening Cocktail Reception at UW Medicine 5:00 PM - 8:00 PM | UW Medicine Orin Smith Lounge and surrounding areas General Session programming will close with an immediate opening of the Evening Cocktail Reception. The UW Medicine reception will feature exclusive tours of research laboratories, along with interactive technology showcased by the Institute for Health Metrics and Evaluation! Cavendish and Forum partners will deliver remarks, repeat the call for greater collaboration, innovation and impact, and highlight the upcoming 2019 San Francisco Forum in February. Be sure to check in with the Cavendish team on unique local dinner destinations to continue the conversations, post-Forum! https://cavendishglobal.com/sfo1-schedule-day-2 daily 0.75 2019-02-19 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1542636914516-2L7UF6B275CE2OFH1U3L/SFO1_Web_2_1.jpg SFO1 Schedule - Day 2 - Registration and Breakfast at UCSF Mission Bay 7:30 AM - 8:10 AM | Fisher Atrium, UCSF Mission Bay Conference Center Registration opened for members at the UCSF Mission Bay Conference Center in San Francisco’s Mission Bay neighborhood. Members met with the Cavendish team to review the Forum schedule, speakers, and work with the Digital Services team to set up Cavendish IQ profiles, schedule one-on-one meetings and more. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1542636914516-2L7UF6B275CE2OFH1U3L/SFO1_Web_2_1.jpg SFO1 Schedule - Day 2 - Registration and Breakfast at UCSF Mission Bay 7:30 AM - 8:10 AM | Fisher Atrium, UCSF Mission Bay Conference Center Registration opened for members at the UCSF Mission Bay Conference Center in San Francisco’s Mission Bay neighborhood. Members met with the Cavendish team to review the Forum schedule, speakers, and work with the Digital Services team to set up Cavendish IQ profiles, schedule one-on-one meetings and more. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1547748130601-8DAOOE8FTJA53AY4KBE4/SFO1_Web_2_2.jpg SFO1 Schedule - Day 2 - Welcome and Opening Remarks 8:05 AM - 8:15 AM | Robertson Auditorium at UCSF Mission Bay Conference Center Photo feature: Cavendish Global’s Managing Partner, Tom McKenzie, delivered opening remarks at the 2018 Chicago Forum. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1547746074966-TCYXY8S7N7K3XIOEG36P/SFO1_Web_2_7.jpg SFO1 Schedule - Day 2 - Moving from Competition to Collaboration: A Model for Success 8:15 AM - 8:45 AM | Moderated by Geoffrey T. Manley, MD, PhD, Vice Chairman and Professor in Residence, Neurological Surgery, UCSF; Co-Director and Principal Investigator, Brain and Spinal Injury Center (BASIC), UCSF; and Chief of Neurosurgery, Zuckerberg San Francisco General Hospital; featuring Garen Staglin, Philanthropist, Co-Founder and Board Chairman, One Mind; and Beth McQuiston, MD, RD, Medical Director, Abbott (Diagnostics) Photo feature: Garen Staglin, Geoffrey T. Manley, MD, PhD, and Beth McQuiston, MD, RD https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1547744172167-2STOSQJIJ7P9JA5BUQ5C/SFO1_Web_2_4.jpg SFO1 Schedule - Day 2 - Groundbreaking Discoveries &amp; Innovations 8:45 AM - 9:45 AM | Cavendish Innovation Partners Cavendish Innovation Partners, early-stage biohealth companies, delivered impact presentations on their latest breakthrough work. Photo feature: Michael Mullan, MBBS (MD), PhD, CEO and CSO, Archer Pharmaceuticals; one of the Innovation Partners that presented at the 2019 San Francisco Forum. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1542393900009-SB06H0XFTA1TYVWYNQA8/SFO1_Web_2_5.jpg SFO1 Schedule - Day 2 - Partnering Meetings &amp; Coffee Break 9:45 AM - 10:30 AM | Fisher Atrium and Robertson Auditorium at the UCSF Mission Bay Conference Center Immediately following Innovation Partner impact presentations, members enjoyed a break to grab coffee, met one-on-one with fellow attendees and continued conversations with Innovation Partners on the details of their presentations, in the exhibition space. Meetings were set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1547747540035-TE8RCAIL3E5O43NV0G1Q/SEA_Web_2_6.jpg SFO1 Schedule - Day 2 - Discussion with Robert C. Malenka, MD, PhD 10:30 AM - 11:00 AM | Robert C. Malenka, MD, PhD, Nancy Friend Pritzker Professor, Psychiatry and Behavioral Sciences, Stanford University; Director, Nancy Priztker Laboratory; and Deputy Director, Stanford Neurosciences Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1547746533536-5WEDKMYT7Y6OVQR8F625/SFO1_Web_2_5.jpg SFO1 Schedule - Day 2 - Fireside Chat with the Merck Global Health Institute 11:00 AM - 11:30 AM | Featuring James Mulry, Head of Global Health Diagnostics, Merck Global Health Institute; together with Nuno Martins, Diagnostics Manager, Merck Global Health Institute. The Global Health Institute was launched in April 2017 with the mission to develop transformative health solutions to support control and elimination programs related to infectious diseases carrying a major toll on children, and to contribute to the United Nations Sustainable Development Goals (SDGs). https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1545078453914-1IWR4OS244VONGJMXDF9/SFO1_Web_2_3.jpg SFO1 Schedule - Day 2 - Keynote Address from Sheri Sobrato Brisson 11:30 AM - 12:00 PM | Sheri Sobrato Brisson, Trustee, The Sobrato Organization and Sobrato Philanthropies; Founder, The Digging Deep Project Sheri Sobrato Brisson is founder of the Digging Deep Project, coauthor of the award-winning book, Digging Deep: A Journal for Young People Facing Health Challenges, and producer of Shadow's Edge, the first-ever mobile game for teens with medical conditions. Sheri is a founding trustee of the Sobrato Family Foundation, a foundation committed to improving the quality of life in California’s Silicon Valley. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1547747708676-4TH9G3LCIS48I81QEPVZ/SFO1_Web_2_5.jpg SFO1 Schedule - Day 2 - Networking Luncheon at UCSF Mission Bay 12:00 PM - 1:15 PM | Fisher Atrium at UCSF Mission Bay Cavendish members and speakers from around the San Francisco Bay Area dined together, over a casual buffet lunch at UCSF Mission Bay. Cavendish luncheons never feature keynote speakers, leaving attendees uninterrupted to network, meet and dine. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1542212346905-XCU3CZ4FT2JO8TFY0OWW/SEA1_Web_2_10.jpg SFO1 Schedule - Day 2 - Impact Investing with Philanthropic Capital 1:15 PM - 1:35 PM | Moderated by Rachel Butler, Executive Director, Cavendish Impact Foundation, together with Timothy Freundlich, CEO, ImpactAssets and Richard Lipkin, COO, Cavendish Impact Capital and Partner, Easton Capital In the fifth installment of a continuing panel series on impact investing, the Cavendish Impact Foundation's Rachel Butler and Richard Lipkin joined philanthropic partner, ImpactAssets' CEO, Timothy Freundlich, to discuss the latest strategies in impact investment using philanthropic capital, and how to approach and participate in transactions from the standpoints of donors and innovators. Photo feature: Peter McCrea and Timothy Freundlich https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1547745341626-1WRK7Q2YMLZLF06L5P76/SFO1_Web_2_11.jpg SFO1 Schedule - Day 2 - Introducing PhilmCo: Moving Ideas to Action 1:35 PM - 2:15 PM | Moderated by Peter Samuelson, Co-Founder and CEO, PhilmCo; together with Keisha Senter, CEO, The Solution Senter and former Vice President, Will and Jada Smith Family Foundation; Jonathan Prince, American Actor, director, movie producer, screenwriter; and Rob Densen, Founder and CEO, Tiller LLC. PhimCo is a double bottom line media company that merges Philanthropy and Filmmaking into a unique model of development, financing, production, distribution and marketing of purposeful films, documentaries and other entertainment. With every project, PhilmCo partners with the stakeholders who have a passion for the very issues being tackled. PhilmCo moves ideas to action. Photo feature (clockwise): Peter Samuelson, Keisha Senter, Rob Densen and Jonathan Prince https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1547746941020-JU0SOQ8QYT5N8794EFIR/SFO1_Web_2_12.jpg SFO1 Schedule - Day 2 - Groundbreaking Discoveries &amp; Innovations 2:15 PM - 3:15 PM | Cavendish Innovation Partners Cavendish Innovation Partners, early-stage biohealth companies, delivered impact presentations on their latest breakthrough work. Photo feature: Mike Peck, President and CEO, Innara Health; one of the Innovation Partners that presented at the 2019 San Francisco Forum. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1542393932185-D65IRZ5573R4L2H0N5U3/SFO1_Web_2_5.jpg SFO1 Schedule - Day 2 - Partnering Meetings &amp; Coffee Break 3:15 PM - 3:45 PM | Fisher Atrium and Robertson Auditorium at the UCSF Mission Bay Conference Center Immediately following Innovation Partner impact presentations, members enjoyed a break to grab coffee, met one-on-one with fellow attendees and continued conversations with Innovation Partners on the details of their presentations, in the exhibition space. Meetings were set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1547763081325-2U911CVBR448PDTKXAC7/SFO1_Web_2_13.jpg SFO1 Schedule - Day 2 - Fireside Chat with the Quantum Leap Healthcare Collaborative 3:45 PM - 4:15 PM | Featuring Karyn DiGiorgio, MSN, MS, RN, Chief Operating Officer, Quantum Leap Healthcare Collaborative; together with Laura J. van’t Veer, PhD, Leader, Breast Oncology Program, and Director, Applied Genomics, and Angela and Shu Kai Chan Endowed Chair in Cancer Research, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco A 501c(3) charitable organization, Quantum Leap Healthcare Collaborative was established in 2005 as a collaboration between medical researchers at University of California, San Francisco and Silicon Valley entrepreneurs. Their mission is to integrate high-impact research with clinical processes and systems technology, resulting in improved data management and information systems, greater access to clinical trial matching and sponsorship, and greater benefit to providers, patients and researchers. QLHC’s goal is to improve and save lives. The founders of QLHC recognize that good ideas and research projects in a University setting were often “orphaned” at the end of a research project. These efforts were frequently left with no funds or organizational structure to adequately engage clinical providers and ultimately benefit patient care. In addition, the intellectual property often created as part of these research endeavors remain untapped and undeveloped. QLHC supports the development and implementation of innovative ways to deliver better, less costly healthcare. They are committed to establishing unique collaborations across the medical, technology and bioscience industries: all necessary components to accelerate healthcare research into the marketplace. Their efforts focus on quality-of-care and quality-of-life issues, and to create initiatives that foster excellent clinical practices using quality improvement disciplines with a strong patient-centric focus. Photo feature: Karyn DiGiorgio, MSN, MS, RN and Laura J. Van’t Veer, PhD https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1549381882275-ISOD026LYN9JANGTKBZ3/ec2.jpg SFO1 Schedule - Day 2 - Big Data Can Solve Autism 4:15 PM - 4:45 PM | Featuring Christian Braemer, founder and CEO, Benefunder, together with Elizabeth Horn, Autism Parent and founder, COMPASS Emerging technologies and a diversified funding strategy are the best chance we have ever had to find answers for autism. COMPASS co-founder and autism parent, Elizabeth Horn, founder of Benefunder, Christian Braemer, explained how. Photo feature: Elizabeth Horn and Christian Braemer https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1548862637372-4LGFSR35TS6NXN56NL0X/SFO1_Web_2_T21.jpg SFO1 Schedule - Day 2 - A Fireside Chat with TIGER 21 4:45 PM - 5:15 PM | Featuring Laird Cagan, San Francisco Chair, TIGER 21, together with Lorine Pendleton, Esq., New York Chair, TIGER 21, and Board Advisor, Cavendish Impact Foundation TIGER 21 (The Investment Group for Enhanced Results in the 21st Century) provides their Members with a close-knit network to discuss topics that matter most. Their 600+ Members are from every industry, and collectively manage more than $50 billion in personal assets. TIGER 21’s mission is to help their Members improve their investment acumen, tackle common issues of wealth preservation, manage family-related challenges, and understand everything from estate planning options, to philanthropic endeavors. Photo feature: Laird Cagan and Lorine Pendleton, Esq. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1547747817813-EZ18C2T0JCTD5XAWE4TB/SFO1_Web_2_5.jpg SFO1 Schedule - Day 2 - Evening Cocktail Reception at UCSF Mission Bay 5:00 PM - 8:00 PM | Fisher Atrium at UCSF Mission Bay General Session programming closed with the immediate opening of the Evening Cocktail Reception. Cavendish and Forum partners delivered remarks, repeated the call for greater collaboration, innovation and impact, and highlighted the upcoming 2019 New York Forum in April - Cavendish’s 20th event! https://cavendishglobal.com/sfo1-schedule-day-1 daily 0.75 2019-01-17 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1542208571373-50F8OXBZSIUOP6GZ14GI/SEA1_Web_1_3.jpg SFO1 Schedule - Day 1 - Cavendish Impact Foundation Investor Roundtable 4:00 PM - 5:30 PM | Participants to be announced! The Cavendish Impact Foundation will host a discussion on the latest trends and topics in impact investment. Details to follow. Please note, this event is a by-invitation-only component of the San Francisco Forum, for pre-qualified investors. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1542208571373-50F8OXBZSIUOP6GZ14GI/SEA1_Web_1_3.jpg SFO1 Schedule - Day 1 - Cavendish Impact Foundation Investor Roundtable 4:00 PM - 5:30 PM | Participants to be announced! The Cavendish Impact Foundation will host a discussion on the latest trends and topics in impact investment. Details to follow. Please note, this event is a by-invitation-only component of the San Francisco Forum, for pre-qualified investors. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1547742910483-BURTTS6J5HZKGGDMIFQ6/SFO1_Web_1_1.jpg SFO1 Schedule - Day 1 - Cavendish Impact Foundation's Investor Networking Reception 6:00 PM - 8:00 PM | Private location to be shared in official RSVP confirmations. Investors are welcome to join a private investor networking reception, hosted by the Cavendish Impact Foundation, together with Cavendish Global and Cavendish Capital Markets. Please note, this event is a by-invitation-only component of the San Francisco Forum, for pre-qualified investors. https://cavendishglobal.com/ny3-schedule-day-1 daily 0.75 2019-02-20 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1550684961359-5P2VLNYARGV93TVW1IIJ/NY3_Web_1_1.jpg NY3 Schedule - Day 1 - Members' Opening Reception 6:00 PM - 8:00 PM | Location to be announced. Before attending the Forum on Thursday, new and returning members are invited to join Cavendish for an evening of great cocktails, great hors d’oeuvres and exceptional networking with friends, old and new. The Opening Reception is always a favorite - we hope to see you there! Photo feature: Facade of the Cornell Club of New York https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1550684961359-5P2VLNYARGV93TVW1IIJ/NY3_Web_1_1.jpg NY3 Schedule - Day 1 - Members' Opening Reception 6:00 PM - 8:00 PM | Location to be announced. Before attending the Forum on Thursday, new and returning members are invited to join Cavendish for an evening of great cocktails, great hors d’oeuvres and exceptional networking with friends, old and new. The Opening Reception is always a favorite - we hope to see you there! Photo feature: Facade of the Cornell Club of New York https://cavendishglobal.com/ny3-schedule-day-2 daily 0.75 2019-04-10 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1550683721796-BFGBQ1OBJAKGM7GY2X91/NY3_Web_2_1.jpg NY3 Schedule - Day 2 - Registration and Networking Breakfast 8:00 AM - 8:50 AM | New York Academy of Sciences (40th Floor) Registration opens for members on the 40th Floor of the New York Academy of Sciences. Members will meet with the Cavendish team to review the Forum schedule, speakers, and work with the Digital Services team to set up Cavendish IQ profiles, schedule one-on-one meetings, and enjoy a delicious breakfast with premier networking. Photo feature: Facade of 7 World Trade Center, home of the New York Academy of Sciences. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1550683721796-BFGBQ1OBJAKGM7GY2X91/NY3_Web_2_1.jpg NY3 Schedule - Day 2 - Registration and Networking Breakfast 8:00 AM - 8:50 AM | New York Academy of Sciences (40th Floor) Registration opens for members on the 40th Floor of the New York Academy of Sciences. Members will meet with the Cavendish team to review the Forum schedule, speakers, and work with the Digital Services team to set up Cavendish IQ profiles, schedule one-on-one meetings, and enjoy a delicious breakfast with premier networking. Photo feature: Facade of 7 World Trade Center, home of the New York Academy of Sciences. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1550680885648-HOHUJQZR8ANOT3B73J9B/SFO1_Web_2_2.jpg NY3 Schedule - Day 2 - Welcome and Opening Remarks 8:50 AM - 9:00 AM | The Auditorium The Forum will begin with opening remarks, celebrating Cavendish’s 20th event in five years and updating members on the newest developments within the Cavendish network. Photo feature: Cavendish Global’s Managing Partner, Tom McKenzie, delivered opening remarks at the 2018 Chicago Forum. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1554389326334-FW2KST4DCPHLC5YOWENA/CG_Web_NY3_6_Lili_3.jpg NY3 Schedule - Day 2 - How a Fast-Approaching Majority-Minority Nation Impacts Health Innovation, Outcomes and Economics 9:00 AM - 9:30 AM | Panel Discussion led by Lili Gil Valletta, Founder and CEO, CulturIntel, Award-Winning Entrepreneur, Business Strategist, Hispanic Market Expert and Media Commentator; featuring Conrod Kelly, Executive Director and US Marketing Leader, Merck; Juliet Nevins, MD, Medical Director, Aetna; and more to be announced! Did you know April is Minority Health Month? It is - as designated by the CDC, NIH and Office of Minority Health! Minorities are disproportionately affected by chronic disease and are reported to achieve up to 40 percent worse health outcomes than the rest of the population, despite having increased access to healthcare. By the year 2040, America will be a majority minority nation which challenges traditional models of clinical trial design, personalized medicine and overall patient understanding and engagement as the profile of our patients rapidly change. Unless current healthcare models and even the science proactively evolve to anticipate these demographic shifts, we may fall short in delivering innovative health and wellness solutions that are inclusive and truly personalized to meet the needs of all patients. This session will bring together leading experts in clinical, data analytics, pharma, payor and other sectors who are innovating today to deliver inclusive healthcare innovations to anticipate the needs of a changing world. Photo feature: Conrod Kelly, Lili Gil Valletta (panel moderator) and Juliet Nevins, MD https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1554893589489-M01MHM6WJA82XU4UG6CK/CG_Web_NY3_IP1.jpg NY3 Schedule - Day 2 - Groundbreaking Discoveries &amp; Innovations Showcase 9:30 AM - 10:30 AM | Cavendish Innovation Partners Cavendish Innovation Partners, individually-curated early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work. Interested in becoming a Cavendish Innovation Partner and presenting at our next Forum in Chicago (June 19, 2019)? Contact Gwen Snyder. Photo feature: Brian Windsor, PhD, CEO, Lung Therapeutics; one of the Innovation Partners presenting at the 2019 New York Forum. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1550684266092-1JO6LKWKOSYPHDT89QQR/NY3_Web_2_5.jpg NY3 Schedule - Day 2 - Partnering Meetings &amp; Coffee Break 10:30 AM - 11:00 AM | Lobby on the 40th Floor Immediately following Innovation Partner presentations, members will enjoy a mid-morning break to grab coffee, meet one-on-one with fellow attendees and continued conversations with Innovation Partners on the details of the presentations, in the exhibition space. The Lobby is offers everyone a giant’s eye-view of the city; on a crystal clear day, one can see from river to river with notable landmarks like the Brooklyn Bridge, Empire State Building, and the George Washington Bridge. Meetings are set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1552507403567-NP2L3IECO7RASEUTJGAB/CG_Web_NY3_Teten.jpg NY3 Schedule - Day 2 - Where are the deals?: Best Practices of Private Equity and Venture Capital Funds in Originating Investment Opportunities 11:00 AM - 11:25 AM | David Teten, Managing Partner, HOF Capital David Teten is a Managing Partner with HOF Capital, an international venture capital fund based in New York and backed by 70 conglomerates and large family offices across 21 countries. David has particular interest in fintech, sales tech, and HR tech. He was previously a Partner for 6 years with ff Venture Capital, one of the best-performing seed- and early-stage venture capital firms in the U.S. David also has advised clients such as Goldman Sachs Special Situations Group, Icahn Enterprises, LLR Partners, Birch Hill Equity Partners, and other institutional investors. He earlier was a serial fintech entrepreneur. David holds a Harvard MBA and Yale BA. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1554894561702-01K6VV6H97M66VNNK22H/CG_Web_NY3_IVCPanel.jpg NY3 Schedule - Day 2 - What is Impact Venture Capital? 11:25 AM - 12:00 PM | Moderated by Stan Kachnowski, PhD, Chairman, HITLAB, featuring Denmark West, Partner, Connectivity Capital Partners; Ramphis Castro, Co-Founder and Managing Director, ScienceVest; Josh Cohen, Managing Director, City Light Capital; and David Teten, Managing Director, HOF Capital Photo feature (clockwise): Stan Kachnowski, PhD, HITLAB; Denmark West, Connectivity Capital Partners; Josh Cohen, City Light Capital; and Ramphis Castro, ScienceVest https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1550697040639-SS8SJYR7FBSTHX00WDSJ/NY3_Web_2_8.jpg NY3 Schedule - Day 2 - Networking Luncheon 12:00 PM - 1:15 PM | Lobby on the 40th Floor Break bread with fellow Cavendish members and speakers over a casual buffet lunch at the New York Academy of Sciences. Cavendish luncheons do not feature keynote speakers, leaving attendees uninterrupted to network, meet and dine. Photo feature: Lobby on the 40th floor, providing ample breakout space for dining, networking and exhibiting. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1550757946323-N9R0R4JR1O5FN0OWJHGO/SFO1_Web_2_9.jpg NY3 Schedule - Day 2 - Weild &amp; Co.: Bullish on Entrepreneurs 1:15 PM - 1:45 PM | Featuring David Weild, Founder, Chairman and CEO, Weild & Co., and former Vice Chairman, The NASDAQ David is the founder of Weild & Co., which is working to revolutionize investment banking by harnessing the power of the cloud. One of the fastest growing investment banks (and investment banking networks) in the United States, Weild & Co. attracts and enables proven and independent investment bankers to better serve the growth and middle market economy (underserved but critical markets to job formation and upward mobility) from anywhere in the United States. Weild & Co. aspires to have profound social impact by enabling entrepreneurs, working mothers, investment bankers that don’t want ‘to be retired’ or those that want to leave larger investment banks to make a difference, especially in underserved communities, to better contribute. David is a former Vice Chairman of Nasdaq and worked with luminaries including Steve Jobs (Founder of Apple and Pixar) and Tom Stemberg (Founder of Staples). He ran corporate finance and equity capital markets at a top 10 Wall Street firm, pricing over 1,000 public equity offerings and was directly involved in early deals for Celgene (biotechnology company that has greatly extended lives for patients with multiple myeloma and helped kids with ADHD), NVIDEA (semiconductor company that sparked the growth in the PC gaming market, redefined computer graphics, parallel computing and helped ignite modern Artificial Intelligence including driverless cars), BlackRock (now the largest asset manager in the world), Chesapeake Energy (now a Fortune 500 company in land-based energy that was an early pioneer in horizontal drilling), Patterson-UTI Energy (largest land based drilling company in the US), and many others that made important contributions to the US and world economy. He is more recently recognized for thought leadership that led him to be called the “Father of the JOBS Act.” The JOBS Act laid the foundation for forms of crowdfunding, private placements, Reg. A+ public offerings and the basis under which most securities token offerings (STOs) are now done in the U.S. David’s thought leadership has been frequently cited by legislators, regulators, academics, politicians and stock exchanges. He has spoken or testified on stock exchange structure in the US Congress and at the SEC. He has addressed the G-20, OECD (Europe and Asia), the European Federation of Securities Exchanges (Switzerland and Norway) and the Arab Federation of Exchanges in Jordan. Mr. Weild received his B.A. from Wesleyan University and his M.B.A. from New York University Stern School of Business. He also studied at the Sorbonne and on exchange at the Ecoles des Hautes Etudes Commerciales (HEC Paris) and the Stockholm School of Economics (Stockholm, Sweden). Mr. Weild is married and the father of three teenagers. Photo feature: David Weild IV https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1554893325434-KWRXX86OYZ49RGG57514/CG_Web_NY3_IP2.jpg NY3 Schedule - Day 2 - Groundbreaking Discoveries &amp; Innovations Showcase 1:45 PM - 2:45 PM | Cavendish Innovation Partners Cavendish Innovation Partners, individually-curated early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work. Interested in becoming a Cavendish Innovation Partner and presenting at our next Forum in Chicago (June 19, 2019)? Contact Gwen Snyder. Photo feature: David Wolf, MD, EE, Astronaut, President and CSO, Spektron Systems, one of the Innovation Partners presenting at the 2019 New York Forum. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1550684602067-75UNZMS2PI7Y99JIMVEM/NY3_Web_2_5.jpg NY3 Schedule - Day 2 - Partnering Meetings &amp; Coffee Break 2:45 PM - 3:30 PM | Lobby on the 40th Floor Immediately following Innovation Partner presentations, members will enjoy a mid-afternoon break to grab coffee, meet one-on-one with fellow attendees and continued conversations with Innovation Partners on the details of the presentations, in the exhibition space. The Lobby is offers everyone a giant’s eye-view of the city; on a crystal clear day, one can see from river to river with notable landmarks like the Brooklyn Bridge, Empire State Building, and the George Washington Bridge. Meetings are set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1554893908833-1UUWW51C15VWW6MYMVWO/CG_Web_NY3_Access.jpg NY3 Schedule - Day 2 - Driving Change through Awareness and Investment 3:30 PM - 4:00 PM | Moderated by Carolee Lee, Founder and CEO, AccessCircles, together with Anula Jayasuriya, Founder, EXXclaim Capital WHAM! is a donor-funded, non-profit, dedicated to improving and elevating the health of women to 21st century standards by applying precision medicine in prevention, diagnosis, treatment and outcomes. WHAM!, Women’s Health Access Matters, has been created as an initiative of AccessCircles to focus on increasing awareness of women’s health issues and implementing strategies that will improve the inequities and bias in research and accelerate scientific discovery in women’s health. WHAM! was founded by Carolee Lee in July 2018 to impact research and awareness of diseases which affect women exclusively, predominantly or differentially . AccessCircles is a by-invitation global network for women providing connectivity, knowledge and access while sharing the collective knowledge, expertise and influence of preeminent thinkers and leaders in their fields. As a 501c3, AccessCircles’ mission is to provide education, thought leadership and connectivity to create sustainable and meaningful change in women's lives. Carolee will be joined in this discussion by Dr. Anula Jayasuriya, Founder of EXXclaim Capital. They will share a dialogue on the opportunities to create change through heightened awareness and investment. in health-care technology and life science companies in this untapped space. Photo feature: AccessCircles founder, Carolee Lee, and Anula Jayasuriya, Founder, EXXclaim Capital https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1551981464831-PO3MHSX6YFNK5995FNS3/CG_Web_NY3_6.jpg NY3 Schedule - Day 2 - Impact Investing with Envestnet 4:00 PM - 4:30 PM | Brett Wayman, Vice President for Impact Investing, Envestnet Envestnet is a leading provider of integrated portfolio, practice management, and reporting solutions to financial advisors and institutions. Envestnet’s open architecture platform encompasses a broad range of institutional-quality research, investment products, and advisory resources. Photo feature: Brett Wayman, Envestnet https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1552502733857-9Y9S27CLEU5CP83ZWVFC/CG_Web_NY3_SFDC.jpg NY3 Schedule - Day 2 - Closing Keynote from the PVBLIC Foundation 4:30 PM - 5:00 PM | Sergio Fernandez de Cordova, Co-Founder and Chairman PVBLIC Foundation is an innovative non-profit media organization that harnesses the power of media to drive social change. An aggregator of media across all platforms, PVBLIC works strategically to pair media space with key non-profits at the local, national and global levels. We utilize existing and emerging technologies to increase issue awareness around important causes and help non-profits amplify their message. At PVBLIC, we believe that media and technology are the new currencies for sustainable development. Photo feature: PVBLIC Chairman, Sergio Fernandez de Cordova, speaks at the SDG Media Zone at the UN General Assembly. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1550690541404-K2EKS7CMEZ455GIX90HC/NY3_Web_2_CR.jpg NY3 Schedule - Day 2 - Networking Cocktail Reception 5:00 PM - 8:00 PM | Lobby on the 40th Floor General Session programming will close with an immediate opening of the Evening Cocktail Reception. Cavendish and Forum partners will deliver remarks, repeat the call for greater collaboration, innovation and impact, and highlight the upcoming 2019 Chicago Forum in June, at the Shirley Ryan AbilityLab. Photo feature: Scene from the evening cocktail reception at the 2018 Chicago Forum. https://cavendishglobal.com/ch3-schedule-day-1 daily 0.75 2019-06-11 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1556894486847-UHOZGMV4IUL3IGIKO0FQ/CH18_Web_Cocktail.jpg CH3 Schedule - Day 1 - Handler Thayer Family Office Event - Registration and Coffee Service 3:00 PM - 4:00 PM | Foyer off the Sky Lobby, on the 10th Floor Registered attendees may stop by the registration desk to collect Forum materials, consult with our Digital Services team on the use of Cavendish IQ for setting partnering meetings, sending messages, profile building, and to grab coffee, ahead of the afternoon family office programming, sponsored by Handler Thayer LLP. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1556894486847-UHOZGMV4IUL3IGIKO0FQ/CH18_Web_Cocktail.jpg CH3 Schedule - Day 1 - Handler Thayer Family Office Event - Registration and Coffee Service 3:00 PM - 4:00 PM | Foyer off the Sky Lobby, on the 10th Floor Registered attendees may stop by the registration desk to collect Forum materials, consult with our Digital Services team on the use of Cavendish IQ for setting partnering meetings, sending messages, profile building, and to grab coffee, ahead of the afternoon family office programming, sponsored by Handler Thayer LLP. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1556894616710-3F0CTLX1PDPAUAWPP0H2/SEA1_Web_2_11.jpg CH3 Schedule - Day 1 - How Family Offices are Investing Private Capital: Structures, Strategies and Investment Themes 4:00 PM - 4:45 PM | Moderated by Steven J. Thayer, JD, Partner, Handler Thayer LLP, featuring Paul Carbone, President and Managing Partner, Pritzker Private Capital, Thomas E. Costello, Principal, Ducchossois Capital Management, and Ward McNally, Managing Partner, McNally Capital https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1556894688382-PWQD6KIAA6S8AUBPUBN8/SEA1_Web_2_11.jpg CH3 Schedule - Day 1 - How and Why Family Offices are Disrupting Private Equity and Venture Capital 4:45 PM - 5:30 PM | Moderated by Ronald S. Diamond, Founder and Chairman, Diamond Wealth Strategies, featuring Brett Rentmeester, Chief Investment Officer, Jaggi Family Office, and Brian Stal, former Principal, The Pritzker Organization https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1556894831175-MSYE4OTEOWTSC9IIHFFI/CH18_Web_Cocktail.jpg CH3 Schedule - Day 1 - Handler Thayer Family Office Event - Cocktail Reception 5:30 PM - 7:30 PM | Foyer and the Searle Gathering Garden on the 10th Floor Handler Thayer’s Family Office programming will close with an immediate opening of the Evening Cocktail Reception. Additionally, the AbilityLab will be providing exclusive tours for attendees, visiting the facility wet labs and research space, highlighting the AbilityLab's newest capabilities and work. https://cavendishglobal.com/ch3-schedule-day-2 daily 0.75 2019-06-12 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557176314643-KPWC8O78ZQKPRMTNVDMC/CG_Web_CH3_2_1.jpg CH3 Schedule - Day 2 - Networking Breakfast &amp; Registration 8:00 AM - 8:40 AM | Sky Lobby and Foyer on the 10th Floor Registered attendees may stop by the registration desk to collect Forum materials, consult with our Digital Services team on the use of Cavendish IQ for setting partnering meetings, sending messages, profile building, and to grab breakfast, ahead of opening remarks. Photo feature: Look above, when you step off the elevators on the 10th floor! The AbilityLab features many brilliant artistic installations throughout its spaces. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557176314643-KPWC8O78ZQKPRMTNVDMC/CG_Web_CH3_2_1.jpg CH3 Schedule - Day 2 - Networking Breakfast &amp; Registration 8:00 AM - 8:40 AM | Sky Lobby and Foyer on the 10th Floor Registered attendees may stop by the registration desk to collect Forum materials, consult with our Digital Services team on the use of Cavendish IQ for setting partnering meetings, sending messages, profile building, and to grab breakfast, ahead of opening remarks. Photo feature: Look above, when you step off the elevators on the 10th floor! The AbilityLab features many brilliant artistic installations throughout its spaces. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1559230439702-NW7VP240WJ8ID2AWI7LE/CG_Web_CH3_2_BO1.jpg CH3 Schedule - Day 2 - Welcome from the AbilityLab 8:40 AM - 8:50 AM | Betsy Owens, Chief Marketing and Innovation Office, Shirley Ryan AbilityLab Since 2013, Betsy has served as Chief Marketing and Innovation Officer at AbilityLab. In this role, she oversees several key areas, including the organization’s marketing and communications, market and referral development, technology and innovation commercialization, and educational outreach. In 2017, Betsy led a rebranding that drove the 66-year-old organization’s renaming (from Rehabilitation Institute of Chicago) and move into the new $550 million, 1.2 million-square-foot research hospital. Previously, Betsy was President and Chief Operating Officer for Farley’s & Sathers. Before that, she oversaw Sears’ Kenmore brand, with profit-and-loss responsibility for the multibillion-dollar business. Her overhaul of Kenmore’s product design, brand positioning and marketing strategy restored Kenmore to the No. 1 appliance brand based on unit and dollar sales. Prior to Sears, Betsy served as Chief Marketing Officer and Senior Vice President at Rand McNally, the leading source for maps, navigation and travel content, where she directed strategy, marketing, brand and product development for five of the company’s businesses. Earlier in her career, she held leadership roles in both North America and Asia for SC Johnson. She also worked in brand management and sales for Gillette and Procter & Gamble. Photo feature: Betsy Owens, Shirley Ryan AbilityLab https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1559155467442-8JR0LAMQIKHFB6VH685R/CG_Web_CH3_2_IQVIA.jpg CH3 Schedule - Day 2 - Welcome and Opening Case Study from IQVIA 8:50 AM - 9:15 AM | Featuring John Stanick, MedTech Global Commercial & Technology, with Chris Chalmers, PharmD, Senior Director of Business Development, and Vik Malik, Commercial Partner https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557174388721-NW2E4C67DMRVD9S01VT2/CG_Web_CH3_2_3.jpg CH3 Schedule - Day 2 - Groundbreaking Discoveries &amp; Innovations Showcase 9:15 AM - 10:15 AM | Cavendish Innovation Partners Cavendish Innovation Partners, individually-curated early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work. Interested in becoming a Cavendish Innovation Partner and presenting at our Chicago Forum (a few spaces remain)? Contact Gwen Snyder. Photo feature: Derrick Johns (left), President and CEO, DiFusion Technologies, will be presenting at the 2019 Chicago Forum. Pictured with him is Joe Crudden (right), Vice President of Research, DiFusion Technologies. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557176614096-AWXD5ZA45BZIM88CQ880/CG_Web_CH3_2_4.jpg CH3 Schedule - Day 2 - Partnering Meetings &amp; Coffee Break 10:15 AM - 11:00 AM | Foyer and Auditorium on the 10th Floor Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations. Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558470431910-6NCLZDN3ZVATN6RXGZAM/CG_Web_CH3_2_5_2.jpg CH3 Schedule - Day 2 - Investing for Impact 11:00 AM - 11:30 AM | Moderated by Ronald S. Diamond, Chairman and CEO, Diamond Wealth Strategies, featuring newly-announced Priya Parrish, Managing Partner, Impact Engine, together with Elise Miller Hoffman, Principal, Life Science Funds I & II, Cultivation Capital Panelists to be announced! This panel discussion will dive into the questions: what is impact investing? Who are the impact investors in Chicago? How do these investors identify and review opportunities? What are best practices for all stakeholders involved and what are the latest success stories? Photo feature (left to right): Priya Parrish, Ronald S. Diamond and Elise Miller Hoffman https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557945885520-9ISQL1UKXLF0OL83HOTY/CH3_Web_2_5.jpg CH3 Schedule - Day 2 - Keynote from Muneer Satter 11:30 AM - 12:00 PM | Muneer A. Satter, Chairman, Satter Investment Management Muneer A. Satter manages Satter Investment Management (SIM), a private investment firm and family office. SIM has significant investments in healthcare companies. He also manages the Satter Foundation, a private family foundation. Photo feature: Muneer A. Satter, Satter Investment Management https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557176091811-O4VLF2YYE9W1SCYM68NN/CG_Web_CH3_2_7.jpg CH3 Schedule - Day 2 - Luncheon in the Sky Lobby 12:00 PM - 1:15 PM | Sky Lobby on the 10th Floor Break bread with fellow Cavendish members over a casual buffet lunch, surrounded by breathtaking views of Streeterville and Lake Michigan. Cavendish luncheons do not feature keynote speakers, leaving attendees uninterrupted to network, meet and dine. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557172441108-UK9N2VCBQWLX0JDGJQ3V/CG_Web_CH3_2_13.jpg CH3 Schedule - Day 2 - Impact Investing with Envestnet 1:15 PM - 1:45 PM | Speakers to be announced! Envestnet is a leading provider of integrated portfolio, practice management, and reporting solutions to financial advisors and institutions. Envestnet’s open architecture platform encompasses a broad range of institutional-quality research, investment products, and advisory resources. Photo feature: Brett Wayman, Envestnet, speaking at the 2019 New York Forum at the New York Academy of Sciences https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557173871031-JF5K44VRUT82VPLMVSBZ/CG_Web_CH3_2_9.jpg CH3 Schedule - Day 2 - Groundbreaking Discoveries &amp; Innovations Showcase 1:45 PM - 2:45 PM | Cavendish Innovation Partners Cavendish Innovation Partners, individually-curated early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work. Interested in becoming a Cavendish Innovation Partner and presenting at our Chicago Forum (a few spaces remain)? Contact Gwen Snyder. Photo feature: Tom Dann, CIO, Cellphire, delivers a presentation at the 2018 Chicago Forum. Read more about Tom’s Cavendish experience here. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557171024340-1177QN3QY85JL95D6N4C/CG_Web_CH3_2_10.jpg CH3 Schedule - Day 2 - Partnering Meetings &amp; Coffee Break 2:45 PM - 3:30 PM | Auditorium Foyer and Exhibition Space Immediately following Innovation Partner presentations, members will enjoy a mid-afternoon break to grab coffee, meet one-on-one with fellow attendees and continued conversations with Innovation Partners on the details of the presentations, in the exhibition space. Meetings are set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557171288838-JJ2R39AWIQJ3D9EU6JS6/CG_Web_CH3_2_11.jpg CH3 Schedule - Day 2 - Panel Discussion: Impact Philanthropy 3:30 PM - 4:00 PM | Moderated by Caren Croland Yanis, Principal, Croland Consulting; former President, Crown Family Philanthropies; former Executive Director of the Oprah Winfrey Foundations (Oprah Angel Network and The Oprah Winfrey Foundation); together with Laura Coy, Director of Philanthropy Strategy Vice President of the William Blair & Company Foundation; William W. Towns, PhD, Executive Director, Benefit Chicago; and Kristin Carlson Vogen, Senior Director of Philanthropic Services, Chicago Community Trust Impact Philanthropy offers an array of methods to advance resources to the individuals and organizations delivering game-changing solutions to our world. This panel discussion will bring together major philanthropic stakeholders from the Chicago area to discuss what are the trends and interests, how are opportunities identified and evaluated, and what should all stakeholders know when becoming involved in this space. Photo feature: Caren Croland Yanis https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1559156420712-DS931WPV46O8EOBT7G8N/CG_Web_CH3_2_TJ.jpg CH3 Schedule - Day 2 - Innovation in Illinois: Fireside Chat with the Leaders 4:00 PM - 4:30 PM | Featuring TJ Augustine, PhD, Vice Chancellor for Innovation, University of Illinois-Chicago; Steven C. Kuemmerle, PhD, Special Adviser, Innovation and Industry Partnerships - Office of Research, Rosalind Franklin University of Medicine and Science; and Leonidas Platanias, MD, PhD, Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Photo feature: TJ Augustine, PhD, University of Illinois-Chicago https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557171813327-SSXA3KD13GQSFXB13HC7/CG_Web_CH3_2_12.jpg CH3 Schedule - Day 2 - Keynote from Paul Alan Cox, PhD 4:30 PM - 5:00 PM | Paul Alan Cox, PhD, Executive Director, Brain Chemistry Labs A native of Utah and Wyoming, Paul Alan Cox graduated in Botany and Philosophy from Brigham Young University. He has published over 200 scientific papers and 4 books. In 1997, TIME magazine named Cox one of 11 “Heroes of Medicine” for his work in ethnobotanical drug discovery. In the same year, he was awarded the Goldman Environmental Prize for his efforts in preserving Samoan rain forests. Cox founded and is chairman of Seacology, an environmental organization which has preserved 98,000 acres of rain forest and 1.7 million acres of coral reef on islands throughout the world. Cox is a resident of Jackson Hole, Wyoming, where he is Director of the Institute for Ethnomedicine. His current ethnobotanical research is focused on neurodegenerative illness with the goal of discovering new therapies for ALS and Alzheimer’s Disease. Photo feature: Paul Alan Cox, PhD https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1557172145426-X528D5U3EIX67B5LZW7F/CG_Web_CH3_2_14.jpg CH3 Schedule - Day 2 - Evening Cocktail Reception and Tours of the AbilityLab 5:00 PM - 8:00 PM | Foyer and the Searle Gathering Garden on the 10th Floor General Session programming will close with an immediate opening of the Evening Cocktail Reception. Cavendish and Forum partners will deliver remarks, repeat the call for greater collaboration, innovation and impact, and highlight the upcoming 2019 Phoenix Forum. Additionally, the AbilityLab will be providing exclusive tours for attendees, visiting the facility wet labs and research space, highlighting the AbilityLab's newest capabilities and work. https://cavendishglobal.com/phx2-schedule-day-1 daily 0.75 2019-09-13 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558037979435-WX899632JNAH432W1SMH/CG_Web_PHX2_1_1.jpg PHX2 Schedule - Day 1 - Registration and Cocktail Bar Opens 3:00 PM - 4:00 PM | Phoenix Convention Center - West Ballroom Registration will open at 3:00 PM for the AZBio Awards Ceremony and Fiesta. Attendees of the Cavendish Forum are invited to join the Arizona bioscience community at both the Awards Ceremony and the evening Fiesta. Photo feature: Scene from 2018’s AZBio Awards Ceremony and Reception. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558037979435-WX899632JNAH432W1SMH/CG_Web_PHX2_1_1.jpg PHX2 Schedule - Day 1 - Registration and Cocktail Bar Opens 3:00 PM - 4:00 PM | Phoenix Convention Center - West Ballroom Registration will open at 3:00 PM for the AZBio Awards Ceremony and Fiesta. Attendees of the Cavendish Forum are invited to join the Arizona bioscience community at both the Awards Ceremony and the evening Fiesta. Photo feature: Scene from 2018’s AZBio Awards Ceremony and Reception. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1568411860844-3J05FO3LY9031ELGR3D7/CG_Web_PHX2_Ducey.jpg PHX2 Schedule - Day 1 - AZBio Awards Ceremony 4:00 PM - 5:30 PM | Phoenix Convention Center - West Ballroom Cavendish will join together with Arizona’s bioscience community, led by AZBio, for the 14th Annual AZBio Awards Ceremony. The AZBio Awards Ceremony celebrates Arizona’s leading educators, innovators and companies. The awards ceremony will feature remarks by Douglas A. Ducey, Governor of the State of Arizona. The 2019 Ceremony will celebrate and honor the Honorable Jane Dee Hull (AZBio Pioneer Award for Lifetime Achievement), Regenesis Biomedical, Inc. (2019 Arizona Bioscience Company of the Year), Martha Brumfield, PhD, Critical Path Institute (Jon W. McGarity Bioscience Leader of the Year), Debbie McCune Davis, TAPI (2019 Public Service Award Honoree), Monica Kraft, MD, University of Arizona (2019 Arizona Bioscience Researcher of the Year), Marti Lindsey, PhD, University of Arizona (Michael A. Cusanovich Bioscience Educator of the Year), and the AZBio Fast Lane Award Honorees: Biosensing Instrument, GT Medical Technologies, OncoMyx. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558038479323-Y8NL1GB5FHXFMZRF2U34/CG_Web_PHX2_1_4.jpg PHX2 Schedule - Day 1 - AZBio Awards Life Science Fiesta 5:30 PM - 8:30 PM | Phoenix Convention Center - West Ballroom The 14th Annual AZBio Awards Ceremony will conclude and open the Awards Fiesta, featuring cocktails and a buffet dinner, networking and exhibitions from the Arizona bioscience community. Cavendish Forum attendees are invited to join the Arizona bioscience community for the Fiesta. https://cavendishglobal.com/phx2-schedule-day-2 daily 0.75 2019-09-27 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558106698304-HGDAO58T5SFBHFTB1527/CG_Web_PHX2_Placeholder.jpg PHX2 Schedule - Day 2 - Networking Breakfast &amp; Registration 8:00 AM - 8:45 AM | Atrium at the Phoenix Biomedical Campus Registered attendees may stop by the registration desk to collect Forum materials, consult with our Digital Services team on the use of Cavendish IQ for setting partnering meetings, sending messages, profile building, and to grab breakfast, ahead of opening remarks. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558106698304-HGDAO58T5SFBHFTB1527/CG_Web_PHX2_Placeholder.jpg PHX2 Schedule - Day 2 - Networking Breakfast &amp; Registration 8:00 AM - 8:45 AM | Atrium at the Phoenix Biomedical Campus Registered attendees may stop by the registration desk to collect Forum materials, consult with our Digital Services team on the use of Cavendish IQ for setting partnering meetings, sending messages, profile building, and to grab breakfast, ahead of opening remarks. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1568929248374-3YMFJY6WIIRXFTEPAUM0/CG_Web_PHX2_Reed.jpg PHX2 Schedule - Day 2 - Welcome from the University of Arizona, College of Medicine 8:45 AM - 9:00 AM | Guy Reed, MD, MS, Dean and Valley of the Sun Professor, University of Arizona, College of Medicine - Phoenix Guy Reed, MD, MS, is an internationally recognized and renowned cardiologist, physician-scientist, educator and health administrator. As dean, he spearheads the college’s proud tradition of excellence in advancing medical education, research and clinical care in the state of Arizona and beyond. Learn more about Dr. Reed. Photo: Guy Reed, MD, MS, Dean, University of Arizona, College of Medicine - Phoenix https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1568929609582-BEAWBST3YNZC1TK07CTF/CG_Web_PHX2_Weild.jpg PHX2 Schedule - Day 2 - Opening Fireside Chat with Weild &amp; Co. 9:00 AM - 9:30 AM | Featuring John Antretter, COO, and Michael Christiansen, CFO, Weild & Co, Inc. Named as one of the fastest-growing investment banks, Weild & Co. provides a broader spectrum of client-focused corporate finance and capital raising services for companies. Details to be announced! Photo: Michael Christiansen and John Antretter, Weild & Co. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558106804857-2XSAYRTGPSG5N9G0MTSX/CG_Web_PHX2_Placeholder.jpg PHX2 Schedule - Day 2 - Groundbreaking Discoveries &amp; Innovations Showcase 9:30 AM - 10:45 AM | Cavendish Innovation Partners Cavendish Innovation Partners, individually-curated early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work. Interested in becoming a Cavendish Innovation Partner and presenting at our Phoenix Forum? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1564413660310-49SAIFU5RX248PJU646R/CG_Web_PHX2_PMCB.jpg PHX2 Schedule - Day 2 - Partnering Meetings &amp; Coffee Break 10:45 AM - 11:30 AM | Outdoor “Canyon” and indoor Atrium at the Phoenix Biomedical Campus Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations. Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. Photo: The “Copper Canyon” area at the newly-constructed Phoenix Biomedical Campus. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1564514611364-8586T2W500RG8FEHN740/page09koerber-walkerjoan_750xx3840-5135-0-625.jpg PHX2 Schedule - Day 2 - Bridging the Valley of Death - Creating Sustainable Models for Funding Innovation 11:30 AM - 12:00 PM | Panel moderated by Joan Koerber-Walker, President and CEO, AZBio, and Trustee, Healthcare Impact Foundation; featuring Brad Halvorsen, Executive Vice President, Flinn Foundation, Charlie Lewis, Senior VP of Venture Development, Skysong Innovations, Doug Hockstad, AVP, The University of Arizona and Tech Launch Arizona. Details to be announced! Photo: Joan Koerber-Walker, President and CEO, AZBio https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1567524236440-VVA5FYAKQM6HJNMQAMJL/CG_Web_PHX2_AZInvestor.jpg PHX2 Schedule - Day 2 - Panel Discussion with Arizona's BioHealth Investors 12:00 PM - 12:30 PM | Moderated by Mara Aspinall, Managing Director, BlueStone Venture Partners, with Timmeko Love, Mayo Clinic Ventures and Managing Partner of the ASU Mayo Clinic MedTech Accelerator; and Jim Goulka, Chairman and Managing Director, Arizona Tech Investors. Details to be announced! Photo: Mara Aspinall, Managing Director, BlueStone Venture Partners, and President and CEO, Health Catalysts https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1564410386593-6A1C7FSF5XVP4EO4D3NB/CG_Web_PHX2_L.jpg PHX2 Schedule - Day 2 - Networking Luncheon 12:30 PM - 1:45 PM | Virginia G. Piper Auditorium on the Phoenix Biomedical Campus Break bread with fellow Cavendish members over a casual buffet lunch at the Phoenix Biomedical Campus. Cavendish luncheons do not feature keynote speakers, leaving attendees uninterrupted to network, meet and dine. Photo: Exterior of the Virginia G. Piper Auditorium in Phoenix. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1569530837548-QO8HP6IL7IWZJSTVXO73/CG_Web_PHX2_Graves.jpg PHX2 Schedule - Day 2 - Bright Lights and Big Science at Arizona State University 1:45 PM - 2:15 PM | Keynote from William Graves, PhD, BioDesign Center for Applied Structural Discovery; Associate Professor, Physics Department Arizona State University Deep within the subterranean confines of Building C—the latest addition to the BioDesign Institute at Arizona State University—a pathbreaking machine is quietly taking shape. Designed to unlock some of nature’s tiniest and most fleeting mysteries, the Compact X-ray Free Electron Laser (CXFEL) is the only instrument of its kind in the world. Photo: William Graves, PhD, Arizona State University, together with the CXFEL Laser https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558113524968-1TNCHN1P62Q28IRZIING/CG_Web_PHX2_Placeholder.jpg PHX2 Schedule - Day 2 - Groundbreaking Discoveries &amp; Innovations Showcase 2:15 PM - 3:30 PM | Cavendish Innovation Partners Cavendish Innovation Partners, individually-curated early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work. Interested in becoming a Cavendish Innovation Partner and presenting at our Phoenix Forum? Contact Gwen Snyder. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1564413736829-T2B63XZKNFPSTF21F7KJ/CG_Web_PHX2_PMCB.jpg PHX2 Schedule - Day 2 - Partnering Meetings &amp; Coffee Break 3:30 PM - 4:15 PM | Outdoor “Canyon” and the indoor Atrium at the Phoenix Biomedical Campus Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations. Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder. Photo: The “Copper Canyon” area at the newly-constructed Phoenix Biomedical Campus. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1564514780679-2TWIZ5SEMB4ZBB3ZJF86/Stephen+Albert+Johnston+2018.jpg PHX2 Schedule - Day 2 - Going to the Dogs - How the Largest Canine Clinical Trial in History May Lead to New Hope for Humans 4:15 - 4:45 PM | Stephen Albert Johnston, PhD, Director, BioDesign Institute, Arizona State University ASU and Calviri have been working on developing a vaccine to PREVENT any cancer. They are testing it now in an 800 dog, owner-enrolled trial that if successful would set the stage to test it in humans. Photo: Stephen Albert Johnston, PhD, Arizona State University https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1568410981737-K5OZPH6OBS6DZYX8IAVO/CG_Web_PHX2_Sweasy.jpg PHX2 Schedule - Day 2 - Panel Discussion: New Directions in Cancer Care 4:45 PM - 5:15 PM | Moderated by Joann Sweasy, PhD, Interim Director, University of Arizona Cancer Center; featuring: Emmanuel Katsanis, MD, Professor, Pediatrics, Pathology and Immunobiology, the Louise Thomas Chair in Pediatric Cancer Research, the Peter and Paula Fasseas Chair in Cancer Research, Director of the Adult & Pediatric Hematopoietic Cellular Therapy & Transplant Program, Chief of the Division of Pediatric Hematology/Oncology and Associate Chair for Research in the Department of Pediatrics, University of Arizona Melissa M. Herbst-Kralovetz, PhD, Associate Professor, Director of the Women’s Health Microbiome Initiative, Department of Basic Medical Sciences and Department of Obstetrics and Gynecology at the University of Arizona College of Medicine - Phoenix Rachna Shroff, MD, MS, Chief, Section of GI Medical Oncology, Director of the UACC Clinical Trials Office, Associate Professor of Medicine, Division of Hematology/Oncology at the University of Arizona Cancer Center Robin B. Harris, PhD, MPH, Professor of Epidemiology, Zuckerman College of Public Health, Co-Director of the Skin Cancer Institute at the University of Arizona Cancer Center Photo: Joann Sweasy, PhD, Interim Director, University of Arizona Cancer Center https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1566582145232-UPOF60IE9A7FOCPGOF3Z/CG_Web_CH3_2_IQVIA.jpg PHX2 Schedule - Day 2 - Presentation from IQVIA MedTech Solutions 5:15 PM - 5:45 PM | Chris Reiling, General Manager & Commercial Leader, US MedTech Solutions, Vik Malik, Commercial Partner & Senior Director, US MedTech Solutions, together with Chris Chalmers, PharmD, Senior Director of Business Development, US Contract Sales & Medical Solutions Details to be announced! https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558119349825-MSQP0TI08O8S6W71I1MO/CG_Web_PHX2_Reception.jpg PHX2 Schedule - Day 2 - Cocktail Reception with the Arizona Bioscience Community, co-hosted with AZBio and IQVIA 6:15 PM - 8:30 PM | Arizona Science Center, 600 E Washington St., Phoenix Forum attendees will join with IQVIA and the larger Arizona bioscience community for an evening of cocktails, hors d’oeuvres, networking and full access to the Arizona Science Center. This is a can’t-miss reception. https://cavendishglobal.com/phx2-schedule-az-summit daily 0.75 2019-09-03 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1564070614631-S41VZ78EW0AKY9KGW0NH/CG_Web_PHX2_AZ1.jpg PHX2 Schedule - AZ Summit - Discovering New Medicines in Arizona Summit Full day-long schedule to be announced! | UA Phoenix Biomedical Sciences Partnership Building Presented by the Arizona Center for Drug Discovery and the University of Arizona Cancer Center. The Summit will highlight key areas of research in discovering effective drug candidates in prevalent diseases in Arizona while establishing collaborations that enable success in these key areas. Click here for more information and registration for the Summit (this does not register you for the October 3 Cavendish Forum). https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1564070614631-S41VZ78EW0AKY9KGW0NH/CG_Web_PHX2_AZ1.jpg PHX2 Schedule - AZ Summit - Discovering New Medicines in Arizona Summit Full day-long schedule to be announced! | UA Phoenix Biomedical Sciences Partnership Building Presented by the Arizona Center for Drug Discovery and the University of Arizona Cancer Center. The Summit will highlight key areas of research in discovering effective drug candidates in prevalent diseases in Arizona while establishing collaborations that enable success in these key areas. Click here for more information and registration for the Summit (this does not register you for the October 3 Cavendish Forum). https://cavendishglobal.com/sfo2-schedule-day-2 daily 0.75 2020-02-03 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1571415812277-AWYMH55BZRL2US37KAFN/CG_Web_SFO2_UCSFLobby.jpg SFO2 Schedule - Day 2 - Registration and Breakfast at UCSF Mission Bay 8:00 AM - 8:45 AM | Fisher Atrium, UCSF Mission Bay Conference Center Registration will open at the UCSF Mission Bay Conference Center in San Francisco’s Mission Bay neighborhood. Guests can meet with the Cavendish team to review the Forum schedule, speakers, and work with the Digital Services team to set up Cavendish IQ profiles, schedule one-on-one meetings and more. Photo: Architecture in the Fisher Atrium at the UCSF Mission Bay Conference Center. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1571415812277-AWYMH55BZRL2US37KAFN/CG_Web_SFO2_UCSFLobby.jpg SFO2 Schedule - Day 2 - Registration and Breakfast at UCSF Mission Bay 8:00 AM - 8:45 AM | Fisher Atrium, UCSF Mission Bay Conference Center Registration will open at the UCSF Mission Bay Conference Center in San Francisco’s Mission Bay neighborhood. Guests can meet with the Cavendish team to review the Forum schedule, speakers, and work with the Digital Services team to set up Cavendish IQ profiles, schedule one-on-one meetings and more. Photo: Architecture in the Fisher Atrium at the UCSF Mission Bay Conference Center. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1571162357280-FBM5024JLW5T3TNB42AK/CG_Web_SFO2_Placeholder.jpg SFO2 Schedule - Day 2 - Welcome and Opening Remarks 8:45 AM - 8:55 AM | Robertson Auditorium at UCSF Mission Bay Conference Center https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1575994036979-CZLLKIGUAE7GY15BE30J/CG_Web_SFO2_Cagan.jpg SFO2 Schedule - Day 2 - Keynote from TIGER 21 8:55 AM - 9:15 AM | Laird Cagan, Managing Director and Co-Founder, Cagan McAfee Capital Partners, and San Francisco Chair, TIGER 21 Laird Q. Cagan is Managing Director and co-founder of Cagan McAfee Capital Partners, LLC (successor to Cagan Capital, LLC) a private investment firm he founded in 1990. During the ‘90s Mr. Cagan invested in and helped build 15 high tech companies with over $500MM of equity capital invested in those companies. Since 2002, CMCP has founded, funded and taken public over 10 companies in a variety of industries including energy, alternative energy, healthcare, information technologies, payments and cleantech. CMCP portfolio companies have raised over $600MM of equity capital and over $2B of project development capital. Photo: Laird Cagan, McAfee Capital Partners and TIGER 21 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1571415366005-KKJMY4WQLYN09KRXSZAS/CG_Web_SFO2_Weild.jpg SFO2 Schedule - Day 2 - Weild & Co.: Bullish on Entrepreneurs 9:15 AM - 9:45 AM | Featuring John Antretter, Managing Director, Investment Banking, Weild & Co., Inc. (named by La Roche as one of the United States’ fastest-growing investment banks) John Antretter, Managing Director of Investment Banking at Weild & Co., will welcome Cavendish to the San Francisco Forum, bringing to our Members the latest snapshot of the present state of capital markets, and the implications for early and middle-market companies in fundraising mode. Weild & Co., dedicated to supporting entrepreneurs in the earlier growth stages, explores viable fundraising methodologies that are impactful to executives, investors, consumers and the larger marketplace. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1575993547122-TMXUINFBVPSJO3WQ0VML/CG_Web_SFO2_Efyian.jpg SFO2 Schedule - Day 2 - Groundbreaking Discoveries &amp; Innovations 9:45 AM - 10:45 AM | Cavendish Innovation Partners Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work. Interested in presenting at the upcoming San Francisco Forum? Contact our team for details. Photo: Angelika Niemz, PhD, President and CEO, Efyian, delivered a presentation at the 2019 San Francisco Forum. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1571416389198-2OEZTHJ9UHRLKH5UF0DT/CG_Web_SFO2_Coffee.jpg SFO2 Schedule - Day 2 - Partnering Meetings &amp; Coffee Break 10:45 AM - 11:30 AM | Fisher Atrium and Robertson Auditorium at the UCSF Mission Bay Conference Center Immediately following Innovation Partner impact presentations, guests will enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations, in the exhibition space. Meetings are set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact our team. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1571415522168-5DVPXQX4B7QEVKYBGXOZ/CG_Web_SFO2_LGV.jpg SFO2 Schedule - Day 2 - Why Cultural Intelligence Matters in Today’s Healthcare Context 11:30 AM - 12:00 PM | Featuring Lili Gil Valletta, Founder and CEO, CulturIntel, Award-Winning Entrepreneur, Business Strategist, Hispanic Market Expert and Media Commentator Value-based models, shifting demographics, social determinants and technology are all coming together in today’s fast changing market. This session will outline some of these dynamics and share how cultural intelligence is essential for innovation and better outcomes. Photo: Lili Gil Valletta, Founder and CEO, CulturIntel https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1572970738017-N8JJ69ZGUOTDOZN04PT4/CG_Web_SFO2_Gewertz.jpg SFO2 Schedule - Day 2 - Fostering Innovation in Healthcare 12:00 PM - 12:30 PM | Featuring Bruce L. Gewertz, MD, Renown Surgeon; Surgeon-in-Chief, Chair of the Department of Surgery, H and S Nichols Distinguished Chair in Surgery, Vice President for Interventional Services and Vice Dean for Academic Affairs, Cedars-Sinai Health System, Los Angeles, CA Photo: Bruce L. Gewertz, MD, Cedars-Sinai Health System https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1571162830728-DVCOIUKW75IVY99FA97V/CG_Web_SFO2_Placeholder.jpg SFO2 Schedule - Day 2 - Networking Luncheon at UCSF Mission Bay 12:30 PM - 1:45 PM | Fisher Atrium at UCSF Mission Bay Cavendish members and speakers from around the San Francisco Bay Area will break bread together, over a casual buffet lunch at UCSF Mission Bay. Cavendish luncheons never feature keynote speakers, leaving attendees uninterrupted to network, meet and dine. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1579629101394-FTGKACZ0OE0KO51SZU1U/CG_Web_SFO2_Placeholder.jpg SFO2 Schedule - Day 2 - Developing Better Treatments for Major Brain Diseases: Risky and Hard but also Essential and Highly Rewarding 1:45 PM - 2:15 PM | Lennart Mucke, MD, Director and Senior Investigator, Gladstone Institute for Neurological Disease Dr. Mucke is the Director of the Gladstone Institute of Neurological Disease. He is also the Joseph B. Martin Distinguished Professor of Neuroscience and a Professor of Neurology at the University of California, San Francisco (UCSF). He has joint appointments in UCSF’s Neuroscience, Biomedical Sciences, and Medical Scientist (MD/PhD) Graduate Training Programs. Dr. Mucke’s research focuses on processes that result in memory loss and other major neurological deficits, with an emphasis on Alzheimer’s disease and related disorders. He has generated informative experimental models of these conditions and used them to identify novel strategies to prevent neurological decline. As the founding Director of the Gladstone Institute of Neurological Disease, he has created a leading program for research and training in disease-focused neuroscience. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1575993678703-RT2UOPIRAMCPJ084Z8VO/CG_Web_SFO2_HepQuant.jpg SFO2 Schedule - Day 2 - Groundbreaking Discoveries &amp; Innovations 2:15 PM - 3:15 PM | Cavendish Innovation Partners Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work. Interested in presenting at the upcoming San Francisco Forum? Contact our team for details. Photo: Greg Everson, MD, CEO, CMO and Managing Member, HepQuant, delivered a presentation at the 2019 San Francisco Forum. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1571416410146-SYJCK5607TEFI6FZDC8E/CG_Web_SFO2_Coffee.jpg SFO2 Schedule - Day 2 - Partnering Meetings &amp; Coffee Break 3:15 PM - 4:00 PM | Fisher Atrium and Robertson Auditorium at the UCSF Mission Bay Conference Center Immediately following Innovation Partner impact presentations, guests will enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations, in the exhibition space. Meetings are set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact our team. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1579628757849-K2J4U9H2MLXWOLSN9JWL/CG_Web_SFO2_Placeholder.jpg SFO2 Schedule - Day 2 - Keynote from Andrew Chung, 1955 Capital 4:00 PM - 4:30 PM | Andrew Chung, Founder and Managing Partner, 1955 Capital Andrew has been a tech investor and entrepreneur for over 20 years. He founded 1955 Capital to invest in transformative companies that can solve the most pressing issues in the developing world. 1955 was the largest venture capital firm debut in Q1 2016 and focuses on sustainability (energy, food, agriculture), education, health, and other emerging technologies. Prior to launching 1955 Capital, Andrew was a general partner at Khosla Ventures, a venture capital firm with over $5 billion under management and the world’s largest sustainable technology venture portfolio. Andrew joined Khosla in 2011 as one of six partners leading the firm. He managed over $500 million in assets and has served as board director or helped advise more than 20 Khosla portfolio companies. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1580318767074-W9O2P298TTA1HEQ4QIN2/CG_Web_SFO2_Placeholder.jpg SFO2 Schedule - Day 2 - San Francisco Investor Panel Discussion 4:30 PM - 5:00 PM | Panelists include Karl Handelsman, Founder, Codon Capital and Investment Director, Roche Venture Fund; Trish Costello, Founder and CEO, Portfolia; and Jan Pensaert, Founder and Managing Partner, Valiance Asset Management (London); and Michael Cole, PhD, Global Neurohealth Ventures Details to be announced! Photo: Panelists (clockwise) , Trish Costello, Portfolia; Jan Pensaert, Valiance Asset Management; Michael Cole, PhD, Global Neurohealth Ventures; and Karl Handelsman, Codon Capital and Roche Venture Fund https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1571163600699-LBSYI8NCBATPE0S2AA0W/CG_Web_SFO2_Placeholder.jpg SFO2 Schedule - Day 2 - Closing Remarks from Cavendish 5:00 PM | Robertson Auditorium at UCSF Mission Bay Conference Center https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/5da49f064a448c3d83acbd08/5da60df19dac4376675be4a9/1580318061576/ SFO2 Schedule - Day 2 - Evening Cocktail Reception at UCSF Mission Bay 5:00 PM - 8:00 PM | Fisher Atrium at UCSF Mission Bay General Session programming will close with the immediate opening of the Evening Cocktail Reception. Cavendish and Forum partners will deliver remarks, repeat the call for greater collaboration, innovation and impact, and highlight the upcoming 2020 New York Forum at the New York Academy of Sciences. https://cavendishglobal.com/sfo2-schedule-day-1 daily 0.75 2020-01-27 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1575466266782-R7JIZQEM9A5KL1XBXHTB/CG_Web_SFO2_DayOne.jpg SFO2 Schedule - Day 1 - Opening Reception in the Salesforce Tower 5:00 PM - 7:00 PM | Hosted by McDermott, Will & Emery on the 56th Floor Cavendish is honored to be teaming together with McDermott, Will & Emery (MWE) to host the 2020 San Francisco Forum’s Opening Reception, the evening before the Forum General Session. Forum guests will convene on the 56th floor of the iconic Salesforce Tower for an evening of great networking, cocktails and hors d’oeuvres and more. Please note: Security at the Salesforce Tower is extremely tight and prior registration with confirmation from Cavendish is required to join this reception. Registrations received less than 24 hours in advance may require on-site processing and confirmation. Photo: Salesforce Tower in San Francisco https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1575466266782-R7JIZQEM9A5KL1XBXHTB/CG_Web_SFO2_DayOne.jpg SFO2 Schedule - Day 1 - Opening Reception in the Salesforce Tower 5:00 PM - 7:00 PM | Hosted by McDermott, Will & Emery on the 56th Floor Cavendish is honored to be teaming together with McDermott, Will & Emery (MWE) to host the 2020 San Francisco Forum’s Opening Reception, the evening before the Forum General Session. Forum guests will convene on the 56th floor of the iconic Salesforce Tower for an evening of great networking, cocktails and hors d’oeuvres and more. Please note: Security at the Salesforce Tower is extremely tight and prior registration with confirmation from Cavendish is required to join this reception. Registrations received less than 24 hours in advance may require on-site processing and confirmation. Photo: Salesforce Tower in San Francisco https://cavendishglobal.com/ny4-schedule-day-1 daily 0.75 2020-03-11 https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/t/5e691dba9d45511c3bbbda94/1582579894524/ NY4 Schedule - Day 1 https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/5e543dc84bf69a70ae609c35/5e5440b6d04b7d3aa8d0aa0d/1582579894524/ NY4 Schedule - Day 1 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582648843486-WC8T28GVA166GCOVUA0O/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Registration and Breakfast at The New York Academy of Sciences 8:00 AM - 8:45 AM | 40th Floor Atrium, The New York Academy of Sciences Registration will open at The New York Academy of Sciences in 7 World Trade Center. This is a secure building and will require photo identification check-in at the security desk. Guests can meet with the Cavendish team to review the Forum schedule, speakers, and work with the Digital Services team to set up Cavendish IQ profiles, schedule one-on-one meetings and more. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582580261396-N3JZOUMZIBN0CPZSEOLO/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Welcome and Opening Remarks 8:45 AM - 8:55 AM | 40th Floor Auditorium Details to be announced! https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582580092604-6W8T2PIH5FWXOY49RIBL/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1583944458289-YFSOS72KF3K9HF7G3N96/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Opening Keynote from the Global Health Investment Fund 9:00 AM - 9:30 AM | Curt LaBelle, MD, President, Global Health Investment Fund The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challenges such as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582580272920-WSC4HN7VFTEGAXLW8Q8G/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Groundbreaking Discoveries & Innovations 9:30 AM - 10:45 AM | Cavendish Innovation Partners Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work. Interested in presenting at the upcoming New York Forum? Contact our team for details. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582644902689-7M5PD7SVT55USU82FVD2/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Partnering Meetings & Coffee Break 10:45 AM - 11:30 AM | 40th Floor Atrium Immediately following Innovation Partner presentations, members will enjoy a mid-morning break to grab coffee, meet one-on-one with fellow attendees and continued conversations with Innovation Partners on the details of the presentations, in the exhibition space. The Lobby is offers everyone a giant’s eye-view of the city; on a crystal clear day, one can see from river to river with notable landmarks like the Brooklyn Bridge, Empire State Building, and the George Washington Bridge. Meetings are set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact our team. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582646851773-X3JTCYL18XP9KNLKIAT8/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - National Institutes of Health: Open For Business 11:30 AM - 12:00 PM | Featuring Michael L. Salgaller, PhD, Technology Transfer Center, National Cancer Institute, National Institutes of Health Dr. Salgaller leads the Invention Development and Marketing Unit (IDMU) within the National Institutes of Health (NIH), where he leverages over 20 years of business, scientific, and investment experience in various life science sectors to support technology development and commercialization. The IDMU serves in a business development role to foster licensing and collaborative activity between buy-side stakeholders and the NIH. He is a long-time industry executive who has held various positions in boutique professional service and early-stage biotechnology firms – as well as several years in government affairs and on the investment team of a venture capital firm dedicated to the life sciences. He is the author of “Biotechnology Entrepreneurship,” and teaches an entrepreneurship class at NIH. He is on the Board of Canines-N-Kids, a foundation supporting cooperation between researchers in pediatric and veterinary oncology. He has written over 100 articles, presentations, and book chapters, and was the editorial boards of several journals. Dr. Salgaller received his PhD in Pathology from The Ohio State University. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582580289824-2JUH5RQYJILLJDK35YIK/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Impact Investor Panel Discussion to be announced! 12:00 PM - 12:30 PM | Panel Chair and Panelists to be announced! Details to be announced! https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582648638474-4Y9L5WHZQ933TSND12GS/CG_Web_NY4_Lunch.jpg NY4 Schedule - Day 1 - Networking Luncheon 12:30 PM - 1:45 PM | Lobby on the 40th Floor Break bread with fellow Cavendish members and speakers over a casual buffet lunch at the New York Academy of Sciences. Cavendish luncheons do not feature keynote speakers, leaving attendees uninterrupted to network, meet and dine. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1583944675178-5RE9H4G0WAL5PKY6YPO8/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Fireside Chat: A Debrief from Davos 2020, with the World Economic Forum 1:45 PM - 2:15 PM | Fireside Chat led by Lili Gil Valletta, CEO, CulturIntel; CNN, Fox News and MSNBC Media Commentator; Hispanic Markets Expert and Business Strategist; with participants to be announced! Together with the World Economic Forum, Lili and panelists will present a debrief from Davos 2020, including the Social Determinants of Health work, and the focus on impact investing, and re-defining value and returns on investments in prevention and health. More details to come! https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582580310325-TWCJWTB6BB7FMVMNU0N3/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Groundbreaking Discoveries & Innovations 2:15 PM - 3:15 PM | Cavendish Innovation Partners Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthrough work. Interested in presenting at the upcoming New York Forum? Contact our team for details. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582644932255-6I5TGLUO0DJ8RR1N8GKX/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Partnering Meetings & Coffee Break 3:15 PM - 4:00 PM | Lobby on the 40th Floor Immediately following Innovation Partner presentations, members will enjoy a mid-afternoon break to grab coffee, meet one-on-one with fellow attendees and continued conversations with Innovation Partners on the details of the presentations, in the exhibition space. The Lobby is offers everyone a giant’s eye-view of the city; on a crystal clear day, one can see from river to river with notable landmarks like the Brooklyn Bridge, Empire State Building, and the George Washington Bridge. Meetings are set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact our team. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582646593320-61FIFHIRB98K5PLVQ1Y0/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Keynote Address from The ALS Association 4:00 PM - 4:30 PM | Speaker to be announced! Details to be announced! https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582645104038-WWMYT29UYUC45ITZ1NSF/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Closing Panel Discussion to be announced! 4:30 PM - 5:00 PM | Panel Chair and Panelists to be announced! Details to be announced! https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1582646414905-OXZRRDBUBLJIFWXBWTRQ/CG_Web_NY4_Placeholder.png NY4 Schedule - Day 1 - Networking Cocktail Reception 5:00 PM - 8:00 PM | Lobby on the 40th Floor General Session programming will close with an immediate opening of the Evening Cocktail Reception. Cavendish and Forum partners will deliver remarks, repeat the call for greater collaboration, innovation and impact, and highlight the upcoming 2020 Chicago Forum, June 22-23, at the Shirley Ryan AbilityLab, as well as the first Los Angeles Forum, October 2020. Photo: Evening Cocktail Reception at the 2019 New York Forum. https://cavendishglobal.com/summit-gallery daily 0.75 2022-01-10 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1634146730490-LV7UUM9YNYESC13CNQVB/CG_WEB_SS17_Event16x9.jpg Summit Gallery - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1634146730490-LV7UUM9YNYESC13CNQVB/CG_WEB_SS17_Event16x9.jpg Summit Gallery - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1630077606656-2KD4PIJDUK7QJQE3KJD6/CG_WEB_SS16_Event16x9.jpg Summit Gallery - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1603738301765-LDNOPQHY0L4IPV12M72K/CG_WEB_SS_PH6.jpg Summit Gallery - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1606845417060-T04OA390R6R7EYD76WH8/CG_WEB_SS_8.jpg Summit Gallery - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1599765771696-NM0406CHTO5CTUHS7273/CG_WEB_SS6_16x9.jpg Summit Gallery - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1591193233700-80SF9FU5WW8022MGSIGV/CG_WEB_SS_JUN20.jpg Summit Gallery - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588722749406-0AJQG0W32WVPJK5J779I/CG_WEB_SS_MAY20.jpg Summit Gallery - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1597934121818-RTIM2VDPRQR9UR0RVCLE/CG_WEB_SS5_16x9.jpg Summit Gallery - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588722710533-7FLBS2BVBACF1WRUYZ7Z/image-asset.jpeg Summit Gallery - Upcoming https://cavendishglobal.com/summit-1-gallery daily 0.75 2021-05-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588771623658-8EHXSR8RV8IIW8LXY84D/CG_WEB_SS_1_LGV1.jpg Summit 1 Gallery - What Big Data and Millions of Digital Discussions Reveal About the Impact of COVID-19 on People's Mindsets and Behaviors Lili Gil Valletta, Founder and CEO, CulturIntel and CIEN+, CNN, Fox News and MSNBC Media Commentator, Hispanic Markets Expert and Business Strategist, based in New York, NY Customers, markets, and businesses may never be the same, which is why today, more than ever, we need to reimagine how we make data-driven decisions to proactively respond and innovate as leaders. Unprecedented times call for unprecedented methods to understand people and proactively prepare for a "new normal." That is why going beyond traditional surveys, panels, or focus groups, Culturintel is using big data and artificial intelligence to better understand how COVID-19 is impacting people's lives and mindsets, across genders, generations, and ethnicities. On May 14th, the audience learned about what the Culturintel COVID-19 People Impact Meter reveals after analyzing over 100 million organic and unbiased digital discussions as people share their experiences in real-time, with nobody asking. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588771623658-8EHXSR8RV8IIW8LXY84D/CG_WEB_SS_1_LGV1.jpg Summit 1 Gallery - What Big Data and Millions of Digital Discussions Reveal About the Impact of COVID-19 on People's Mindsets and Behaviors Lili Gil Valletta, Founder and CEO, CulturIntel and CIEN+, CNN, Fox News and MSNBC Media Commentator, Hispanic Markets Expert and Business Strategist, based in New York, NY Customers, markets, and businesses may never be the same, which is why today, more than ever, we need to reimagine how we make data-driven decisions to proactively respond and innovate as leaders. Unprecedented times call for unprecedented methods to understand people and proactively prepare for a "new normal." That is why going beyond traditional surveys, panels, or focus groups, Culturintel is using big data and artificial intelligence to better understand how COVID-19 is impacting people's lives and mindsets, across genders, generations, and ethnicities. On May 14th, the audience learned about what the Culturintel COVID-19 People Impact Meter reveals after analyzing over 100 million organic and unbiased digital discussions as people share their experiences in real-time, with nobody asking. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588772108301-J5ZBAO1ZHRG32E39C09H/CG_WEB_SS_1_JO1.jpg Summit 1 Gallery - Answering the Unmet Need: Measuring Iron Stores at the Point of Care Jerry O’Brien, CEO, Radisens Diagnostics, Ltd., based in County Cork, Ireland As a result of their life-giving altruism, blood donors have high prevalence of iron deficiency with adverse effects including pregnancy complications, cognitive impairment and other conditions. Assessing iron stores in the lab post-donation is too late - a sensitive point-of-care test is needed as a duty of care. Other applications include improving pediatric care and as an emerging early-warning tool for acute respiratory infections. On May 14th, we will learn more about Radisens’ approach to addressing this unmet need with implications on one of health’s largest supply lines: blood donation. Meet Jerry by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588774400265-EIT4B5GIELPHI5L4K7RZ/CG_WEB_SS_1_PH2.jpg Summit 1 Gallery - Treating Inflammation in Severe Respiratory Disease – COVID-19 and Beyond Peter B. Heifetz, PhD, President and CEO, OrPro Therapeutics, Inc., based in San Diego, Calif. Inflammation and airway obstruction in severe respiratory disease are significant drivers of morbidity and mortality that are not addressed by vaccines or anti-virals. We are developing a treatment to prevent severe respiratory disease progression and hospitalization in response to infection with SARS-Cov-2 and other acute viral respiratory pathogens, including emerging agents that could be the next pandemic. Designed for easy delivery in an inhaled form, this treatment provides a novel approach to addressing unmet medical needs across a spectrum of respiratory conditions including acute viral lung injury, acute respiratory distress syndrome (ARDS) and chronic lung diseases such as cystic fibrosis, bronchiectasis and COPD. Meet Peter and OrPro by logging in to Cavendish IQ. https://cavendishglobal.com/summit-2-gallery daily 0.75 2021-05-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588775278079-UY1AQ0E140JFV6K3A26C/CG_WEB_SS_2_KN1.jpg Summit 2 Gallery - The Importance of Children’s Hospitals During the COVID-19 Pandemic Kurt Newman, MD, President and CEO, Children’s National Medical Center, Washington, DC During his presentation, Dr. Kurt Newman introduced and discussed Children’s National Hospital’s ongoing experience with COVID-19, the new Multisystem Inflammatory Syndrome in Children, and current and future research and innovation initiatives. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588775278079-UY1AQ0E140JFV6K3A26C/CG_WEB_SS_2_KN1.jpg Summit 2 Gallery - The Importance of Children’s Hospitals During the COVID-19 Pandemic Kurt Newman, MD, President and CEO, Children’s National Medical Center, Washington, DC During his presentation, Dr. Kurt Newman introduced and discussed Children’s National Hospital’s ongoing experience with COVID-19, the new Multisystem Inflammatory Syndrome in Children, and current and future research and innovation initiatives. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1591029242193-AUSU99BA5IDW0TKZW424/20170718_julia_finkel_7.jpg Summit 2 Gallery - AlgometRx: Providing a Mechanistic Approach to the Objective Measurement of Pain and Analgesic Drug Effect Julia C. Finkel, MD, Founder, AlgometRx, Inc., based in Florham Park, NJ Dr. Julia Finkel is a pediatric anesthesiologist and Director of Pain Medicine R&D at the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Hospital in Washington, D.C. and Professor of Anesthesiology, Pediatrics and Critical Care Medicine at George Washington University. Dr. Finkel studies analgesic pharmacology in infants and children and develops pharmacodynamic assessment tools and methodologies both in the laboratory and for pediatric clinical applications. Dr. Finkel and her team developed a platform technology to objectively measure pain and analgesic drug effect. In 2015, she founded AlgometRx, Inc. to commercialize the technology. On June 4th, Dr. Finkel introduced us to AlgometRx, a mobile health medical device startup. The AlgometRx device is a handheld platform technology that implements proprietary algorithms to provide healthcare practitioners the toolbox to optimize pain assessment and treatment. Meet Dr. Finkel and AlgometRx by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1590588071263-Z963GN707XMH2ZGR8R6L/Triaj1.png Summit 2 Gallery - Triaj, Inc. - A New Digital Healthcare and MedTech Innovation Martin R. Eichelberger, MD, FACS, FAAP, Founder, President and CEO, Triaj, Inc., based in Annapolis, MD Medical errors are the third leading cause of death in the United States (Johns Hopkins). Significant disparity exists in the quality of care provided by healthcare professionals, due to lack of access to “just-in-time,” evidence-based protocols, to a knowledge gap of current practice and to the rapid change in new methods of care. This is especially critical at the early stage of patients with illness or injury, when timely decisions impact life-or-death outcomes. Lack of effective, best-practice protocols throughout the patient care process engenders low quality care outcome, escalates the cost of treatment and fragments the health care system which must absorb new technology, medications and techniques. Triaj is revolutionizing the diagnosis, treatment, and care of patients through an advanced clinical decision support system for healthcare professionals, which provides best practice, patient treatment which is available anywhere, anytime as a cloud-based, communications network solution. Meet Dr. Eichelberger and Triaj by logging in to Cavendish IQ. https://cavendishglobal.com/forums-previous daily 0.75 2020-05-07 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588869147832-AP6UUB4XLEXI284X5BO8/CG_WEB_FS_SFO2.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588869147832-AP6UUB4XLEXI284X5BO8/CG_WEB_FS_SFO2.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588868844639-HQ75FLTYYJRDRRB2PDL8/CG_WEB_FS_PHX2.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588868689462-Y2HEJ0D4JYTBZK83JGXE/CG_WEB_FS_CH3.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588868194723-B72GS68AQPJGLEIOSF8U/CG_WEB_FS_NY3.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588868194883-LUYEGBLY795TAQE9FLKQ/CG_WEB_FS_SFO1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588867823123-AOJ46JEH0ZS0TOFONVBU/CG_WEB_FS_SEA1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588867823216-HEZGB6THBKA75H5Y42HK/CG_WEB_FS_CH2.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588865944785-T23HEMSKDA5SE0OLSHTI/CG_WEB_FS_BG2.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588865355854-SDEGJ9EVZGP3CIB4N2UD/CG_WEB_FS_SD4.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588865356972-ETT0BO87P0MAJ8OZMHE3/CG_WEB_FS_NY2.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588865354974-WTKW0PHKKW9NECMXT002/CG_WEB_FS_CH1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588873546707-BOPTWHLLYJ0QTKP1JDW1/CG_WEB_FS_DC1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588804036453-2DYASYKDF2FNE9VJ9BHR/CG_WEB_FS_SD3.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588804061088-UL7EILEVYHEQ88TC1B0U/CG_WEB_FS_PHX1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588801841172-9596QDAUCIW4A92EH2R6/CG_WEB_FS_SD2.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588801186703-OFBOQCTNE8UFW5MUVGDT/CG_WEB_FS_BG1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588801186881-FUGCKIO0UIMGEWTYFS8A/CG_WEB_FS_PB1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588799948825-6TDG7TYY7R5GIV7T6JIX/CG_WEB_FS_NYU1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588799948358-J49C7ZPSGABL63MSUI3Q/CG_WEB_FS_CHO1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588800452620-DRQ4FU0BI5PTBEM0MAF7/CG_WEB_FS_CLE1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588800453272-BF76MZMFCF9N588G1O55/CG_WEB_FS_SD1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588800452665-BVS7W30W4BGSM9D4U6YW/CG_WEB_FS_OX1.jpg Forums - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588800454464-VA4XNDLMU5CCGBWWKSXA/CG_WEB_FS_UN1.jpg Forums - Previous https://cavendishglobal.com/forums-upcoming daily 0.75 2021-03-09 https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/t/6046c317c7835a4a8502bd2e/1588871106680/ Forums - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588871122550-MXSS2WS2BB4IDCF8HNUY/CG_WEB_FS_NY4.jpg Forums - Upcoming https://static1.squarespace.com/static/54dcd925e4b05c8b9b528c85/5eb43ce80ba7a95f5b10be2d/5eb43fc2ae6f2d0441f6cb5d/1588871106680/ Forums - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588871122032-BAAR0LONO40OEFQADIBB/CG_WEB_FS_SFO3.jpg Forums - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588874428388-BI6JWUNKBR9E1A1MNNAH/CG_WEB_FS_CH4.jpg Forums - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588874794437-3S9PWXPJKG729A861HTM/CG_WEB_FS_LAX1.jpg Forums - Upcoming https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1615250172768-VN6ZFYCQOY6NVGVXZCII/CG_WEB_PB2_Event16x9.jpg Forums - Upcoming https://cavendishglobal.com/cleveland-example daily 0.75 2020-05-07 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588880401621-53UNM5B6F1FU06IOS5OD/433549LOGO.jpg Cleveland - Example - Registration and Networking Breakfast 8:00 AM - 9:00 AM | Cleveland Clinic Main Foyer Guests registered with the Cavendish team. Digital Services provided servicing. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588880401621-53UNM5B6F1FU06IOS5OD/433549LOGO.jpg Cleveland - Example - Registration and Networking Breakfast 8:00 AM - 9:00 AM | Cleveland Clinic Main Foyer Guests registered with the Cavendish team. Digital Services provided servicing. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588880184345-VPGLC880MH42SQU7L9U2/433549LOGO.jpg Cleveland - Example - Opening Keynote from Cleveland Clinic Senior Leadership 9:00 AM - 10:00 AM | Featuring Dr. Leader, Senior Leader, Cleveland Clinic Dr. Leader spoke about leadership at the Clinic. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588880379110-P1I3REZ6RS6FXDYD71PF/image-asset.jpeg Cleveland - Example - Registration and Networking Breakfast 8:00 AM - 9:00 AM | Cleveland Clinic Main Foyer Guests registered with the Cavendish team. Digital Services provided servicing. https://cavendishglobal.com/forum-series daily 0.75 2023-12-30 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1589301592646-L1F3Z1Q2ELPYFXUGQUTS/SCRM-2.jpg Forums https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1589312411448-AV03V5E8UF4FSC3XJSGZ/8J5A5081.jpg Forums https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1589302165144-7FBAH4Y8C2XMRZD3NRHJ/cg_members.jpg Forums https://cavendishglobal.com/summit-gallery-previous daily 0.75 2022-01-10 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1639421018095-GUXE7U473AJIGB7GLZHQ/cg-web-ss19-16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1639421018095-GUXE7U473AJIGB7GLZHQ/cg-web-ss19-16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1639419923480-SBDBZFXNP2M8XH3ABG49/image-asset.jpeg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1634146730490-LV7UUM9YNYESC13CNQVB/cg-web-ss17-event16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1630077606656-2KD4PIJDUK7QJQE3KJD6/CG_WEB_SS16_Event16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1625753623056-IIE2JUYWDA1WFWRGH5CV/CG_WEB_SS15_Event16x9_HP.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1618515467641-M5WYD9L38B8QBILXL9I2/CG_WEB_SS14_Event16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1618515467528-XQYPOFPZO4KOYUFGC126/CG_WEB_SS13_Event16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1619115645539-8ARZN4UABBOV8WKOYL7C/CG_WEB_SS12_Event16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1615245371748-TBO95ST7KGQDS3U4J5RC/CG_WEB_SS11_Event16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1615243873507-OXDFH96KOIO54EKL758F/CG_WEB_SS10_Event16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1611592595931-A9KDM4EREMDVAQTG73YL/CG_WEB_SS9_16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1606845417060-T04OA390R6R7EYD76WH8/CG_WEB_SS_8.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1603738301765-LDNOPQHY0L4IPV12M72K/CG_WEB_SS_PH6.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1599765771696-NM0406CHTO5CTUHS7273/CG_WEB_SS6_16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1597934121818-RTIM2VDPRQR9UR0RVCLE/CG_WEB_SS5_16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1597769779085-CLKKEU3WHLAI3IMCL721/CG_WEB_SS4_FINAL_16x9.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1594320187991-LEUXQN1QZS2O93NHAJJ1/CG_WEB_SS_SUM3.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1591292349869-PQPB48GKIX3TGXZLI126/CG_WEB_SS_SUM2.jpg Summit Gallery - Previous https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1593020284826-86C0PPTR5QU5UZ0X0YGW/CG_WEB_SS_MAY20.jpg Summit Gallery - Previous https://cavendishglobal.com/summit-3-gallery daily 0.75 2021-09-28 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1591717712185-2FQICZOLLCKI92YL2YZ5/293448_0008.jpg Summit 3 Gallery - How Family Offices Are Investing Differently as a Result of COVID-19 Ronald S. Diamond, Chairman and CEO, Diamond Wealth, based in Chicago, IL; Chicago Chair, TIGER 21; former Director, Stanford University Global Family Office Initiative Mr. Diamond is the former Director of the Stanford University Global Family Office Initiative and served as former Chairman of the Advisory Board at Stanford University for the Disruptive Technology and Digital Cities Program. In addition, Mr. Diamond guest lectures at Stanford’s Graduate Business School, Graduate Engineering School, and the Entrepreneur program. He serves on the Advisory Board of 10 privately held companies and acts as Chairman for 4 of them. Mr. Diamond is also the Chair of two TIGER 21 chapters in Chicago. A frequent speaker at Family Office and Alternative Investment Conferences, Mr. Diamond has spoken at over 100 conferences across the globe. Mr. Diamond is also the Founder of Family Office World — (www.familyofficeworldpodcast.com) a podcast whose mission is to educate the market about Family Offices. Earlier in his career, Mr. Diamond founded Pinnacle Capital — a $250 million hedge fund that outperformed the S&P index 10 out of 10 years — before ultimately selling his company to an international investment firm. Previously, Mr. Diamond served as a Senior Managing Director at Bear Stearns. He began his career as an analyst at Drexel Burnham Lambert. Deeply committed to giving back, Mr. Diamond is an active philanthropist and civic leader. He is Chairman of the Advisory Board for the World Peace Initiative launched at Stanford University. He also serves as the Chairman of the Advisory Board of JSC and currently sits on the Board at the JCC and JUF. Mr. Diamond studied at Northwestern University, graduating Magna Cum Laude and earning his degree in Economics. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1591717712185-2FQICZOLLCKI92YL2YZ5/293448_0008.jpg Summit 3 Gallery - How Family Offices Are Investing Differently as a Result of COVID-19 Ronald S. Diamond, Chairman and CEO, Diamond Wealth, based in Chicago, IL; Chicago Chair, TIGER 21; former Director, Stanford University Global Family Office Initiative Mr. Diamond is the former Director of the Stanford University Global Family Office Initiative and served as former Chairman of the Advisory Board at Stanford University for the Disruptive Technology and Digital Cities Program. In addition, Mr. Diamond guest lectures at Stanford’s Graduate Business School, Graduate Engineering School, and the Entrepreneur program. He serves on the Advisory Board of 10 privately held companies and acts as Chairman for 4 of them. Mr. Diamond is also the Chair of two TIGER 21 chapters in Chicago. A frequent speaker at Family Office and Alternative Investment Conferences, Mr. Diamond has spoken at over 100 conferences across the globe. Mr. Diamond is also the Founder of Family Office World — (www.familyofficeworldpodcast.com) a podcast whose mission is to educate the market about Family Offices. Earlier in his career, Mr. Diamond founded Pinnacle Capital — a $250 million hedge fund that outperformed the S&P index 10 out of 10 years — before ultimately selling his company to an international investment firm. Previously, Mr. Diamond served as a Senior Managing Director at Bear Stearns. He began his career as an analyst at Drexel Burnham Lambert. Deeply committed to giving back, Mr. Diamond is an active philanthropist and civic leader. He is Chairman of the Advisory Board for the World Peace Initiative launched at Stanford University. He also serves as the Chairman of the Advisory Board of JSC and currently sits on the Board at the JCC and JUF. Mr. Diamond studied at Northwestern University, graduating Magna Cum Laude and earning his degree in Economics. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1591718148046-GKCZG1WA6HXNY5G66O8Y/Angus+headshot+square.jpg Summit 3 Gallery - Liberate Medical: Weaning Patients Off Mechanical Ventilation on Day One Angus McLachlan, PhD, Co-Founder and CEO, Liberate Medical, based in Crestwood, KY Dr. Angus McLachlan co-founded Liberate Medical and has served as a member of its board of directors and its Chief Executive Officer since 2013. From 2014 to 2016, he also served as the Director for Device Integration and Strategy for Revon Systems. Dr. McLachlan completed his doctoral research on Liberate Medical’s proprietary electrical muscle stimulation technology and was responsible for the initial product development of VentFree and SecondBreath, which led to the technology being spun out of Apellis Pharmaceuticals. He is co-inventor on all of Liberate Medical’s patents and has authored several important publications in the field of abdominal functional electrical stimulation. Dr. McLachlan received his M.Eng. in Mechanical Engineering and his Ph.D. in Biomedical Engineering from the University of Glasgow, Scotland. Meet Dr. McLaughlin and Liberate Medical by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1593180013073-DF6697INJ3WOPV2PU9JQ/theresa-deisher.png Summit 3 Gallery - Mobilizing the Supercharged Immune Armies Within Theresa Deisher, PhD, President and CEO, AVM Biotechnology, based in Seattle, Wash. To combat disease, we are armed with a special weapon: AVM0703. AVM0703 is a purer and loaded formulation of dexamethasone which has been used at lower doses since 1958 for other purposes. Our supra-pharmacologic dose has a novel mechanism of action (MOA) to mobilize the body’s own natural supercharged immune cells that are ten times more activated than ordinary immune cells. AVM0703 has activity in mouse models even against aggressive, impossible to cure cancer models. Preclinical studies show dramatic tumor reduction with supercharged NKT (Natural Killer T Cells) which are tenfold more efficient in killing tumors than normal NKT cells. Recently the UK has adopted 10 daily doses of 0.6 mg/kg dexamethasone (total 6 mg/kg) as standard of care for severe COVID-19 patients. Dexamethasone is the only drug that has been shown to reduce COVID-19 mortality (by 30%). Our purer and loaded AVM0703 could safely deliver the total 6 mg/kg dose as a single acute 1 hour IV infusion. Based on preclinical cancers models and compassionate use in cancer and GvHD patients, we hypothesize that AVM0703 could reduce days in ICU from 10+ days down to 2-3 days. Our passion is to deliver drugs that work rapidly and that are safe, effective, and affordable, to treat serious worldwide illness like cancer, autoimmunity, and life-altering infectious disease. We will serve overlooked populations; pediatric and adolescent patients, frail and elderly, and the poorer amongst us. We develop products that improve outcomes without additional suffering because we believe that side effects from treatments of cancers or infections should never be worse than the diseases themselves. Meet Dr. Deisher and AVM by logging in to Cavendish IQ. https://cavendishglobal.com/summit-4-gallery daily 0.75 2021-05-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1595262692116-495OMEBRYK4D7RMR9QCD/Greenwood_Jim_3163_crop.jpg Summit 4 Gallery - Politics and the Future of Biotech Innovation The Honorable James C. Greenwood, former President and CEO, Biotechnology Innovation Organization (BIO), based in Washington, DC Just as we enter the golden age of gene therapy, cell therapy, immunotherapy, CRISPR and advances in vaccine technology, elected officials in the White House, Congress, governors’ mansions and state legislatures are poised to kill medical innovation. Will cynical and/or ignorant politicians pass laws that will drive investment away from the life sciences and undermine the promise of treating and curing untold numbers of diseases? Jim Greenwood, the former President and CEO of the Biotechnology Innovation Organization (BIO), United States Representative and state legislator shared his predictions about how the November 2020 elections would shape the future of drug development. Meet Jim by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1595262692116-495OMEBRYK4D7RMR9QCD/Greenwood_Jim_3163_crop.jpg Summit 4 Gallery - Politics and the Future of Biotech Innovation The Honorable James C. Greenwood, former President and CEO, Biotechnology Innovation Organization (BIO), based in Washington, DC Just as we enter the golden age of gene therapy, cell therapy, immunotherapy, CRISPR and advances in vaccine technology, elected officials in the White House, Congress, governors’ mansions and state legislatures are poised to kill medical innovation. Will cynical and/or ignorant politicians pass laws that will drive investment away from the life sciences and undermine the promise of treating and curing untold numbers of diseases? Jim Greenwood, the former President and CEO of the Biotechnology Innovation Organization (BIO), United States Representative and state legislator shared his predictions about how the November 2020 elections would shape the future of drug development. Meet Jim by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1595614214979-ZZ98J6K1XIYBXVF7GGSP/0.jpg Summit 4 Gallery - First Treatment for Age-Related Macular Degeneration - A Visual Disease Affecting More 110 Million Worldwide, including 10 Million Americans, and stealing the independence of our Senior population. John VeLure, President and CEO, i-Lumen Scientific, Inc., based in Bloomington, Minn. Imagine losing the ability to read, drive or walk without assistance. Age-related macular degeneration (or AMD) is a debilitating visual disease that destroys quality of life. It affects the central field of vision and this progressive disease is the leading cause of blindness in those over 65, with more than 1 in 4 people being afflicted with AMD. Worldwide, it affects 110 Million people – including 26.0 Million in the US and Europe. Now, imagine having a solution that can restore lost vision. i-Lumen's non-surgical, office-based therapeutic uses surface micro-current stimulation applied to the eye to restore and mitigate this degenerative visual disease. The 5 day treatment regimen has demonstrated effectiveness in more than 60% of patients treated. This innovative technology will enable ophthalmic practices to finally treat a patient population that they could only previously monitor vision degradation overtime. Learn about i-Lumen’s breakthrough ophthalmic technology that will not only help reduce overall society costs but addresses a significant humanitarian issue – enabling our senior population to maintain their independence and ‘age-in-place’. John Velure, President & CEO, has more than 20 years experience in leading medical device companies leveraging surface neural stimulation to treat a variety of chronic health conditions. Previously, he was Founder and President of Neurotech, a surface neural stimulation company, specializing in orthopedic therapies, which he sold to Theragen in 2015 for a significant multiple. He also served as SVP of business development at Medibio, a publicly traded mental health diagnostic company. Prior to this, he was Senior Director at Compex Technologies US, a world leader in surface neural stimulation for pain management and rehabilitation, and led the growth of the US medical business, which led to the sale of the Company to Encore Medical/DJO. Mr. Velure was also Director of Sales and Marketing for American Medtech, a urology company that utilized surface compression and stimulation for the treatment of ED and led the sale of the Company to Pos-T-Vac, a leader in ED devices. Meet John and i-Lumen by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1595612437650-VQJ5E2P8T5X7VNNTT726/unnamed.jpg Summit 4 Gallery - Autem Medical: Extending and Improving the Lives of Cancer Patients Worldwide Michael Choukas, CEO, Autem Medical, Inc., based in Hanover, NH The Autem gEM™ System leverages our novel electromagnetic technology to offer safe, non-invasive, non-toxic and accessible treatment for advanced stage cancer patients with no or limited treatment options. Autem’s proprietary amplitude-modulated electromagnetic frequency (AM-EMF) technology, algorithms and AI identify dynamic patient-specific frequencies for patient prognosis, treatment and stratification for care and risk management. Patients live longer, with a higher activity level and quality of life, often with reduced exposure to toxic late stage treatments and consumption of healthcare services. Meet Michael and Autem Medical by logging in to Cavendish IQ. https://cavendishglobal.com/summit-5-gallery daily 0.75 2021-05-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1597771401659-N06E8U13N835VAE36W8T/Karl-Handelsman.png Summit 5 Gallery - Biotech Moonshots Making the 'Impossible' Possible Karl Handelsman, founder of Codon Capital and Investment Director, Roche Venture Fund, joining in from the San Francisco Bay Area Did 2020 have you searching for good news? Here is a story where the results are outpacing the hype. Karl Handelsman, founder and Managing Partner of Codon Capital, and Investment Director of the Roche Venture Fund, explained the biotech frontier for non-scientists. The accelerating pace of basic science is fueling technology development empowering small teams to tackle the hardest problems in human and planetary health. Importantly, these biotech "moonshots" are reaching escape velocity with tens of millions of dollars in dozens of months. Meet Karl by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1597771401659-N06E8U13N835VAE36W8T/Karl-Handelsman.png Summit 5 Gallery - Biotech Moonshots Making the 'Impossible' Possible Karl Handelsman, founder of Codon Capital and Investment Director, Roche Venture Fund, joining in from the San Francisco Bay Area Did 2020 have you searching for good news? Here is a story where the results are outpacing the hype. Karl Handelsman, founder and Managing Partner of Codon Capital, and Investment Director of the Roche Venture Fund, explained the biotech frontier for non-scientists. The accelerating pace of basic science is fueling technology development empowering small teams to tackle the hardest problems in human and planetary health. Importantly, these biotech "moonshots" are reaching escape velocity with tens of millions of dollars in dozens of months. Meet Karl by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1597935816161-FFXIIY75XMYMIHFF37KY/JS+Headshot+10-16.JPG Summit 5 Gallery - AcuityBio: ABC103 Preventing Lung Cancer Recurrence John ‘Jay’ Schwartz, PhD, President and Chief Executive Officer, AcuityBio Corporation, joining in from Boston, Mass. AcuityBio’s lead product candidate, ABC103, utilizes the FDA-approved drug paclitaxel with 510k cleared components, creating a proprietary solution to prevent post-surgical lung cancer recurrence. ABC103 is designed to be administered at the time of resection with approved endoscopic cutting staplers as part of standard surgical procedures enabling localized and sustained levels of paclitaxel for more than 60 days preventing recurrence. Additional high value for medicine near-term pipeline projects leveraging off ABC103's development are in the pipeline. Dr. Schwartz has a track record as a successful MIT academic, serial entrepreneur, translational medicine expert, venture-backed cofounder and angel investor. He has a demonstrated track record of identifying and driving commercially viable, early stage technologies through clinical development to acquisition exits. For the last 20 years, Dr. Schwartz has given back to the entrepreneurial ecosystem as a business mentor with the prestigious MIT Venture Mentoring Service as well as for the last three years as an NSF ICorps instructor. Learn more about AcuityBio and meet Dr. Schwartz by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1598900925378-ZB8M946EZYFLGWKAX5JP/Baker.jpg Summit 5 Gallery - Potential for Reducing Severity and Mortality in COVID-19 with Pravibismane: An Inhaled Anti-Infective Drug Brett Baker, MSc, DC, President and Chief Scientific Officer, together with Steven Schellong, Vice President of Capital Development and IR, Microbion Corporation, joining in from Bozeman, MT “If grippe condemns, the secondary infections execute.” Louis Cruveilhier, Physician 1919 Research of viral respiratory pandemics over the past 100 years has shown that the vast majority of deaths are attributed to secondary bacterial infections, also known as 'bacterial superinfections'. Research is now showing that bacteria are also responsible for increased severity and mortality in COVID-19 patients. In this presentation Microbion describes how their inhaled anti-infective, pravibismane, may help to prevent and treat secondary bacterial lung infections and cytokine storm in COVID-19 patients. Pravibismane is the first in a new class of anti-infective drugs with a novel mechanism of action, and is the first known anti-infective drug to have both broad-spectrum potency against a wide range of drug-resistant bacteria/superbugs and fungi, and an unprecedented ability to prevent and eradicate bacterial biofilms. Pravibismane’s potential has been validated through $17M in non-dilutive grant awards from CARB-X and the Cystic Fibrosis Foundation to fund studies for treatment of bacterial lung infections in cystic fibrosis patients. Meet Dr. Baker and Mr. Schellong by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1597934773429-DRAPHWPMYLCMH1C81CDK/x-therma-0549-Xiaoxi.jpg Summit 5 Gallery - Wait Not in Vain: Nature-Inspired Nano-Science Enables Organ Transplants on Demand Xiaoxi Wei, PhD, Founder and Chief Executive Officer, X-Therma, Inc., joining us from the San Francisco Bay Area Dr. Wei is an award winning start-up entrepreneur and chemistry professional in the area of biomimetic nanoscience and biopreservation in Regenerative Medicine. Being persistent on her life vision to enable "organs on-demand" since a very young age, she pursued her scientific endeavor in biomimetic Chemistry in the US. She founded X-Therma Inc. in San Francisco Bay Area in October 2014 and led the breakthrough innovation in biopreservation, which has demonstrated successful traction in Regenerative Medicine from cell & gene therapy, tissue engineering to whole organs for transplant. The highest impact of this technology would be saving the 80% of wasted human organs discarded for transplant (TAM $45B, USA) by extending the organ shelf-life from hours to days. The technology also enables centralized manufacturing processes for Regenerative Medicine products. The company is backed by multi-billion cell therapy companies, US DoD and high profile investors. She comes from an entrepreneurial family and has inherited the entrepreneur spirit. She is experienced in business development and managed an $8M engineering project while completing her Ph.D. study. She is a major author of 8 peer reviewed research papers and inventor of 2 high-impact patents. She serves as a healthcare advisor for the University of California Regents working group on innovation transfer and entrepreneurship, is a scientific advisor for Life Extension Foundation and was the Vice Chair of Younger Chemists Committee of the American Chemical Society (ACS), and California ACS executive committee member. She is a distinguished member of the RULEBREAKER society, Germany. She is the PI of 10 federal and state grants/contracts to develop breakthrough cryoprotectants enabling complex tissue/organ cryopreservation. She led the X-Therma research endeavors at The Molecular Foundry, Lawrence Berkeley National Laboratory 2015-2020. Xiaoxi gained multiple recognitions internationally and nationwide. MEDy award of XMED 2019; BUZZ-of-BIO 2019; Global championship of "Hello Tomorrow" in Global Health, 2019; SVIEF annual champion 2018, Patrick Soon-Shiong Innovation Award, 2015. Meet Dr. Wei and learn more about X-Therma by logging in to Cavendish IQ. https://cavendishglobal.com/summit-6-gallery-a daily 0.75 2020-10-13 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1599767477278-0NKAKYZOXPWEOUPFV3XN/Marcia.Photo+%282%29.jpg Summit 6 Gallery A - Marcia Nelson Managing Director, ShareNett; and Co-Founder, Triple C Advisory Marcia is a Managing Director at ShareNett, a members-only global network of professional investors collaborating on curated, quality investment opportunities. Marcia has spent a large portion of her career working in and for family offices and private dealmakers. She was previously at Alberleen Family Office Solutions, an independent investment advisory firm backed by family offices, and she formerly worked for an ultra-high-net-worth philanthropic family as well as a sports and entertainment family. Over the last 20 years, she has developed a strong network of private families, institutional investors, and advisers who are increasingly seeking access to quality direct deal flow from trusted, experienced partners.
 Triple C Advisory is a business life cycle consulting firm Marcia co-founded. Working off three pillars – Customer Acquisition, Consulting and Capital – the firm works with early stage companies as an advisor and board member to prepare them to receive institutional-grade investments. Marcia serves on the boards of several industry-related organizations, including: as President of ACG-NY (Association for Corporate Growth), which focuses on driving middle-market investments; as a board member of VentureCapitall.Org, a non-profit early-stage start up accelerator; and with the investment committee for University Impact, a donor-advised fund. She is also an advisor to a Utah-based Single Family Office. 
Marcia was named one of the 2020 Most Influential Women in Mid-Market M&A by Mergers & Acquisitions magazine, was listed as one the 2018 Who’s Who In Impact Investing by the Denver Business Journal and was honored with the 2017 ACG-NY Women of Leadership Award. She received her BA from Southern Utah State College and her MBA from the Gabelli School at Fordham University. Marcia holds Series 7 and 63 licenses. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1599767477278-0NKAKYZOXPWEOUPFV3XN/Marcia.Photo+%282%29.jpg Summit 6 Gallery A - Marcia Nelson Managing Director, ShareNett; and Co-Founder, Triple C Advisory Marcia is a Managing Director at ShareNett, a members-only global network of professional investors collaborating on curated, quality investment opportunities. Marcia has spent a large portion of her career working in and for family offices and private dealmakers. She was previously at Alberleen Family Office Solutions, an independent investment advisory firm backed by family offices, and she formerly worked for an ultra-high-net-worth philanthropic family as well as a sports and entertainment family. Over the last 20 years, she has developed a strong network of private families, institutional investors, and advisers who are increasingly seeking access to quality direct deal flow from trusted, experienced partners.
 Triple C Advisory is a business life cycle consulting firm Marcia co-founded. Working off three pillars – Customer Acquisition, Consulting and Capital – the firm works with early stage companies as an advisor and board member to prepare them to receive institutional-grade investments. Marcia serves on the boards of several industry-related organizations, including: as President of ACG-NY (Association for Corporate Growth), which focuses on driving middle-market investments; as a board member of VentureCapitall.Org, a non-profit early-stage start up accelerator; and with the investment committee for University Impact, a donor-advised fund. She is also an advisor to a Utah-based Single Family Office. 
Marcia was named one of the 2020 Most Influential Women in Mid-Market M&A by Mergers & Acquisitions magazine, was listed as one the 2018 Who’s Who In Impact Investing by the Denver Business Journal and was honored with the 2017 ACG-NY Women of Leadership Award. She received her BA from Southern Utah State College and her MBA from the Gabelli School at Fordham University. Marcia holds Series 7 and 63 licenses. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1601052144531-O5M22ETQU4KAQFXKU3BI/1000x-1.jpg Summit 6 Gallery A - Clifford H. Friedman Chairman and CEO, ShareNett; Founder and Chief Investment Officer, Cold Spring Ventures (SFO) Clifford H. Friedman has filled roles ranging from Chairman, CEO, Founder, Board Member, Lead Investor, in addition to serving in various senior executive operational roles. Demonstrated history of just under 40 years of private equity, venture capital, investment management, financial, and various senior operational roles with a focus on Media, Communications, Technology and FinTech. Served on over 30 private and public corporate Boards, raised capital and, supported strategic negotiations in a variety of countries globally ranging from United States, UK, Italy, Spain, Japan, Sweden, Germany, France, Brazil, Mexico and 7 GCC (Gulf Cooperation Counsel) countries. Skilled in value creation through a systematic process of working with management teams, board members, customers, creating and negotiating strategic partnerships globally to drive revenue and profitability that positions companies for successful liquidity events for all stakeholders. Friedman is the Chairman and CEO of ShareNett, a fully regulated private/closed global co-investment platform, providing 360 degree solutions for family offices, that brings highly curated investment opportunities across multiple assets classes, geographies and industries. hareNett was created by a family office, for family offices and owned by family offices. Prior to ShareNett, Mr. Friedman was a Managing Director and Member of the Management Committee of Raptor Group Holdings. Raptor Group Holdings is a private investment company backed by the Family Office of Jim Pallotta. Jim, former Vice Chairman of Tudor Investments, is a world class and, highly successful professional investor for over 30 years. Mr. Friedman was Managing Director and Founding Partner, responsible for Partnership investment activities at Highbridge Principle Strategies, Constellation Growth Capital. Mr. Friedman has served as a director, chairman of, and/or advisor to the following companies: Hibernia Networks, Widevine Technology, Savvis Communications, Net Insight AB, College Sports Television (CSTV), TVONE, Capital IQ, Active Health Management, The Street.com, Network 24, Origin Digital, Vivid Logic, TV Azteca (Mexico’s second largest broadcast network), Netscape and InterTrust. He also supported Highbridge Principal Strategies media based investments which includes; Digital Cinema Implementation Partners (DCIP). Mr. Friedman served as a Senior Vice President of Universal Studios where he was responsible for the creation and development of the Studio’s New Media Group. Mr. Friedman’s responsibilities at Universal Studios included working with all of Universal’s divisions to develop, execute and create investments, acquisitions, strategic alliances, multimedia applications, international expansion and other new business opportunities. Mr. Friedman served as Vice President--Strategic Development at NBC, where his responsibilities involved leveraging existing franchises to create new business opportunities. While at NBC, he helped to form the joint venture between NBC and Microsoft (MSNBC) and formulated NBC’s Latin American strategy. Mr. Friedman was a Senior Managing Director in the Media and Technology Group at Bear Stearns. During this period he was ranked an “All American Analyst” by the Institutional Investor Magazine poll of Wall Street institutional clients. While at Bear Stearns, he published “New Age Media--The Merging of Media, Communications, Computing and Consumer Electronics” in 1993 and a follow-on publication, “New Age Media II,” in 1994. During this period, Mr. Friedman also led Bear Stearns’ efforts to raise $225M to launch the New Age Media Fund, Inc. and helped advise several major media and technology companies. Concurrent with his time spent at Bear Stearns in the early 1990’s, Mr. Friedman launched a self-funded, private venture capital and consulting company in 1992 called Cold Spring Ventures. Investments included early stage, seed investments in Netscape Communications, InterTrust Technologies, Scoop, FFE Intellectual Property-AS Roma, Volta Industries, PingThings, DriveWealth, Revolt TV and Media, Verance, Potamus, Phase, ShareNett Holdings, Liquid Markets Group, Templum, Fusion Telecom. Mr. Friedman was a Senior Securities Analyst in the High Technology Group at Cyrus J. Lawrence Inc. From 1981 - 1985 he was a Senior Engineer at Hazeltine Corporation’s Wheeler Research Laboratory where he was involved in the analysis, design, and fabrication and testing of advanced communications systems, designed simulation software and developed new business areas. Mr. Friedman earned a Bachelor of Science in Electrical Engineering and Computer Science from NYU Tandon School of Engineering (Polytechnic University), a Masters of Science in Electrophysics from NYU Tandon School of Engineering (Polytechnic University) and a Masters of Business Administration in Finance and Investments from Adelphi University. He has been awarded two patents in the field of communications and has been published in various international technical and financial journals. He is also a co-inventor of a patent pending: Systems and Methods for trading, clearing, and settling securities transactions using blockchain technology. Additionally, he also taught several Undergraduate and Graduate Engineering classes as an Adjunct Professor at SUNY Stony Brook. Mr. Friedman is a Director/Member of the International Academy of Television Arts & Sciences. Board of Trustees-North Shore Long Island Jewish Health System (He is on Board of Trustee’s for Huntington Hospital, chairman of the Private Equity sub-committee and member of the Investment Committee on the Northwell Health System (formerly North Shore/LIJ). He is also the recipient of the 2002 Ellis Island Medal of Honor, and holds a Series 7, Series 63, and Series 82 set of securities licenses with Morningside Securities LLC (a subsidiary of ShareNett Holdings, LLC) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1601051749049-CS3FQCBYSGZ9OJ4ZBO0S/KHR+professional+photo.jpg Summit 6 Gallery A - Katherine Hill Ritchie Director and Board Member, Nottingham Spirk Family Office, and Founder, Private Capital Investments Mrs. Hill Ritchie has worked for seven single-family offices and also as an advisor through her firm, Private Capital Investments. Her current role is Director and Board Member for Nottingham Spirk Family Office, and her past roles include: Simon Group Holdings, Eden Capital, PEX Global and she was a Senior Analyst and Investment Committee Member for the Saad family office’s $3.5 billion investment portfolio. She was a Director for Wedge Alternatives, and also Hedgefund.net. She is an Angel Investor and Advisor to start-ups and is on the investment committee for University Impact, a social impact VC fund. Katherine received her MBA from Fordham University and her BS in Psychology from University of Maryland. Her Board member activities include: Chair of the ACG New York Family Office Committee, Board Member of ACG NY, and Family Office Advisory Board of TriState Capital. Her past philanthropic volunteer activities include: Global Co-Chair of The Guild, the Philanthropy and Education Committees of 100 Women in Finance, Fordham MBA Overseers Board, All Special Kids, Lighthouse Organization and Cancer101. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1601051802288-MWIK9LVNFI4FOP7SVE79/Mark-Kendell-Headshot-267x300.png Summit 6 Gallery A - Mark Kendell Serial Entrepreneur and Private Investor, and Founder, Kendell & Associates Mark is a purpose-driven serial entrepreneur and runs his family office focusing on direct investments and what he calls “true impact” opportunities. Very early in his career, he founded Kendell & Associates, a venture banking firm, specializing in the creation, financing, and operation of a broad spectrum of companies, innovations and investment opportunities. Since that time, he has provided leadership as an entrepreneur and investor in building new innovative companies and technologies. His ventures have covered a wide range, from one of the original national chains of quick lubrication stores, SuperLube (later became Jiffy Lube); a Utah-based pharmaceutical company, Royal Pharmaceutical Company, (technology ultimately acquired by GSK – becoming the product Abreva); an innovative research engine company, Intelisys / iArchives, (acquired by Ancestry.com); Great Western Aviation, one of the inter-mountain area’s leading general aviation FBO / charter companies (acquired by a Pvt. Equity Group); an innovative medical device company (acquired by G.E. Medical), to an industrial waste water cleaning technology. His incubator continues to develop other ideas from a very powerful AI engine for data analytics, cyber security and other educational applications. Currently his focus is expanding a media / entertainment company Celeris Media, LLC which are creating fresh new “principle and family-friendly based content” for motion pictures, television, book publishing, events and video games. He is also developing BuildStar Technologies, a construction management platform, and Previdence Corp., a SAMD (software as a medical device) company in the mental health industry. As a result of his entrepreneurial ventures, he was awarded number 15 in the ACE (Venture Magazine) annual "Top 100 Young Entrepreneurs in the USA." He was also awarded the State of Utah’s “Pioneer of Progress” by the Governor of Utah, for Science and Technology. Mr. Kendell attended Weber State University in Business Administration, (Lacks one class to “officially graduate”). He is a frequent lecturer and participant in family office conferences and symposia on subjects ranging from impact investing, entrepreneurial development, technology development, direct investing, and related topics in the United States, Europe, China, Africa and Mexico. He and his wife have five children and 8.7 grandchildren and live in Huntsville Utah. They enjoy skiing, hiking, water skiing and ranching. He loves aerobatic flying and studying ecclesiastical history. He loves serving on the Board of groups that make a measurable social impact like, The Stan Lee Foundation (literacy), and A Child’s Hope Foundation (building orphanages). https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1602086957412-OB3EPY327PF1XPSF32H8/1310374.jpg Summit 6 Gallery A - Andrew Trister, MD, PhD Deputy Director, Digital Health Innovation, Bill & Melinda Gates Foundation Andrew Trister leads digital health innovation at Bill & Melinda Gates Foundation. His team’s focus is to leverage integrated mobile technology and data systems to aid in the appropriate use and process of performing diagnostics as well as to enable high quality healthcare and wellness solutions in resource limited settings. The team leverages advanced technologies and data science built around mobile devices as an interface to advance the goals of the foundation through internal and external partnerships. Andrew is a physician scientist passionate about leveraging technology to improve health care for all. He believes the combination of multiscale digital data from patients can impact our understanding, prevention and treatment of disease. He joined the foundation from Apple, where he led clinical research and machine learning efforts in health special projects. Prior to Apple, he was the senior physician at Sage Bionetworks, where he focused on incentives for researchers and participants to collaborate on large datasets and translating those findings to clinical settings. Andrew completed residency in radiation oncology at the University of Washington, earned an MD, PhD in bioengineering, MSE and BSE in computer science, and a BA in biological basis of behavior all from the University of Pennsylvania. https://cavendishglobal.com/summit-6-gallery-b daily 0.75 2021-05-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1601052571429-Y6B3JPT9TK258W5USAS2/download.jpg Summit 6 Gallery B - Cellphire: Unleashing the power of platelets, to revolutionize transfusion medicine and enable novel cellular therapies Thomas Dann, Chief Investment Officer, Cellphire, Inc., based in Rockville, MD Cellphire is developing technology and products that have potential applications in diverse health care fields from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine. The fragility of the national supply of platelets is a topic of discussion of several task forces and agencies planning the nation's response to a pandemic such as avian influenza. This and other natural or man-made disasters would interrupt the constant supply of platelets that is needed to maintain an adequate supply or treat bleeding casualties. Meet Tom Dann and Cellphire by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1601052571429-Y6B3JPT9TK258W5USAS2/download.jpg Summit 6 Gallery B - Cellphire: Unleashing the power of platelets, to revolutionize transfusion medicine and enable novel cellular therapies Thomas Dann, Chief Investment Officer, Cellphire, Inc., based in Rockville, MD Cellphire is developing technology and products that have potential applications in diverse health care fields from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine. The fragility of the national supply of platelets is a topic of discussion of several task forces and agencies planning the nation's response to a pandemic such as avian influenza. This and other natural or man-made disasters would interrupt the constant supply of platelets that is needed to maintain an adequate supply or treat bleeding casualties. Meet Tom Dann and Cellphire by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1601052573617-O39FZZK36D9R4D9CK3CF/0.jpg Summit 6 Gallery B - NeuroDex – blood based brain diagnostics Oded Biran, Chief Executive Officer, NeuroDex, based in Boston, Mass. NeuroDex is bringing the personalized medicine revolution to dementia, neurology, and psychiatry. On October 15th, Oded Biran delivered an overview of NeuroDex and how his company is leveraging blood-based brain vesicles for advancing the treatment of brain-based, and other neurological indications. Meet Oded and learn more about NeuroDex by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1602087096497-4I9BPPPFITIPA5EE79AH/0+copy.jpg Summit 6 Gallery B - LactaLogics: A commitment to the world's smallest, most vulnerable patients Glenn Snow, co-founder and Chief Executive Officer, LactaLogics, Inc., based in Port Saint Lucie, FL LactaLogics is utilizing state-of-the-art technology so more at-risk infants will be able to have access to safe, high-quality human milk. Meet Glenn and learn more about LactaLogics by logging in to Cavendish IQ. https://cavendishglobal.com/summit-7-gallery-a daily 0.75 2020-10-27 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1603736452449-J50SIM2XJB1NJCYLMVCP/image-asset.jpeg Summit 7 Gallery A - Katherine Hill Ritchie Director and Board Member, Nottingham Spirk Family Office, and Founder, Private Capital Investments Mrs. Hill Ritchie has worked for seven single-family offices and also as an advisor through her firm, Private Capital Investments. Her current role is Director and Board Member for Nottingham Spirk Family Office, and her past roles include: Simon Group Holdings, Eden Capital, PEX Global and she was a Senior Analyst and Investment Committee Member for the Saad family office’s $3.5 billion investment portfolio. She was a Director for Wedge Alternatives, and also Hedgefund.net. She is an Angel Investor and Advisor to start-ups and is on the investment committee for University Impact, a social impact VC fund. Katherine received her MBA from Fordham University and her BS in Psychology from University of Maryland. Her Board member activities include: Chair of the ACG New York Family Office Committee, Board Member of ACG NY, and Family Office Advisory Board of TriState Capital. Her past philanthropic volunteer activities include: Global Co-Chair of The Guild, the Philanthropy and Education Committees of 100 Women in Finance, Fordham MBA Overseers Board, All Special Kids, Lighthouse Organization and Cancer101. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1603736452449-J50SIM2XJB1NJCYLMVCP/image-asset.jpeg Summit 7 Gallery A - Katherine Hill Ritchie Director and Board Member, Nottingham Spirk Family Office, and Founder, Private Capital Investments Mrs. Hill Ritchie has worked for seven single-family offices and also as an advisor through her firm, Private Capital Investments. Her current role is Director and Board Member for Nottingham Spirk Family Office, and her past roles include: Simon Group Holdings, Eden Capital, PEX Global and she was a Senior Analyst and Investment Committee Member for the Saad family office’s $3.5 billion investment portfolio. She was a Director for Wedge Alternatives, and also Hedgefund.net. She is an Angel Investor and Advisor to start-ups and is on the investment committee for University Impact, a social impact VC fund. Katherine received her MBA from Fordham University and her BS in Psychology from University of Maryland. Her Board member activities include: Chair of the ACG New York Family Office Committee, Board Member of ACG NY, and Family Office Advisory Board of TriState Capital. Her past philanthropic volunteer activities include: Global Co-Chair of The Guild, the Philanthropy and Education Committees of 100 Women in Finance, Fordham MBA Overseers Board, All Special Kids, Lighthouse Organization and Cancer101. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1603820148085-DAEOO1Q7TY2HH5S3ZZHI/john-nottingham-1.jpg Summit 7 Gallery A - John Nottingham Co-President, Nottingham Spirk Family Office John Nottingham is the Co-Founder of Nottingham Spirk, a family office and a leading business innovation firm with over 1,300 patents, of which 95% have been commercialized. The Nottingham Spirk “Vertical Innovation™” process has helped partner companies earn over $50 billion in combined sales for product lines like Dirt Devil, Little Tikes, Dutch Boy, and AXE. Nottingham Spirk partners with other family offices to create companies based on NS innovations, like the Crest SpinBrush venture which was sold to P&G, returning $475 million, 24 times EBITDA to family office investors. Their Swiffer Sweep+Vac venture was also sold to P&G. The ThermoScan Ear Thermometer venture was sold to Braun/Gillette for $175 million. Their new Tempo Walk Autonomous Golf Caddie was recently acquired by Club Car. Their CardioInsight non-invasive electrocardiographic mapping venture was acquired by Medtronic and has so far returned over $100 million to investors. Nottingham Spirk was recently recognized by Fast Company as one of the 100 Best Workplaces for Innovators in the World. The Nottingham Spirk current portfolio of venture companies include TecTraum; concussion therapy system, Sterifre; low cost disinfection system, XaTek; blood coagulation monitor, HairClinical; break-through technology in hair care, and Polar Delight; single-serve premium ice cream dispensing system. Nottingham Spirk recently partnered and co-invested with InvestIndustrial to acquire Jacuzzi Brands and is currently co-creating the next generation of premium spa products to double sales, triple profits and drive equity growth. John serves on the Cleveland Clinic Board of Trustees, Case Western Reserve University Technology Commercialization Board, CWRU Think[box] Makerspace Advisory Board, boards of Global Center for Health Innovation, Great Lakes Biomimicry, and Cleveland Institute of Art, as well as several private equity company boards of directors. John is one of the top individual patent holders in the USA, a Fellow of the National Academy of Inventors, an inductee of the Inside Business Hall of Fame, and a winner of the EY Entrepreneur of the Year Award. Other awards include Gold IDEA Award, Edison Gold Award and DuPont Packaging Gold Award. He has presented numerous times at family office events on the subject of innovating for maximum equity growth for portfolio companies. He has been featured on the Today Show, NBC Nightly News, CNN, The Wall Street Journal, Fortune, Forbes, Japan Forbes, Bloomberg BusinessWeek, New York Times, Wired and Fast Company. https://cavendishglobal.com/summit-7-gallery-b daily 0.75 2021-05-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1605196222626-QOG6W7P0Y0RENG955PK7/Brian_Frenzel_7229ba453e.png Summit 7 Gallery B - Tosk: Unleashing the Power of Companion Drugs Brian Frenzel, President, Chief Executive Officer and Director, Tosk, joining the Summit from Mountain View, CA Tosk is working to improve the quality of life and outcomes for patients by preventing the adverse side effects of existing cancer therapies, and blocking the activity of cancer genes. Brian will join the November Summit to unveil a brand new lead project that he and his colleagues have developed this year. Brian is a highly experienced biomedical company executive, previously serving as CEO of Centaur Pharmaceuticals, CEO of Adeza Biomedical, CEO of Vesta Medical, and COO of Genelabs Technologies, all of which went public or were acquired by large pharmaceutical companies. Earlier in his career, He was director of corporate planning at Syntex Corporation, a principal at Booz, Allen & Hamilton, a consultant at the Boston Consulting Group, and a lieutenant in the United States Navy Nuclear Power Program. Brian holds a BS in physics and an MBA from Stanford University. You may have met Brian at previous Cavendish Forums, in his concurrent role with Band of Angels. Meet Brian and Tosk by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1605196222626-QOG6W7P0Y0RENG955PK7/Brian_Frenzel_7229ba453e.png Summit 7 Gallery B - Tosk: Unleashing the Power of Companion Drugs Brian Frenzel, President, Chief Executive Officer and Director, Tosk, joining the Summit from Mountain View, CA Tosk is working to improve the quality of life and outcomes for patients by preventing the adverse side effects of existing cancer therapies, and blocking the activity of cancer genes. Brian will join the November Summit to unveil a brand new lead project that he and his colleagues have developed this year. Brian is a highly experienced biomedical company executive, previously serving as CEO of Centaur Pharmaceuticals, CEO of Adeza Biomedical, CEO of Vesta Medical, and COO of Genelabs Technologies, all of which went public or were acquired by large pharmaceutical companies. Earlier in his career, He was director of corporate planning at Syntex Corporation, a principal at Booz, Allen & Hamilton, a consultant at the Boston Consulting Group, and a lieutenant in the United States Navy Nuclear Power Program. Brian holds a BS in physics and an MBA from Stanford University. You may have met Brian at previous Cavendish Forums, in his concurrent role with Band of Angels. Meet Brian and Tosk by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1604944307401-S26ZDKN3Z64LDT17GFCT/Rob-Boyce-Headshot-Feb-2019-e1550349713550.jpg Summit 7 Gallery B - Healing After Birth: Preventing A Rare Pediatric Disease Robert Boyce, Chief Executive Officer, Plakous Therapeutics, joining in from Winston-Salem, North Carolina Plakous Therapeutics, established in 2016, has developed a patent-pending, placenta-derived, acellular platform biotherapeutic for the prevention of the rare pediatric disease, Necrotizing Enterocolitis (NEC). In June 2020, Plakous received both Orphan Drug and Rare Pediatric Disease designations from the FDA, and, in July 2020, Plakous received a $1.72M fast track Phase I and II SBIR grant from the NIH for NEC. This grant includes funding for the pre-clinical and potency experiments required for our IND filing. Most recently, the company signed an agreement with the Mayo Clinic to develop a natural history study for NEC. Meet Robert and learn more about Plakous by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1605196021870-HAQ2ON031CT5IK26EZ7Q/dillon.jpg Summit 7 Gallery B - HUSH: A New First in Secondhand Smoke Harm Reduction Dillon Galynsky, Co-Founder and Chief Executive Officer, HUSH, joining the Summit from New York City HUSH is on a mission to rid the world of secondhand smoke. The team will introduce a new handheld filtration technology for both cannabis and tobacco, providing users the ability to capture all fumes and odor. As regulations and cultural shifts continue to favor smokeless and odorless consumption, HUSH is positioned to be the leading consumer product to provide a game-changing solution. The company presents dynamic domestic and international intellectual property ownership, and the team includes members of award-winning ELEVEN, and a former RI State Department of Health Executive Director. Meet Dillon and learn more about HUSH’s work by logging in to Cavendish IQ. https://cavendishglobal.com/summit-8-gallery-a daily 0.75 2020-12-17 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1606855753358-74Z82Y9T4PRV9ROQFWEU/s4nAL6Yw.jpg Summit 8 Gallery A - Jens Wandel Special Adviser on Reforms to the Secretary-General of the United Nations; Secretary General's Designate managing the COVID-19 Response and Recovery Fund Mr. Jens Wandel was appointed in 2018 by United Nations Secretary-General António Guterres, as Special Adviser to the Secretary-General on Reforms. As Special Adviser, Mr. Wandel coordinates the three Reform streams: Sustainable Development, Peace and Security and Management. Mr. Wandel has had many years of distinguished service within UNDP. He served as Assistant Administrator (Assistant Secretary-General), Director of Bureau of Management from 2012 to 2017. Mr. Wandel has also served in several management functions focusing on change initiatives, including as Director, Centre for Business Solution, as Management Adviser and Project Director for the Work Improvement Tools Project and as a country-level coordinator of UNDP’s New Horizon 2001 change management exercise. Mr. Wandel has also held various leadership positions at the country level, including as United Nations Resident Coordinator and UNDP Resident Representative, Turkmenistan; UNDP Deputy Resident Representative, Kyrgyzstan; and UNDP Assistant Resident Representative, Viet Nam. Mr. Wandel brings a combination of substantive programming knowledge and operational expertise covering both UNDP and United Nations agencies. He has been the architect of a major business re-engineering project for UNDP and provides strategic leadership to support the organization’s change agenda. Mr. Wandel holds a Master of Arts equivalent in political science (development and public management), University of Aarhus, Denmark. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1606855753358-74Z82Y9T4PRV9ROQFWEU/s4nAL6Yw.jpg Summit 8 Gallery A - Jens Wandel Special Adviser on Reforms to the Secretary-General of the United Nations; Secretary General's Designate managing the COVID-19 Response and Recovery Fund Mr. Jens Wandel was appointed in 2018 by United Nations Secretary-General António Guterres, as Special Adviser to the Secretary-General on Reforms. As Special Adviser, Mr. Wandel coordinates the three Reform streams: Sustainable Development, Peace and Security and Management. Mr. Wandel has had many years of distinguished service within UNDP. He served as Assistant Administrator (Assistant Secretary-General), Director of Bureau of Management from 2012 to 2017. Mr. Wandel has also served in several management functions focusing on change initiatives, including as Director, Centre for Business Solution, as Management Adviser and Project Director for the Work Improvement Tools Project and as a country-level coordinator of UNDP’s New Horizon 2001 change management exercise. Mr. Wandel has also held various leadership positions at the country level, including as United Nations Resident Coordinator and UNDP Resident Representative, Turkmenistan; UNDP Deputy Resident Representative, Kyrgyzstan; and UNDP Assistant Resident Representative, Viet Nam. Mr. Wandel brings a combination of substantive programming knowledge and operational expertise covering both UNDP and United Nations agencies. He has been the architect of a major business re-engineering project for UNDP and provides strategic leadership to support the organization’s change agenda. Mr. Wandel holds a Master of Arts equivalent in political science (development and public management), University of Aarhus, Denmark. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1606856176358-8WH8Y39W28Q8AL7AEJ90/1_Vo6eNZLjlSdasJwHeh6zNQ.jpg Summit 8 Gallery A - Sergio Fernández de Córdova Executive Chairman, PVBLIC Foundation Sergio is a world-leading expert on innovative public-private multistakeholder governance models, from shaping social initiatives, regulatory frameworks to smart city policy & programs. Chairman & Founder, PVBLIC Foundation, an organization focused on using media, technology & data to drive impact & change. Chairman & Founder of P3 Smart City Partners, a smart city & smart infrastructure, public-private partnership government advisory & investment company. Co-Founder & Executive Vice-Chair of the Blockchain Commission for Sustainable Development a multi-sectoral framework to support the United Nations system. In all of his work, he leads the global development and policy work behind structuring Public Private Partnerships (PPP) around smart infrastructure & policy framework with local, state + federal governments. In his philanthropic endeavors, as Chairman of PVBLIC he leads the foundations engagement with Governments from the White House to the United Nations and multinationals; public & private. Sergio has developed partnerships that today hosts the Latino Impact Summit, SDG Media Zone & Media For Social Impact Summit, Blockchain for Impact; all in collaboration with various UN agencies. The collective platforms all focus on raising awareness and encourage action for the 17 Sustainable Development Goals. Sergio has been celebrated locally and internationally for the work of his various business for over a decade. In 2012, Dell Inc. named Sergio one of its #Inspired 100 leading global influencers. In 2015 Meet LATAM recognized Sergio as Entrepreneurial Latin Global Leader & Influencer. In 2016 the Humanitarian Innovation Forum honored Sergio at the UN with the Global Social Impact Award. In November, Crain 's honored Sergio as a Visionaries ' finalist to the Hispanic Executive & Entrepreneur Award and he was most recently named top 3 most influential people, by the United Nations Social 500 list and in 2018 was celebrated as the Real Leaders magazine’s Top 100 Global Visionary Leaders A graduate of Rutgers University with a Bachelor 's in Sociology, Sergio also completed the Massachusetts Institute of Technology; Birthing of Giants® executive program. Read Sergio’s full bio here. https://cavendishglobal.com/summit-8-gallery-b daily 0.75 2021-05-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1607454868785-4G53LI9QB9A3OBR1LD10/Michael+Cole+headshot.jpg Summit 8 Gallery B - Cutting-Edge Solutions to Address the Impact of the COVID-19 Pandemic on Mental Health Michael Cole, PhD, MBA, Chief Executive Officer, NeuroHealth Technologies, joining us from the San Francisco Bay Area The COVID-19 pandemic has greatly amplified the incidence, and personal, social, and economic costs of mental illness; and this impact will continue long after a COVID-19 vaccine is distributed. Unfortunately, mental health generally has been neglected by investors and impact funds. Unlike other areas of medicine, mental health treatments have seen little significant innovation in decades. Another critical concern is the extreme shortage of mental health care providers that existed before the pandemic and has risen exponentially. The pandemic forced a rapid shift to telehealth to meet this unprecedented demand, but remote mental health care is still in its infancy. It is ripe for applications of data science, artificial intelligence, and neuroscience. NeuroHealth Technologies is developing Neuro-ARTTM, a remote, data-centric, precision mental health care platform. Our solution will provide digital biomarkers for real-time patient insights, asynchronous assessment for scalability, and predictive analytics for precision therapy. Clinical studies are planned for long-term addiction recovery, cognitive rehabilitation with aging, and treatment of depression and anxiety disorders. NeuroHealth Technologies is building cutting- edge solutions to revolutionize mental health care. The future of mental health care is here. Dr. Cole serves as CEO at NeuroHealth Technologies, an early-stage company developing a data-centric precision mental health platform called Neuro-ARTTM to improve treatment outcomes, improve provider experience, and derive additional revenue streams for healthcare systems through enhanced care. He is also a part-time Assistant Clinical Professor at UC Berkeley. Dr. Cole’s previous work at early-stage companies includes developing a computerized remote care platform for assessment and treatment monitoring of individuals with cognitive disorders, developing an AI in silica research platform for neurological disorders, and developing machine learning-based neuroimaging diagnostic algorithms for mental illnesses and neurologic diseases. Previous positions include a joint appointment as Associate Clinical Professor at UC Davis School of Medicine and Director of the VA Northern California Neuropsychology Residency Program, and Director of Medical Affairs at Pacira Pharmaceuticals. Dr. Cole received his PhD in clinical neuropsychology from the University of Florida, completed his clinical neuropsychology internship and NIH Fellowship at the UCLA School of Medicine, and obtained an Executive MBA from UC Berkeley. Meet Dr. Cole through Cavendish IQ! Click to log in. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1607454868785-4G53LI9QB9A3OBR1LD10/Michael+Cole+headshot.jpg Summit 8 Gallery B - Cutting-Edge Solutions to Address the Impact of the COVID-19 Pandemic on Mental Health Michael Cole, PhD, MBA, Chief Executive Officer, NeuroHealth Technologies, joining us from the San Francisco Bay Area The COVID-19 pandemic has greatly amplified the incidence, and personal, social, and economic costs of mental illness; and this impact will continue long after a COVID-19 vaccine is distributed. Unfortunately, mental health generally has been neglected by investors and impact funds. Unlike other areas of medicine, mental health treatments have seen little significant innovation in decades. Another critical concern is the extreme shortage of mental health care providers that existed before the pandemic and has risen exponentially. The pandemic forced a rapid shift to telehealth to meet this unprecedented demand, but remote mental health care is still in its infancy. It is ripe for applications of data science, artificial intelligence, and neuroscience. NeuroHealth Technologies is developing Neuro-ARTTM, a remote, data-centric, precision mental health care platform. Our solution will provide digital biomarkers for real-time patient insights, asynchronous assessment for scalability, and predictive analytics for precision therapy. Clinical studies are planned for long-term addiction recovery, cognitive rehabilitation with aging, and treatment of depression and anxiety disorders. NeuroHealth Technologies is building cutting- edge solutions to revolutionize mental health care. The future of mental health care is here. Dr. Cole serves as CEO at NeuroHealth Technologies, an early-stage company developing a data-centric precision mental health platform called Neuro-ARTTM to improve treatment outcomes, improve provider experience, and derive additional revenue streams for healthcare systems through enhanced care. He is also a part-time Assistant Clinical Professor at UC Berkeley. Dr. Cole’s previous work at early-stage companies includes developing a computerized remote care platform for assessment and treatment monitoring of individuals with cognitive disorders, developing an AI in silica research platform for neurological disorders, and developing machine learning-based neuroimaging diagnostic algorithms for mental illnesses and neurologic diseases. Previous positions include a joint appointment as Associate Clinical Professor at UC Davis School of Medicine and Director of the VA Northern California Neuropsychology Residency Program, and Director of Medical Affairs at Pacira Pharmaceuticals. Dr. Cole received his PhD in clinical neuropsychology from the University of Florida, completed his clinical neuropsychology internship and NIH Fellowship at the UCLA School of Medicine, and obtained an Executive MBA from UC Berkeley. Meet Dr. Cole through Cavendish IQ! Click to log in. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1607625501299-JMB5WFU73G8HLBL2OJ98/dr-james-f-mcdonnell-profile-89afc41a.jpg Summit 8 Gallery B - Pharmazz, Inc.: Bringing Endothelins to Market Anil Gulati, MD, PhD, Founder, Chairman and Chief Executive Officer, Pharmazz, joining from Chicago, IL Pharmazz is a revenue-generating research-and-development critical care company whose first compound, Lyfaquin, is selling in India, since November 2020, to treat hypovolemic shock in life-or-death circumstances. US FDA advanced Lyfaquin without a Phase I or a Phase II. Pharmazz has a US FDA Phase III application on file, since November 1, 2020, under the agency's Special Protocol Assessment program. Pharmazz has more indications for Lyfaquin as well as two additional endothelins in its pipeline, one of which is in Phase III in India for ischemic stroke. These are the first endothelins brought to market. Each is first-in-kind and w/o competition. Pharmazz is preparing to fund the start of the US FDA Phase III, to grow sales in India, to expand sales to other Asian nations and to prepare for an IPO. Dr. Gulati is leading clinical development and commercialization of first-in-class drug products in critical care medicine. He led the discovery, development and launch of Lyfaquin for hypovolemic shock. He has 54 issued patents and is Professor Emeritus at Midwestern University, and is recipient of Paul R. Dawson Biotechnology Award 2014, and Littlejohn Award 2014. Dr. Gulati is a United States Fulbright Scholar 2008-2009 and winner of International Ranbaxy Research Award 2007. Dr. Gulati was the Scientific Reviewer, United States Defense Medical Research and Development Program, Combat Casualty Care Research Program 2016 and 2017. Meet Dr. Gulati and learn more about Pharmazz on Cavendish IQ. Click to log in to IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1607546599089-EU6TEC0AFJV18M3YD5GB/cg-web-ss8-cytogel.jpg Summit 8 Gallery B - Cytogel: A Transformational Pain Solution Dean Maglaris, Chairman and Chief Executive Officer, Cytogel Pharma, and A. Thomas McLellan, MS, PhD, Scientific Advisor to Cytogel Pharma, Professor Emeritus at the University of Pennsylvania, and former US Deputy Director of the Office of National Drug Control Policy (2009-2012) Cytogel is a clinical stage bio-pharmaceutical company developing first-in-class drug candidates, from the novel endomorphin family of molecules, that target key pain pathways and alleviate pain. This groundbreaking approach is backed by scientific evidence that elucidates its novel mechanism of action, differentiating it from that of the existing opioids and presenting an attractive alternative treatment for people in pain. Mr. Dean Maglaris is a seasoned leader with more than 30 years in the pharmaceutical industry, joining Cytogel as its CEO in 2005. He has successfully guided the company through the identification of attractive compounds and the development of its lead compound, CYT-1010, which is entering Phase 2 clinical development, following a successful Phase 1 study in humans. Mr. Maglaris has long understood the need for a breakthrough solution to effectively and safely treat moderate to severe pain and has recognized the potential benefits CYT-1010 could provide to patients. As such, Cytogel has a clear priority on developing this new class of drugs and continually pursuing new intellectual property, which has resulted in several issued patents. Dr. Thomas McLellan is founder of the Treatment Research Institute (TRI), an independent, nonprofit research and development organization dedicated to science-driven reform of treatment and policy in substance use, and Professor of Psychiatry at the University of Pennsylvania. He has more than 35 years of experience in addiction treatment research. In 2016, he served as Senior Editor for the US Surgeon General report on Facing Addiction. From 2009 to 2010, he was Science Adviser and Deputy Director of the White House Office of National Drug Control Policy (ONDCP), a Congressional-confirmed Presidential appointment to help shape the nation’s public policy approach to illicit drug use. At ONDCP, McLellan worked on a broad range of drug issues, including formulation and implementation of the President’s National Drug Control Strategy and promotion of drug treatment through the broader revamping of the national health care system. In 1992, he founded and led TRI to transform the way research is employed in the treatment of and policy making around substance use and abuse. In his career, he has published over 450 articles and chapters on addiction research and successfully completed over 150 NIH research grants. From 2000-2009 he was Editor-in-Chief of the Journal of Substance Abuse Treatment, and he has also served on several other editorial boards of scientific journals. Dr. McLellan is the recipient of several distinguished awards including the Life Achievement Awards of the American and British Societies of Addiction Medicine (2001 & 2003); the Robert Wood Johnson Foundation Innovator Award (2005); and awards for Distinguished Contribution to Addiction Medicine from the Swedish (2002) and Italian (2002) Medical Associations. In the 1980s, with his colleagues from the Center for the Studies of Addiction at the University of Pennsylvania, Dr. McLellan introduced the Addiction Severity Index and, later, the Treatment Services Review. Both are among the most widely used assessment instruments in the world. Learn more about Cytogel and meet both Dean Maglaris and Dr. Thomas McLellan on Cavendish IQ. Click to log in. https://cavendishglobal.com/summit-9-gallery-a daily 0.75 2021-01-04 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1609782134685-BJ8NH4KFVM2RL6T8M07C/%25282019-0829%2529%2B1-%2BLarry%2BLevy%2BHeadshot%2B.jpg Summit 9 Gallery A - Lawrence ("Larry") F. Levy Managing Partner, Levy Family Partners; Co-Founder and Chairman Emeritus, Levy Restaurants; and Chairman, Del Taco Restaurants, Inc., joining from Chicago, Ill. Larry is a serial entrepreneur who brings his value-added approach to his many various endeavors, developments, investments and philanthropy. Levy Restaurants - Founded in 1978, Larry built Levy Restaurants from a single delicatessen in Chicago into an internationally recognized specialized food service organization with the market leading share of sports and entertainment catering throughout North America and Europe and a network of acclaimed restaurants. Levy Restaurants disrupted sports concessions by providing restaurant quality dining and hospitality in sports and entertainment venues. From its initial start of catering the skyboxes for the Chicago White Sox Comiskey Park in 1982, the company grew to become the full food service restaurateur for more than 100 sports and entertainment venues across the globe including stadiums and arenas for all major sports leagues, convention facilities, and music/performance venues. Throughout the company’s 40 year history, Levy Restaurants has hosted and continues to cater marquee events such as the Kentucky Derby, Major League Baseball’s World Series, the All-Star Games of MLB, NHL & NBA, NFL’s Super Bowl, the GRAMMY Awards and the U.S. Open Tennis Tournament. Larry sold Levy Restaurants to the Compass Group of London in 2006, but remains Chairman Emeritus. Levy Family Partners (LFP) - Larry and two of his sons, Managing Partners Ari Levy and Steven Florsheim, manage LFP’s portfolio of operating businesses, real estate and other investments. LFP owns significant stakes in the Esperanza Resort in Cabo San Lucas, Mexico, a portfolio of real estate assets, Del Taco Restaurants Inc. (NASDAQ:TACO), and Blaze Fast-Fire’d Pizza. The private equity and venture holdings of LFP have included investments in a diverse set of private companies, including, Intensity Therapeutics, Cleversafe, Base, Home Depot Supply, Lakeview Investment Group, Nest, Organic Life, Peloton, Signal, Space X, Swipesense, Sunbit, Apervita and Salesforce Tower Chicago. Real Estate – Larry has had a simultaneous career in real estate development and investment. Major projects have included the recently completed River Point, a 1.1 million square foot office building in partnership with Hines and Ivanhoe Cambridge; Chicago Mercantile Exchange Center; One South Dearborn, in partnership with Hines; One Magnificent Mile; and Woodfield Lake Office Campus and the redevelopment of 321 North Clark. In all more than 10 million square feet developed. In addition, LFP has interests in Diversified Real Estate Capital, Waypoint Residential and RedHill Realty Investors, all sponsors of multiple real estate projects. Diversified is the co-sponsor of the Cresset + Diversified QOZ Fund which has provided equity for major real estate projects. Awards and Recognition - IFMA Gold Plate Award as Restaurateur of the Year in the United States; the Ivy Award, the restaurant industry’s Academy Award, for Spiaggia, Bistro 110 and Levy Restaurants. Larry and his wife Carol created and endowed the Levy Institute of Entrepreneurial Practice and the Levy Social Entrepreneur Lab at Kellogg Graduate School of Management at Northwestern University. 2001 Ernst & Young’s Master Entrepreneur of the Year Award. Sports Business Journal winner of the 2017 Champion of Sports Award. Boards – The Art Institute of Chicago, Kellogg Graduate School of Management, Lincoln Park Zoo, Northwestern Memorial Hospital and Northwestern University. Larry previously served as Chairman of the Chicago Chapter of the Young Presidents Organization and the Rhodes Scholarship Selection Committee. Larry received his B.S. and M.B.A. at Northwestern University. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1609782134685-BJ8NH4KFVM2RL6T8M07C/%25282019-0829%2529%2B1-%2BLarry%2BLevy%2BHeadshot%2B.jpg Summit 9 Gallery A - Lawrence ("Larry") F. Levy Managing Partner, Levy Family Partners; Co-Founder and Chairman Emeritus, Levy Restaurants; and Chairman, Del Taco Restaurants, Inc., joining from Chicago, Ill. Larry is a serial entrepreneur who brings his value-added approach to his many various endeavors, developments, investments and philanthropy. Levy Restaurants - Founded in 1978, Larry built Levy Restaurants from a single delicatessen in Chicago into an internationally recognized specialized food service organization with the market leading share of sports and entertainment catering throughout North America and Europe and a network of acclaimed restaurants. Levy Restaurants disrupted sports concessions by providing restaurant quality dining and hospitality in sports and entertainment venues. From its initial start of catering the skyboxes for the Chicago White Sox Comiskey Park in 1982, the company grew to become the full food service restaurateur for more than 100 sports and entertainment venues across the globe including stadiums and arenas for all major sports leagues, convention facilities, and music/performance venues. Throughout the company’s 40 year history, Levy Restaurants has hosted and continues to cater marquee events such as the Kentucky Derby, Major League Baseball’s World Series, the All-Star Games of MLB, NHL & NBA, NFL’s Super Bowl, the GRAMMY Awards and the U.S. Open Tennis Tournament. Larry sold Levy Restaurants to the Compass Group of London in 2006, but remains Chairman Emeritus. Levy Family Partners (LFP) - Larry and two of his sons, Managing Partners Ari Levy and Steven Florsheim, manage LFP’s portfolio of operating businesses, real estate and other investments. LFP owns significant stakes in the Esperanza Resort in Cabo San Lucas, Mexico, a portfolio of real estate assets, Del Taco Restaurants Inc. (NASDAQ:TACO), and Blaze Fast-Fire’d Pizza. The private equity and venture holdings of LFP have included investments in a diverse set of private companies, including, Intensity Therapeutics, Cleversafe, Base, Home Depot Supply, Lakeview Investment Group, Nest, Organic Life, Peloton, Signal, Space X, Swipesense, Sunbit, Apervita and Salesforce Tower Chicago. Real Estate – Larry has had a simultaneous career in real estate development and investment. Major projects have included the recently completed River Point, a 1.1 million square foot office building in partnership with Hines and Ivanhoe Cambridge; Chicago Mercantile Exchange Center; One South Dearborn, in partnership with Hines; One Magnificent Mile; and Woodfield Lake Office Campus and the redevelopment of 321 North Clark. In all more than 10 million square feet developed. In addition, LFP has interests in Diversified Real Estate Capital, Waypoint Residential and RedHill Realty Investors, all sponsors of multiple real estate projects. Diversified is the co-sponsor of the Cresset + Diversified QOZ Fund which has provided equity for major real estate projects. Awards and Recognition - IFMA Gold Plate Award as Restaurateur of the Year in the United States; the Ivy Award, the restaurant industry’s Academy Award, for Spiaggia, Bistro 110 and Levy Restaurants. Larry and his wife Carol created and endowed the Levy Institute of Entrepreneurial Practice and the Levy Social Entrepreneur Lab at Kellogg Graduate School of Management at Northwestern University. 2001 Ernst & Young’s Master Entrepreneur of the Year Award. Sports Business Journal winner of the 2017 Champion of Sports Award. Boards – The Art Institute of Chicago, Kellogg Graduate School of Management, Lincoln Park Zoo, Northwestern Memorial Hospital and Northwestern University. Larry previously served as Chairman of the Chicago Chapter of the Young Presidents Organization and the Rhodes Scholarship Selection Committee. Larry received his B.S. and M.B.A. at Northwestern University. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1609786576388-GOWI91M2KPT1HRWUIZD9/BLOGS11-150729964-AR.jpg Summit 9 Gallery A - Leonard Batterson Founder, Chairman and Chief Executive Officer, VCapital Management, based in Chicago, Ill. Leonard (“Len”) is a veteran venture capitalist and entrepreneur who has invested in and founded many venture-backed entrepreneurial companies and venture capital investment organizations since 1982. He is currently Chairman and CEO of Batterson Venture Capital, LLC (“BVC”), headquartered in Chicago, Illinois. Previously, Len was the Managing General Partner of Batterson, Johnson & Wang LP, one of the first private venture capital firms in Illinois focused on early-stage high technology and life sciences companies. He was also an early or founding investor in other major venture capital and private equity firms including Advent International, APAX, Athena SA, M/C Partners and U.S. Venture Partners. Earlier in his career as a venture capitalist, Len specialized in the turnaround and revitalization of entrepreneurial companies as Principal of Leonard Batterson Associates. From 1985 to 1987, Len was the Director of the Venture Capital Division of Allstate Insurance Company, one of the nation’s oldest, largest and most successful venture capital operations. There, Len played an integral role in the financing and restructuring of Control Video Corporation, which became America Online, Inc. He also sourced and introduced Allscripts to the venture capital industry while at Allstate. Len has since been a founding or early investor in a number of successful entrepreneurial companies, including Cleversafe, CyberSource, Beyond.com, Atlantic American Cablevision, Health Magazine (subsequently acquired by AOL/Time Warner), Illinois Superconductor Corporation (OTC: ISCO), and Nanophase Technologies Corporation (NASDAQ: NANX). AOL, Allscripts, and Cybersource have all become $1 billion+ valued companies. Len received his BA from Washington University, a Juris Doctor degree from Washington University, and an MBA from Harvard Business School. He is the author of Raising Venture Capital and the Entrepreneur (Prentice-Hall). As a thought leader on venture capital investing, Len is a frequent speaker and regularly consulted by business reporters. Len is the co-author of Building Wealth through Venture Capital: A Practical Guide for Investors and the Entrepreneurs They Fund. https://cavendishglobal.com/summit-9-gallery-b daily 0.75 2021-05-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1610999009475-42TIRZM5ALQ0GJ7DCWPZ/DSC_3688.jpg Summit 9 Gallery B - Falls: The Silent Epidemic of Our Aging Population and How the Tango Belt Redefines Safer Mobility Wamis Singhatat, Chief Executive Officer and Chief Technology Officer, ActiveProtective Technologies, joining the Summit from Fort Washington, PA Falls are the number one cause of fatal injury in US older adults, and fall deaths continue to rise at an alarming rate. Despite the magnitude and severity of elderly falls, no standard of care currently exists for high-fall-risk individuals. ActiveProtective, an early-stage venture-backed company, has developed a truly innovative solution to this problem. The Tango Belt is the first-ever connected wearable device to enable safer mobility by intervening with airbag protection during serious hip-impacting falls. Its proprietary AI-based platform also sends automatic caregiver alerts and remotely monitors balance and function for tele-health and tele-rehab applications. Wamis Singhatat is the Interim CEO and CTO at ActiveProtective. He is an established technology development leader with over 20 years of experience developing wearable and implantable medical devices in orthopedics and injury prevention from startups to Fortune 50 companies, including leadership roles within one of Johnson & Johnson’s largest orthopedic business units. His passion is tackling large unmet clinical needs by developing innovations that redefine the standard of care. Wamis received his Masters in Biomedical Engineering from the University of California, Davis, and a Bachelors in Mechanical Engineering from the University of Akron. He holds 29 patents in a variety of fields and has authored multiple papers on medical technology in peer-reviewed journals. Meet Wamis and learn more about ActiveProtective by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1610999009475-42TIRZM5ALQ0GJ7DCWPZ/DSC_3688.jpg Summit 9 Gallery B - Falls: The Silent Epidemic of Our Aging Population and How the Tango Belt Redefines Safer Mobility Wamis Singhatat, Chief Executive Officer and Chief Technology Officer, ActiveProtective Technologies, joining the Summit from Fort Washington, PA Falls are the number one cause of fatal injury in US older adults, and fall deaths continue to rise at an alarming rate. Despite the magnitude and severity of elderly falls, no standard of care currently exists for high-fall-risk individuals. ActiveProtective, an early-stage venture-backed company, has developed a truly innovative solution to this problem. The Tango Belt is the first-ever connected wearable device to enable safer mobility by intervening with airbag protection during serious hip-impacting falls. Its proprietary AI-based platform also sends automatic caregiver alerts and remotely monitors balance and function for tele-health and tele-rehab applications. Wamis Singhatat is the Interim CEO and CTO at ActiveProtective. He is an established technology development leader with over 20 years of experience developing wearable and implantable medical devices in orthopedics and injury prevention from startups to Fortune 50 companies, including leadership roles within one of Johnson & Johnson’s largest orthopedic business units. His passion is tackling large unmet clinical needs by developing innovations that redefine the standard of care. Wamis received his Masters in Biomedical Engineering from the University of California, Davis, and a Bachelors in Mechanical Engineering from the University of Akron. He holds 29 patents in a variety of fields and has authored multiple papers on medical technology in peer-reviewed journals. Meet Wamis and learn more about ActiveProtective by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1610999288882-CL6FS5J4OA75Q26NRT0S/J.Rafferty.png Summit 9 Gallery B - Vesteck: Increasing Long-Term Patient Survival Introducing Joseph Rafferty, Chief Executive Officer, Vesteck, Inc., joining the Summit from West Chester, PA Meet Joseph and learn more about Vesteck by logging in to Cavendish IQ. https://cavendishglobal.com/summit-10-gallery-a daily 0.75 2021-01-25 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1611594807643-Q3ZHXK9TY3630OD2770G/Muneer+2.jpg Summit 10 Gallery A - Muneer A. Satter Founder, Satter Investment Management (SIM), and founder, Satter Foundation, joining the Summit from Chicago, Ill. Muneer A. Satter manages Satter Investment Management (SIM), a private investment firm and family office. SIM has significant investments in healthcare companies. He also manages the Satter Foundation, a private family foundation. Mr. Satter is a retired partner at Goldman Sachs, where he was a partner of the firm for sixteen years. He spent his career in the Merchant Banking Division which manages the firm’s private investments. Mr. Satter joined Goldman Sachs in 1988 and moved to London in 1992 to start up and co-head the firm’s Merchant Banking Group in Europe. He later returned to New York and was the global head of the Mezzanine Group, where he raised and managed over $30 billion of assets. The mezzanine fund had a compound annual return of 12.9% for the sixteen years until Mr. Satter retired in 2012. This compares to 5.6% for the S&P 500 and 5.9% for the high yield index. He was also a senior member of the Investment Committee which made investment decisions involving companies with a total enterprise value of several hundred billion dollars. He was chairman of the Risk Committee for the Merchant Banking Division, which at the time had over $80 billion of assets under management. He is vice chairman of the Board of the Goldman Sachs Foundation and GS Gives, where he is also chairman of the Investment Committee overseeing $1.2 billion of assets. He is a member of the Board of Northwestern University where he is chairman of the Finance Committee. He is also a member of the Board of the Navy SEAL Foundation. He is a member of the Board of the Northwestern Medical Group (over 1,000 doctors and over $1 billion of revenue). He is on the Board of Advisors of Accelerate Institute (which provides leadership training for school principals) and on the Board of Trustees of the US Olympic and Paralympic Foundation. Additionally, he is on the Board of Advisors of the American Enterprise Institute. He was formerly on the Board of World Business Chicago (chaired by Mayor Rahm Emanuel). He is a member of the Council on Foreign Relations. He is a former co-chairman of Room to Read (which builds 2,000 libraries and schools per year in developing countries). He is a former member of the Board of the Nature Conservancy where he was chairman of the Finance Committee overseeing a $1.8 billion endowment. Mr. Satter is a director of Annexon which is a complement cascade pathway company focused on autoimmune and neurologic diseases. He was chairman of Akebia Therapeutics from 2012-2018, during which time it grew from a private company with a $60 million valuation to a publicly-traded biotech company with a $1.5 billion dollar valuation, focused on the treatment of anemia. He is on the board of directors of REX – Real Estate Exchange, Inc. Mr. Satter received a B.A. from Northwestern University, and a JD/MBA from Harvard Law School and Harvard Business School. He lives in Chicago, IL with his wife, Kristen, and their five daughters. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1611594807643-Q3ZHXK9TY3630OD2770G/Muneer+2.jpg Summit 10 Gallery A - Muneer A. Satter Founder, Satter Investment Management (SIM), and founder, Satter Foundation, joining the Summit from Chicago, Ill. Muneer A. Satter manages Satter Investment Management (SIM), a private investment firm and family office. SIM has significant investments in healthcare companies. He also manages the Satter Foundation, a private family foundation. Mr. Satter is a retired partner at Goldman Sachs, where he was a partner of the firm for sixteen years. He spent his career in the Merchant Banking Division which manages the firm’s private investments. Mr. Satter joined Goldman Sachs in 1988 and moved to London in 1992 to start up and co-head the firm’s Merchant Banking Group in Europe. He later returned to New York and was the global head of the Mezzanine Group, where he raised and managed over $30 billion of assets. The mezzanine fund had a compound annual return of 12.9% for the sixteen years until Mr. Satter retired in 2012. This compares to 5.6% for the S&P 500 and 5.9% for the high yield index. He was also a senior member of the Investment Committee which made investment decisions involving companies with a total enterprise value of several hundred billion dollars. He was chairman of the Risk Committee for the Merchant Banking Division, which at the time had over $80 billion of assets under management. He is vice chairman of the Board of the Goldman Sachs Foundation and GS Gives, where he is also chairman of the Investment Committee overseeing $1.2 billion of assets. He is a member of the Board of Northwestern University where he is chairman of the Finance Committee. He is also a member of the Board of the Navy SEAL Foundation. He is a member of the Board of the Northwestern Medical Group (over 1,000 doctors and over $1 billion of revenue). He is on the Board of Advisors of Accelerate Institute (which provides leadership training for school principals) and on the Board of Trustees of the US Olympic and Paralympic Foundation. Additionally, he is on the Board of Advisors of the American Enterprise Institute. He was formerly on the Board of World Business Chicago (chaired by Mayor Rahm Emanuel). He is a member of the Council on Foreign Relations. He is a former co-chairman of Room to Read (which builds 2,000 libraries and schools per year in developing countries). He is a former member of the Board of the Nature Conservancy where he was chairman of the Finance Committee overseeing a $1.8 billion endowment. Mr. Satter is a director of Annexon which is a complement cascade pathway company focused on autoimmune and neurologic diseases. He was chairman of Akebia Therapeutics from 2012-2018, during which time it grew from a private company with a $60 million valuation to a publicly-traded biotech company with a $1.5 billion dollar valuation, focused on the treatment of anemia. He is on the board of directors of REX – Real Estate Exchange, Inc. Mr. Satter received a B.A. from Northwestern University, and a JD/MBA from Harvard Law School and Harvard Business School. He lives in Chicago, IL with his wife, Kristen, and their five daughters. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1611594701495-Q0VELEKGKPAIWDRZS32U/Kevin-Rochford.jpeg Summit 10 Gallery A - Kevin Rochford Partner, Investor Relations, Satter Management, joining the Summit from Chicago, Ill. Kevin Rochford is a Partner at Satter Management. He joined Satter Management after eight years at Bessemer Trust as a Managing Director having overseen the Chicago, Dallas, and New York City offices, working with large families and family offices. Prior to Bessemer, Mr. Rochford was a Managing Director for Nuveen Investments. Previously, he spent 13 years with Northern Trust, most recently as Chairman and CEO of Northern Trust’s Western Region. While at Northern, he also lived in London and oversaw investment activities there, as well as Hong Kong and Tokyo. Prior, Mr. Rochford held roles at the Board of Governors of the Federal Reserve System. Mr. Rochford served as an artillery officer in the U.S. Marine Corps after college and was recalled to duty for the Persian Gulf War. Mr. Rochford received his bachelor’s from Williams College and an M.B.A. from New York University. He serves on the boards of the Museum of the City of New York, Lookingglass Theatre, the Naval War College Foundation, and Truth in Accounting. He is also a member of the Economic Club of Chicago and the Chicago Council on Global Affairs. He lives in Chicago, IL with his wife and has two children. https://cavendishglobal.com/summit-10-gallery-b daily 0.75 2021-05-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1612884589218-0LX3JF1XRV8RHCLXPOAR/Michel+Bazinet.jpg Summit 10 Gallery B - Replicor: Developing the cure for 300 million people affected by chronic Hepatitis B Dr. Michel Bazinet, Chief Executive Officer and Chief Medical Officer, Replicor, Inc., joining the Summit from Montreal, Quebec. Dr. Bazinet previously joined Cavendish at the very first Forum in 2014, hosted at the United Nations in New York. Dr. Bazinet will describe the current prevalence of chronic hepatitis B and the serious medical and social consequences of this disease. He will then review the poor efficacy of currently approved drugs and explain how Replicor is developing a new approach that will revolutionize the management of chronic hepatitis B by offering a new treatment that will generate much higher cure rates with a high safety track record. We will also describe how our drug will also have a major impact in the treatment of chronic hepatitis D which affects between 15 and 30 million people worldwide. Current state of development will be described as well as how new funds will be used to progress toward our ultimate goal of saving millions of lives. Dr. Michel Bazinet has been the CEO and Chief Medical Officer of Replicor Inc. since 2003. He is responsible for the development strategy of the Company and oversees all operations, including the planning of clinical trials. Previously, Dr. Bazinet worked as assistant professor in the departments of Urology and Oncology at McGill University in Montreal. He did his medical training at Sherbrooke University, his urology training at McGill University after which he did a 3-year fellowship in human tumor immunology and urologic oncology at the Memorial Sloan-Kettering Cancer Center in New York from 1984 to 1987. In 1996 Dr. Bazinet founded a company called Mediconsult and was its Medical Director. Mediconsult became listed on NASDAQ in 1999 and was acquired in 2000. Dr. Bazinet has previously served as a member of the board of Directors for 2 public companies and has been a consultant for many biotechnology projects. Dr. Bazinet is one of the two listed inventors on 239 patents owned by Replicor, of which 169 have already been granted and an additional 70 patents are still pending. Meet Dr. Bazinet and learn more about Replicor by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1612884589218-0LX3JF1XRV8RHCLXPOAR/Michel+Bazinet.jpg Summit 10 Gallery B - Replicor: Developing the cure for 300 million people affected by chronic Hepatitis B Dr. Michel Bazinet, Chief Executive Officer and Chief Medical Officer, Replicor, Inc., joining the Summit from Montreal, Quebec. Dr. Bazinet previously joined Cavendish at the very first Forum in 2014, hosted at the United Nations in New York. Dr. Bazinet will describe the current prevalence of chronic hepatitis B and the serious medical and social consequences of this disease. He will then review the poor efficacy of currently approved drugs and explain how Replicor is developing a new approach that will revolutionize the management of chronic hepatitis B by offering a new treatment that will generate much higher cure rates with a high safety track record. We will also describe how our drug will also have a major impact in the treatment of chronic hepatitis D which affects between 15 and 30 million people worldwide. Current state of development will be described as well as how new funds will be used to progress toward our ultimate goal of saving millions of lives. Dr. Michel Bazinet has been the CEO and Chief Medical Officer of Replicor Inc. since 2003. He is responsible for the development strategy of the Company and oversees all operations, including the planning of clinical trials. Previously, Dr. Bazinet worked as assistant professor in the departments of Urology and Oncology at McGill University in Montreal. He did his medical training at Sherbrooke University, his urology training at McGill University after which he did a 3-year fellowship in human tumor immunology and urologic oncology at the Memorial Sloan-Kettering Cancer Center in New York from 1984 to 1987. In 1996 Dr. Bazinet founded a company called Mediconsult and was its Medical Director. Mediconsult became listed on NASDAQ in 1999 and was acquired in 2000. Dr. Bazinet has previously served as a member of the board of Directors for 2 public companies and has been a consultant for many biotechnology projects. Dr. Bazinet is one of the two listed inventors on 239 patents owned by Replicor, of which 169 have already been granted and an additional 70 patents are still pending. Meet Dr. Bazinet and learn more about Replicor by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1613417535107-829HCXTG3QJSFXDGQ8S9/Chip+Appelbaum.jpeg Summit 10 Gallery B - Novilase® Laser Therapy – Improving the Treatment of Breast Cancer Henry “Chip” R. Appelbaum, President and CEO, Novian Health, joining the Summit from Chicago, IL. Novian Health is ready for the commercial launch of its proprietary image-guided laser system for focal destruction of tumors. Novian’s first product, Novilase Breast Therapy, intended as a minimally invasive alternative to lumpectomy, has an addressable market in Europe and the U.S. of $2 billion. It is performed in an outpatient setting such as a breast center. Novilase has shown improved efficacy at a lower cost versus lumpectomy. Patients benefit from a quicker recovery (hours not days), no need for cosmetic reconstruction, and improved health-related quality of life outcomes. An immunotherapeutic benefit may also accrue to patients as a result of the thermal ablation, potentially reducing the risk of recurrence even further. Recognized as the industry leader in its space, it is the only ablation device with a CE Mark for the treatment of cancerous and benign breast tumors. In the U.S., FDA has de-risked the Company’s path to market with IDE approval for a 510(k) pivotal study that can be completed in less than two years. Mr. Appelbaum was appointed President and CEO of Novian Health in February of 2005 and has more than 30 years of business development, marketing and sales, and science management experience. Previously, Mr. Appelbaum spent five years as Vice President of Corporate Development at Source Precision Medicine, a molecular diagnostics startup he helped found, and nine years at Amgen where he held different executive positions. He holds an MBA from the University of Chicago and a MS in Chemical Engineering from MIT. Meet Chip and learn more about Novian Health by logging in to Cavendish IQ. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1613685889525-LA6J8MTGXKYO3FP9H6J7/1586983697946.jpeg Summit 10 Gallery B - Anecare: Reversing the effects of anesthesia in the brain after surgery for children and seniors Introducing Michael Slatter, Chief Executive Officer, Anecare, joining the Summit from Salt Lake City, UT. Anecare has created ANEclear, the only FDA approved, CE Marked commercially available technology that reverses the effects of anesthetics in the brain to quickly return brain function, breathing and consciousness after surgery; delivering a safer, lower cost recovery. This technology was developed by a team of anesthesiology researchers from the University of Utah and has generated sales of 45,000 disposable devices for adult use and revenue of $2.4M The effects of anesthesia are widely known and have particular concern for children and seniors: — 50% of children experience delirium after surgery, which can lead to injury, need for restraint, and other drug intervention. — Delirium is the most common surgical complication in seniors over age 65, with 20-30% of these patients experiencing cognitive dysfunction. Recently published research confirms how inhaled anesthetics shut down electrical signaling in neurons in the brain that control brain function, consciousness and breathing. ANEclear’s patented process accelerates washout of the unwanted residual anesthetics from the brain at the end of surgery and restores electrical signaling to return brain function; impacting brain health for kids and seniors during their recovery from anesthesia. https://cavendishglobal.com/summit-11-gallery-a daily 0.75 2021-03-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1615248709993-MOCS6FA0HJSBIK9RAGLY/Margret-Trilli.jpg Summit 11 Gallery A - Margret Trilli Chief Executive Officer and Chief Investment Officer, ImpactAssets, joining the Summit from the San Francisco Bay Area Margret's 25-year career includes executive leadership, investment and operating roles for large and small companies including Barclays Global Investors/Blackrock and Charles Schwab. Her experience spans investment management, product management, strategy and planning, reengineering, turnarounds and business building. Margret’s investment expertise spans direct private equity and venture capital, international equities, currency hedging, commercial real estate, energy, natural resources, ESG/values-aligned strategies and impact investing. She founded Intentional Capital, a boutique private equity firm serving custom direct investments to a select group of family offices, many of whom have fully developed impact investing strategies. Margret also serves on the boards and investment committees of three family offices. Margret graduated from Stanford Graduate School of Business and holds a degree in Economics from University of California Santa Barbara. Margret lives in San Francisco, CA with her husband and children. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1615248709993-MOCS6FA0HJSBIK9RAGLY/Margret-Trilli.jpg Summit 11 Gallery A - Margret Trilli Chief Executive Officer and Chief Investment Officer, ImpactAssets, joining the Summit from the San Francisco Bay Area Margret's 25-year career includes executive leadership, investment and operating roles for large and small companies including Barclays Global Investors/Blackrock and Charles Schwab. Her experience spans investment management, product management, strategy and planning, reengineering, turnarounds and business building. Margret’s investment expertise spans direct private equity and venture capital, international equities, currency hedging, commercial real estate, energy, natural resources, ESG/values-aligned strategies and impact investing. She founded Intentional Capital, a boutique private equity firm serving custom direct investments to a select group of family offices, many of whom have fully developed impact investing strategies. Margret also serves on the boards and investment committees of three family offices. Margret graduated from Stanford Graduate School of Business and holds a degree in Economics from University of California Santa Barbara. Margret lives in San Francisco, CA with her husband and children. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1616442730646-8D5N6FZXQBLGA8C4VB7W/RB_bw.jpg Summit 11 Gallery A - Rachel Butler President, Catalytic Impact Foundation (CIF), joining the Summit from Boston, Massachusetts As President of the CIF, Rachel has extensive experience and expertise analyzing, evaluating, and investing in early- and mid-stage companies in the life sciences and healthcare industry. Since 2016, she has reviewed hundreds of such companies and served as a team leader, overseeing and managing the research, analysis, and investment processes, to select companies for presentation and/or investment, beginning at Cavendish Global and then at CIF. She is a lead member of the investment team that invested in the CIF portfolio of innovative healthcare companies. Previously, she served as co-founder and Editor-in-Chief of Asthma Magazine, a patient education publication for asthma and allergy. The magazine was used by the NHLBI to educate participants in its nationwide children’s asthma (CAMP) study; by Merck to launch its first-in-class asthma drug, Singulair; and by the American Lung Association, the American Academy of Asthma, Allergy and Immunology, the National Association of School Nurses, health maintenance organizations, disease management companies, and private practitioners throughout the country, to educate their patients about the condition. Subsequently, she guided the company through its acquisition by Elsevier Health Sciences, a leading publisher of medical journals, where she continued as Editor-in-Chief for five years. She is a graduate of St. Lawrence University, a trustee and treasurer of the Ross Conservation Trust. She is married with four children and lives near Boston, MA. https://cavendishglobal.com/summit-11-gallery-b daily 0.75 2021-05-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1615248264006-5ZJYTA6Z910PT1L4HKNX/RH+headshot.+.jpeg Summit 11 Gallery B - New Frontiers in Pain and Mental Health - Expanding Care to Those in Need. Richard Hanbury, Chief Executive Officer, Sana Health, who joined the March Summit from Colorado Richard Hanbury is the inventor of Sana, a neuromodulation platform for pain relief and deep relaxation, which he developed to eradicate his own life-threatening pain problem following a spinal-chord injury from a jeep crash near Sana, Yemen, in 1992. It is now his life’s mission to develop Sana to help others. Sana is an at-home treatment for pain and mental health. Sana uses audio-visual neuromodulation to guide the brain into a deeply relaxed state, reducing anxiety and increasing neuroplasticity. Because of this Sana is the first device that is able to treat all the major compounding co-morbidities of chronic pain – pain, anxiety, depression, and sleep issues. Sana is 90% complete on a pivotal FDA study - 120 person RCT at Duke University, and a 120 person RCT is also underway at Mount Sinai, for neuropathic pain. Sana is seeking to carry out pivotal trials in anxiety, depression, MS pain, Cerebral Palsy, CRPS, CPS and PTSD. Founder-developed to solve his own underlying nerve damage pain following a jeep crash in Yemen, the device is now poised to solve a large unmet need in the treatment of fibromyalgia, with multiple other pain and mental health indications to follow. Learn more about Sana Health and meet Richard by logging in to Cavendish IQ.. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1615248264006-5ZJYTA6Z910PT1L4HKNX/RH+headshot.+.jpeg Summit 11 Gallery B - New Frontiers in Pain and Mental Health - Expanding Care to Those in Need. Richard Hanbury, Chief Executive Officer, Sana Health, who joined the March Summit from Colorado Richard Hanbury is the inventor of Sana, a neuromodulation platform for pain relief and deep relaxation, which he developed to eradicate his own life-threatening pain problem following a spinal-chord injury from a jeep crash near Sana, Yemen, in 1992. It is now his life’s mission to develop Sana to help others. Sana is an at-home treatment for pain and mental health. Sana uses audio-visual neuromodulation to guide the brain into a deeply relaxed state, reducing anxiety and increasing neuroplasticity. Because of this Sana is the first device that is able to treat all the major compounding co-morbidities of chronic pain – pain, anxiety, depression, and sleep issues. Sana is 90% complete on a pivotal FDA study - 120 person RCT at Duke University, and a 120 person RCT is also underway at Mount Sinai, for neuropathic pain. Sana is seeking to carry out pivotal trials in anxiety, depression, MS pain, Cerebral Palsy, CRPS, CPS and PTSD. Founder-developed to solve his own underlying nerve damage pain following a jeep crash in Yemen, the device is now poised to solve a large unmet need in the treatment of fibromyalgia, with multiple other pain and mental health indications to follow. Learn more about Sana Health and meet Richard by logging in to Cavendish IQ.. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1616428663464-JZWYUN5PZMO0NRV0MR4D/Steve+Stephansen+Headshot.jpeg Summit 11 Gallery B - Establishing a New Standard of Guided Care for Heart Failure Patient Management Steve Stephansen, Chief Executive Officer, Lifewave Biomedical, who joined the Summit from the San Francisco Bay Area Heart failure (or congestive heart failure) has been the disease of highest incidence and prevalence in the U.S. as well as the EU, Japan, Southeast Asia, and MENA (prior to COVID19). Heart failure has the highest hospitalization and re-hospitalization rates, highest cost to the healthcare system and highest mortality. Heart failure incidence continues to rapidly grow and while new therapies and interventions are being developed, it remains a challenging disease. Healthcare systems are seeking care improvements that enable better care in home and remote clinics. LifeWave Biomedical is developing the CardioConnect™ system that will be the first cost effective non-invasive physiologic sensor that delivers a single clinically actionable parameter that can enable guided-care in home environments. The CardioConnect system is being designed to reduce hospitalization, improve quality-of-life, and significantly lower cost to health care systems in treating the disease. Steve Stephansen is the CEO of LifeWave Biomedical. He holds 40 years of engineering, marketing, sales, and CEO experience in information technology businesses in both Fortune 500 and startup businesses. He is experienced in the global commercialization of innovative technology products, including semiconductor solutions for high speed computing and signal processing, Internet video capture systems, displays, and business connectivity software. He has previous CEO experience at two technology startups, at WebV2, Inc. and Agoura Technologies, Inc. Previous to his CEO experience, he held the position of VP of Marketing & Sales at Information Storage Devices where he grew annual sales from $0 to $55M sales in four years, leading to successful initial and secondary public offerings. He is a graduate of the Stanford Graduate School of Business, Rensselaer Polytechnic Institute, and Lehigh University. Learn more about Lifewave BIomedical and meet Steve by logging in to Cavendish IQ. https://cavendishglobal.com/summit-12-gallery-a daily 0.75 2021-04-06 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1617727176453-GVTLNRJIVGOKD1UY167X/charlie.jpeg Summit 12 Gallery A - Charles D. Hammerman President and CEO, The Disability Opportunity Fund (DOF) joining the Summit from New York, NY Charlie Hammerman brings many years of involvement with initiatives for people with disabilities and significant experience in the financial markets. Prior to the creation of The DOF, Hammerman founded the Burton Blatt Institute at Syracuse University, an organization to advance civic, economic and social participation of persons with disabilities in a global society. In 2007 Hammerman was appointed Director of CDFI Initiatives at Syracuse University. Hammerman was a senior member of Private Executive Services, a division of Merrill Lynch’s Global Private Client Group. He also spent 4 years with Merrill Lynch’s Equity Capital markets division and 4 years in the Office of the General Counsel. Before Merrill Lynch, he was an Assistant US Attorney in New York and began his career as an associate at Morgan Lewis and Bockius. At Merrill Lynch, Hammerman spearheaded the creation of it’s “Disability Awareness Professional Network” in its world headquarters. As a result of his leadership, Merrill Lynch was recognized by Diversity Inc. magazine as the “number one company for employment of people with disabilities” in 2005 and 2006. Hammerman received his BA from Washington University in St. Louis and his JD from Fordham University in 1988. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1617727176453-GVTLNRJIVGOKD1UY167X/charlie.jpeg Summit 12 Gallery A - Charles D. Hammerman President and CEO, The Disability Opportunity Fund (DOF) joining the Summit from New York, NY Charlie Hammerman brings many years of involvement with initiatives for people with disabilities and significant experience in the financial markets. Prior to the creation of The DOF, Hammerman founded the Burton Blatt Institute at Syracuse University, an organization to advance civic, economic and social participation of persons with disabilities in a global society. In 2007 Hammerman was appointed Director of CDFI Initiatives at Syracuse University. Hammerman was a senior member of Private Executive Services, a division of Merrill Lynch’s Global Private Client Group. He also spent 4 years with Merrill Lynch’s Equity Capital markets division and 4 years in the Office of the General Counsel. Before Merrill Lynch, he was an Assistant US Attorney in New York and began his career as an associate at Morgan Lewis and Bockius. At Merrill Lynch, Hammerman spearheaded the creation of it’s “Disability Awareness Professional Network” in its world headquarters. As a result of his leadership, Merrill Lynch was recognized by Diversity Inc. magazine as the “number one company for employment of people with disabilities” in 2005 and 2006. Hammerman received his BA from Washington University in St. Louis and his JD from Fordham University in 1988. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1617727173370-HEF0L6NMTPHMMONRUVBA/Screen+Shot+2021-04-05+at+2.38.14+PM.png Summit 12 Gallery A - Kilty Mahoney Managing Director and Registered Representative, ShareNett, joining the Summit from Philadelphia, Penn. Kilty has over 20 years of investment banking experience, building and expanding market sector practices at leading financial institutions including Bank of America and Salomon Brothers. She is a creative and trusted strategic and business development advisor to founders and C-suite executives across Technology, Media and Telecom, having completed tens of billions of M&A and capital transactions. Kilty holds a BA in Economics from Mount Holyoke College and completed her MBA at Harvard Business School. She holds the Series 7 and 79 FINRA licenses. https://cavendishglobal.com/summit-12-gallery-b daily 0.75 2021-05-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1618595374980-L3O9J2OD3C212OB27IZJ/mirmir136-007127+%281%29.jpeg Summit 12 Gallery B - Floreo: Leveraging the Power of Virtual Reality Vijay Ravindran, Co-Founder and Chief Executive Officer, Floreo, joining the Summit from Washington, DC Vijay Ravindran is an accomplished entrepreneur and technology executive with experience in online retail at Amazon and the news media industry for The Washington Post Company. Vijay is the founder and CEO of Floreo, a venture-backed start-up developing virtual reality learning for people with autism spectrum disorder, ADHD and anxiety. Vijay’s career spans digital commerce and news media. He joined Amazon in 1998 when the company sold books and music. He later served as director of the ordering department at Amazon and led the team that launched Amazon Prime. As Chief Digital Officer for The Washington Post Company, he founded WaPo Labs and oversaw the development of over a dozen products in digital news and launched Washington Post Social Reader and Trove, a personalized news web application. He is an engineering graduate of the University of Virginia and serves on the Board of The Lenfest Institute for Journalism and the Alliance for Excellent Education. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1618595374980-L3O9J2OD3C212OB27IZJ/mirmir136-007127+%281%29.jpeg Summit 12 Gallery B - Floreo: Leveraging the Power of Virtual Reality Vijay Ravindran, Co-Founder and Chief Executive Officer, Floreo, joining the Summit from Washington, DC Vijay Ravindran is an accomplished entrepreneur and technology executive with experience in online retail at Amazon and the news media industry for The Washington Post Company. Vijay is the founder and CEO of Floreo, a venture-backed start-up developing virtual reality learning for people with autism spectrum disorder, ADHD and anxiety. Vijay’s career spans digital commerce and news media. He joined Amazon in 1998 when the company sold books and music. He later served as director of the ordering department at Amazon and led the team that launched Amazon Prime. As Chief Digital Officer for The Washington Post Company, he founded WaPo Labs and oversaw the development of over a dozen products in digital news and launched Washington Post Social Reader and Trove, a personalized news web application. He is an engineering graduate of the University of Virginia and serves on the Board of The Lenfest Institute for Journalism and the Alliance for Excellent Education. https://cavendishglobal.com/summit-13-gallery-a daily 0.75 2021-04-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1619116018277-LJCJO1I40M5QH1SWJIHD/nola%2Bmasterson%2Bmedium.jpg Summit 13 Gallery A - Nola E. Masterson Managing Director, Science Futures Management Co. LLC, and Lead, Portfolia FemTech Funds I & II Nola E. Masterson, MSc. is a biotechnology industry leader and forward thinker with more than 45 years of business experience in the life sciences industry and in venture capital investment. She founded Science Futures, Inc. in 1982 and as an analyst and consultant communicated the power that was to be found in the new field of biotechnology. Masterson was the first biotech Analyst on Wall Street working for Drexel Burnham Lambert and Merrill Lynch. Ms. Masterson worked with prominent venture funds. She has served as a Consultant at Kleiner Perkins Caufield & Byers and Oak Investments and IVP to create companies such as IDEC, Resound, and InSite Vision. Ms. Masterson serves as Managing Director of Science Futures Management Company, LLC and also works as an advisor, board member and investor. She has served as a Special advisor to the Board of Directors at Nativis, Inc, and is a current investor. She is a special advisor to several private companies and is Chair Emeritus of California Life Science Institute and served as founder and General Partner of Science Futures LLC I and Science Futures LLC II. She served as a Strategy Advisor at First Warning Systems, Inc., since September 2012 now called Cyrcadia Health, Inc and is the chair of the Advisory Board. Ms. Masterson started her own venture fund in 1998. As a venture investor, she served on the Board of EpiCept Corporation and on the Board of Nanostream, Inc. She served as an Industry Advisor at TVM Capital GmbH and its Venture Partner from 2000 to 2005. She also opened the San Francisco office of TVM and became a Venture Partner. She is the co- founder and first CEO of Sequenom, Inc. (SQNM), she has served on the Board of Directors at Omicia, Inc. now called Fabric Genomics. She served as a member of the Board and then Chairman of Repros Therapeutics Inc. (RPRX) until its sale to Allergan. She served as a Board of Director Member at EmbraceHer Innovations, Inc. and she serves as a Member of Global Advisory Board and is a Mentor at Astia, Inc. She is on the Board of Directors for Resonance-Med, a software for hearing Solutions Company in Chicago. She recently joined the board of directors of the start-up Lynx Bio in San Diego. She is an Adjunct Professor at University of California in the School of Management, teaching the business of biotechnology. She is the co-chair of the Northern California chapter of the Women Corporate Directors. The American College of corporate Directors awarded her the Advanced Professional Director Certificate. She is an experienced global executive having worked at Millipore for 8 years and Ames Company, a diagnostic division of Bayer. She serves on the community leadership board for the American Diabetes Association. She is a graduate of the Stanford Law School Board of Directors College course. She received a B.S. in Biology and Chemistry from Marymount College, a Medical Technology (ASCP) certification and a M.Sc. in Biological Sciences from George Washington University and completed Ph.D. course work in Molecular Biology at the University of Florida, where she taught in the Environmental Engineering Department. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1619116018277-LJCJO1I40M5QH1SWJIHD/nola%2Bmasterson%2Bmedium.jpg Summit 13 Gallery A - Nola E. Masterson Managing Director, Science Futures Management Co. LLC, and Lead, Portfolia FemTech Funds I & II Nola E. Masterson, MSc. is a biotechnology industry leader and forward thinker with more than 45 years of business experience in the life sciences industry and in venture capital investment. She founded Science Futures, Inc. in 1982 and as an analyst and consultant communicated the power that was to be found in the new field of biotechnology. Masterson was the first biotech Analyst on Wall Street working for Drexel Burnham Lambert and Merrill Lynch. Ms. Masterson worked with prominent venture funds. She has served as a Consultant at Kleiner Perkins Caufield & Byers and Oak Investments and IVP to create companies such as IDEC, Resound, and InSite Vision. Ms. Masterson serves as Managing Director of Science Futures Management Company, LLC and also works as an advisor, board member and investor. She has served as a Special advisor to the Board of Directors at Nativis, Inc, and is a current investor. She is a special advisor to several private companies and is Chair Emeritus of California Life Science Institute and served as founder and General Partner of Science Futures LLC I and Science Futures LLC II. She served as a Strategy Advisor at First Warning Systems, Inc., since September 2012 now called Cyrcadia Health, Inc and is the chair of the Advisory Board. Ms. Masterson started her own venture fund in 1998. As a venture investor, she served on the Board of EpiCept Corporation and on the Board of Nanostream, Inc. She served as an Industry Advisor at TVM Capital GmbH and its Venture Partner from 2000 to 2005. She also opened the San Francisco office of TVM and became a Venture Partner. She is the co- founder and first CEO of Sequenom, Inc. (SQNM), she has served on the Board of Directors at Omicia, Inc. now called Fabric Genomics. She served as a member of the Board and then Chairman of Repros Therapeutics Inc. (RPRX) until its sale to Allergan. She served as a Board of Director Member at EmbraceHer Innovations, Inc. and she serves as a Member of Global Advisory Board and is a Mentor at Astia, Inc. She is on the Board of Directors for Resonance-Med, a software for hearing Solutions Company in Chicago. She recently joined the board of directors of the start-up Lynx Bio in San Diego. She is an Adjunct Professor at University of California in the School of Management, teaching the business of biotechnology. She is the co-chair of the Northern California chapter of the Women Corporate Directors. The American College of corporate Directors awarded her the Advanced Professional Director Certificate. She is an experienced global executive having worked at Millipore for 8 years and Ames Company, a diagnostic division of Bayer. She serves on the community leadership board for the American Diabetes Association. She is a graduate of the Stanford Law School Board of Directors College course. She received a B.S. in Biology and Chemistry from Marymount College, a Medical Technology (ASCP) certification and a M.Sc. in Biological Sciences from George Washington University and completed Ph.D. course work in Molecular Biology at the University of Florida, where she taught in the Environmental Engineering Department. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1619116242634-BA4AKNUF3S2MQ6ALVNVJ/EQ-2%2B%282%29%2B%281%29.jpg Summit 13 Gallery A - Dr. Jane van Dis, MD, FACOG Medical Director, Maven Clinic; Lead, Portfolia FemTech Fund I; Co-Founder and CEO, Equity Quotient; Co-Founder, OB Best Practice in partnership with OBGProject; Co-Founder, TIME’S UP Healthcare Dr. Jane van Dis, MD, FACOG is a practicing OB-GYN, volunteer clinical faculty at USC Keck Verdugo Hills, Medical Director at Maven Clinic and Medical Advisor to women’s health companies such as Flex, and Bobbie Baby. She is also Co-Founder and CEO of Equity Quotient, Co-Founder of OB Best Practice in partnership with OBGProject, Co-Founder of TIME'S UP Healthcare and Co-Founder of Diana Consulting. A highly sought after medical advisor and national expert and speaker on equity in the workplace, she has published on the topic in the NEJM, Slate, and Harvard Business Review. She advises 5 health care startups, and Co-Admins a popular Facebook group (501c3) of 4800+ ObGyns, Ob Mom Group. Dr. can Dis is also a Founding Member of the Womxn’s Health Collaborative, a national non-profit seekings to empower womxn from diverse backgrounds to succeed and become leaders in science and medicine in the field of women’s health. She is a single mom to twins. https://cavendishglobal.com/summit-14-gallery-a daily 0.75 2021-06-23 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1619116679627-QSDNQ322OLRNDEW10AKN/5B779E33-EB9F-4386-B441-D04F017154E7.jpg Summit 14 Gallery A - Jamie Metzl Technology Futurist, Geopolitics Expert, Social Entrepreneur, Sci-Fi Novelist Jamie Metzl is a technology and healthcare futurist, geopolitical expert, novelist, social entrepreneur, media commentator, Senior Fellow of the Atlantic Council, Singularity University faculty member, and the Founder and Chair of the global social movement OneShared.World. In 2019, he was appointed to the World Health Organization expert advisory committee on human genome editing. Jamie previously served in the U.S. National Security Council, State Department, Senate Foreign Relations Committee, and as a Human Rights Officer for the United Nations in Cambodia. He serves on the Advisory Council to Walmart’s Future of Retail Policy Lab and has been an election monitor in Afghanistan and the Philippines and advised the government of North Korea on the establishment of Special Economic Zones. Jamie appears regularly on national and international media his syndicated columns and other writing on science, technology, health, politics, and international affairs are featured regularly in publications around the world. He is the author of a history of the Cambodian genocide, the historical novel The Depths of the Sea, and the genetics thrillers Genesis Code and Eternal Sonata. The highly revised paperback edition of his bestselling non-fiction book Hacking Darwin: Genetic Engineering and the Future of Humanity was released in April 2020. A founder and Co-Chair of the national security organization Partnership for a Secure America, Jamie is a board member of the International Center for Transitional Justice, the American University in Mongolia, and Parsons Dance, and a member of the Advisory Board of the Brandeis International Center for Ethics, Justice, and Public Life. He is a member of the Council on Foreign Relations and a former White House Fellow and Aspen Institute Crown Fellow. Jamie holds a Ph.D. from Oxford, a JD from Harvard Law School, and is a magna cum laude, Phi Beta Kappa graduate of Brown University. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1619116679627-QSDNQ322OLRNDEW10AKN/5B779E33-EB9F-4386-B441-D04F017154E7.jpg Summit 14 Gallery A - Jamie Metzl Technology Futurist, Geopolitics Expert, Social Entrepreneur, Sci-Fi Novelist Jamie Metzl is a technology and healthcare futurist, geopolitical expert, novelist, social entrepreneur, media commentator, Senior Fellow of the Atlantic Council, Singularity University faculty member, and the Founder and Chair of the global social movement OneShared.World. In 2019, he was appointed to the World Health Organization expert advisory committee on human genome editing. Jamie previously served in the U.S. National Security Council, State Department, Senate Foreign Relations Committee, and as a Human Rights Officer for the United Nations in Cambodia. He serves on the Advisory Council to Walmart’s Future of Retail Policy Lab and has been an election monitor in Afghanistan and the Philippines and advised the government of North Korea on the establishment of Special Economic Zones. Jamie appears regularly on national and international media his syndicated columns and other writing on science, technology, health, politics, and international affairs are featured regularly in publications around the world. He is the author of a history of the Cambodian genocide, the historical novel The Depths of the Sea, and the genetics thrillers Genesis Code and Eternal Sonata. The highly revised paperback edition of his bestselling non-fiction book Hacking Darwin: Genetic Engineering and the Future of Humanity was released in April 2020. A founder and Co-Chair of the national security organization Partnership for a Secure America, Jamie is a board member of the International Center for Transitional Justice, the American University in Mongolia, and Parsons Dance, and a member of the Advisory Board of the Brandeis International Center for Ethics, Justice, and Public Life. He is a member of the Council on Foreign Relations and a former White House Fellow and Aspen Institute Crown Fellow. Jamie holds a Ph.D. from Oxford, a JD from Harvard Law School, and is a magna cum laude, Phi Beta Kappa graduate of Brown University. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1624456068276-PYKZDDP39HEUEYXXYCVE/jeremy_schwartz_crop.jpg Summit 14 Gallery A - Jeremy Schwartz, CFA® Executive Vice President, Global Head of Research, WisdomTree Asset Management Jeremy Schwartz has served as Executive Vice President, Global Head of Research since November 2018 and leads WisdomTree’s investment strategy team in the construction of WisdomTree’s equity indexes, quantitative active strategies and multi-asset model portfolios. Mr. Schwartz joined WisdomTree in May 2005 as a Senior Analyst, adding to his responsibilities in February 2007 as Deputy Director of Research and thereafter, from October 2008 to October 2018, as Director of Research. Prior to joining WisdomTree, he was head research assistant for Professor Jeremy Siegel and helped with the research and writing of Stocks for the Long Run and The Future for Investors. Mr. Schwartz also is co-author of the Financial Analysts Journal paper, What Happened to the Original Stocks in the S&P 500? He received his B.S. in Economics from The Wharton School of the University of Pennsylvania and hosts the Wharton Business Radio program Behind the Markets on SiriusXM 132. Mr. Schwartz is also a member of the CFA Society of Philadelphia. https://cavendishglobal.com/summit-15-gallery-a daily 0.75 2021-07-14 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1625757919747-96F8OOO78SX23YLURYI9/heatherPotters.jpg Summit 15 Gallery A - Heather Callender-Potters Co-Founder and Vice Chairman, PharmaJet, based in Golden, Colo. Ms. Callender-Potters has over 25 years of active investment experience including private equity fund management and international investment (BCEE; Enterprise Investors) across multiple jurisdictions, and has managed individual investments and financial investor consortiums, ranging from $1 million to an excess of $100 million. She has also held board positions with several companies across a variety of industries ranging from auto-parts, to systems integration, publishing, and light-manufacturing. Ms. Callender-Potters has a BA in International Management from Claremont McKenna College and an MBA from the Wharton School at the University of Pennsylvania. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1625757919747-96F8OOO78SX23YLURYI9/heatherPotters.jpg Summit 15 Gallery A - Heather Callender-Potters Co-Founder and Vice Chairman, PharmaJet, based in Golden, Colo. Ms. Callender-Potters has over 25 years of active investment experience including private equity fund management and international investment (BCEE; Enterprise Investors) across multiple jurisdictions, and has managed individual investments and financial investor consortiums, ranging from $1 million to an excess of $100 million. She has also held board positions with several companies across a variety of industries ranging from auto-parts, to systems integration, publishing, and light-manufacturing. Ms. Callender-Potters has a BA in International Management from Claremont McKenna College and an MBA from the Wharton School at the University of Pennsylvania. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1626270219572-VZMYUSV08DM4JSEXKA01/57ec4d5c4e0c63b85fb4f487314cf156.png Summit 15 Gallery A - Saralyn Mark, MD Saralyn Mark, MD, an endocrinologist, geriatrician and women's health specialist is the founder, president and CEO of SolaMed Solutions, LLC, a boutique consulting firm. In this capacity, she has served as a medical and scientific policy advisor providing scientific and strategic direction for organizations and agencies including the White House Office of Science and Technology Policy, the Bill and Melinda Gates Foundation Strategic Investment Fund, academia, industry, and non-governmental and professional society organizations. She is also the founder and president of iGIANT®, the only nonprofit in the world accelerating the translation of research into gender/sex-specific design elements across all sectors. Dr. Mark was the first Senior Medical Advisor to the Office on Women's Health within the Department of Health and Human Services for 11 years and to the National Aeronautics and Space Administration (NASA) for 18 years and now serves on the NASA Steering Committee on Precision Innovation for Space Exploration. As Senior Medical Advisor, Dr. Mark was responsible for the development and analysis of initiatives and programs on emerging technologies, public health preparedness, physician workforce issues, sex and gender-based medicine and women's health on Earth and in space. As a pioneer in women's health, she designed the first women's health fellowship in the United States, helped create the National Centers of Leadership in Academic Medicine, the National Centers of Excellence in Women's Health in academic and community health centers across the country and landmark educational campaigns on critical health issues. Dr. Mark is a Diplomate of the National Board of Medical Examiners and had been the civilian representative to the Surgeon General Physician Advisory Committee. She has chaired or served on over 60 national and international editorial and advisory boards, commissions and task forces including the President's Interagency Council on Women, the National Institutes of Health Federal Work Group on Bone Diseases, the NASA Medical Policy Board, NCQA HEDIS Measurement Advisory Panel, the United Nations (UN) Global Commission on Women's Health, the UN Council on Gender Health, APCO Worldwide International and Healthcare Advisory Councils, the Society for Women's Health Research Board, and the Dean’s Scientific Advisory Board for George Mason University. She is the lead/spokesperson on COVID-19 for the American Medical Women’s Association (AMWA). Dr. Mark is an Associate Professor adjunct at the Yale University School of Medicine in the Departments of Medicine, and Obstetrics and Gynecology as well as at the Georgetown University School of Medicine. Dr. Mark is also an Affiliate Professor and Distinguished Senior Fellow in the School of Public Policy at George Mason University and a visiting Senior Lecturer at Kings College - London. She is an alumna of the New York University School of Medicine and Barnard College of Columbia University and completed her residency, fellowships and first academic appointment at the University of California at San Francisco School of Medicine (UCSF). In 2014, she was awarded an honorary Doctor of Laws degree from Wayne State University School of Medicine following her commencement address. Dr. Mark has published and delivered over 700 lectures in the United States and abroad. She is the author of Stellar Medicine: A Journey Through the Universe of Women's Health (Brick Tower Press). She has made over 500 television, radio, on-line and print appearances including CNN, NBC, ABC, Fox, Forbes, Business Insider and The Washington Post. Dr. Mark has received many accolades and awards from the federal government and prominent medical organizations such as the Secretary of Health Award for Distinguished Public Service, the Assistant Secretary of Health Award for Outstanding Team Performance and the Gynecologic Cancer Foundation's Public Service Award. She is the recipient of the 2011 AMWA Lila A. Wallis Award for Lifetime Achievement in Women's Health and the 2017 NYU School of Medicine Alumni Leadership Award. Dr. Mark continues to foster the development of innovative programs, policies and products that affect the lives of people around the world. https://cavendishglobal.com/summit-13-gallery-b daily 0.75 2021-05-25 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1621624512758-6IM0XVCA9LTS5X18KB1Z/kelly.jpg Summit 13 Gallery B - Introducing Innovative Designs, Inc. Welcoming Kelly Londy, Chief Executive Officer, Innoblative Designs, Inc., joining the Summit from Ann Arbor, Mich. Innoblative Designs, Inc. (“Innoblative”) is an advanced electrosurgical medical device company developing next-generation radiofrequency ablation (“RFA”) technology for cancer therapy and beyond. Spun out of Northwestern University and based in Chicago, IL, the Company’s pioneering work in RF energy has disruptive potential for treating solid cancerous and non-cancerous tumors beginning in its flagship markets of liver, breast, and lung. Innoblative is dedicated to innovating technology to help surgeons effectively treat surgical margins to improve the standard of care, focus on better patient experience, reduce the cost of treatment, and provide solutions to address clinical needs. Learn more about Innoblative and meet Kelly on May 27th by completing your RSVP here. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1621624512758-6IM0XVCA9LTS5X18KB1Z/kelly.jpg Summit 13 Gallery B - Introducing Innovative Designs, Inc. Welcoming Kelly Londy, Chief Executive Officer, Innoblative Designs, Inc., joining the Summit from Ann Arbor, Mich. Innoblative Designs, Inc. (“Innoblative”) is an advanced electrosurgical medical device company developing next-generation radiofrequency ablation (“RFA”) technology for cancer therapy and beyond. Spun out of Northwestern University and based in Chicago, IL, the Company’s pioneering work in RF energy has disruptive potential for treating solid cancerous and non-cancerous tumors beginning in its flagship markets of liver, breast, and lung. Innoblative is dedicated to innovating technology to help surgeons effectively treat surgical margins to improve the standard of care, focus on better patient experience, reduce the cost of treatment, and provide solutions to address clinical needs. Learn more about Innoblative and meet Kelly on May 27th by completing your RSVP here. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1621624713941-DUZ7B8XBFCFGCQLGF09Y/1517741655679.jpeg Summit 13 Gallery B - Introducing Seal Rock Therapeutics, Inc. Introducing Neil McDonnell, PharmD, Co-Founder and Chief Executive Officer, Seal Rock Therapeutics, Inc., joining the Summit from Seattle, Wash. Seal Rock Therapeutics is targeting the liver to deliver a first-in-class NASH therapy. Non-alcoholic steatohepatitis (NASH) is a severe, often lethal, liver disease characterized by inflammation and fibrosis (scarring) emerging from earlier-stage non-alcoholic fatty liver disease (NAFLD). Exploding in prevalence by the global obesity and diabetes epidemics, approximately one fourth of the world’s population now have NAFLD. The resulting NASH frequently leads to liver cancer and cirrhosis and will soon become the number one reason for liver transplantation. Well over 16 million patients worldwide suffer from NASH, and with no approved drugs available, face little prospects for improvement. An effective NASH drug will prevent the pain and suffering of millions of people, helping to ease the tremendous societal and economic burden this disease inflicts across the globe. Founded to create new drugs for such serious, life-threatening, inflammatory, and fibrotic conditions, Seal Rock Therapeutics has successfully developed and is now advancing its lead drug, SRT-015, into clinical trials for NASH. The process by which NASH arises from fatty liver is multi-factorial, but there is one common cellular pathway from which much of the inflammation, fibrosis, and cell death arise. As a central choke point, this common pathway makes an excellent target for disease control. Seal Rock’s drugs block this pathway by inhibiting the kinase ASK1, which acts as a key molecular “on-off switch” in regulating cellular injury. By identifying ASK1 as a critical therapeutic target and leveraging their specialized kinase expertise and know-how, the Seal Rock team has successfully designed a platform of drugs to inhibit ASK1. As an oral ASK1 inhibitor that goes selectively to the site of disease, the liver, Seal Rock’s first clinical candidate SRT-015 is ideally suited for NASH. Building upon this success, other ASK1 inhibitors from Seal Rock’s proprietary platform are being positioned toward other major inflammatory and fibrotic diseases including kidney, heart, and neurodegenerative disorders such as Parkinson’s disease. Neil McDonnell is the founding CEO of Seal Rock Therapeutics, created in 2016 to develop regenerative drugs for inflammatory and fibrotic diseases with inadequate treatment options. Neil has spent over 25 years in drug development and executive leadership roles in start-up biotechs, public biotechs and global pharmaceutical companies. He has previous CEO experience as CEO of Metacrine, a San Diego-based biotech dedicated to developing drugs for NASH and diabetes. Before Metacrine, Neil was Senior Vice President and head of the Cardiovascular and Metabolic Disease therapeutic area at Takeda Pharmaceuticals, responsible for the R&D and R&D pipeline strategy in these areas. Prior to this, Neil was Vice President of Program Management at the Seattle-based public biotech ZymoGenetics, where he oversaw all program development teams, and began his biotech career at Immunex, an oncology and immunology company acquired by Amgen. Learn more and meet Neil at the May 27th Summit by completing your RSVP here. https://cavendishglobal.com/summit-14-gallery-b daily 0.75 2021-06-23 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1624456538148-OMLZ2FHRBJJNWQQJVTH2/JK+Pic.png Summit 14 Gallery B - HanGenix: Protecting Lives and Preventing Costs Introducing Jeff Kline, Chief Executive Officer, HanGenix Solutions, joining the Summit from Atlanta, Georgia HanGenix Solutions is a high-tech organization bringing together a novel, patent-protected technology, robust software and analytics, process improvement and change management practices to monitor and improve hand hygiene compliance. HanGenix’ mission is to save thousands of lives while driving millions of dollars out of the healthcare system by helping healthcare facilities improve hand-hygiene compliance. By creating an "Alliance for Compliance," HanGenix is bringing together the best people, process, data, and technology to help organizations improve patient care, drive higher quality, and improve financial performance by reducing unnecessary infections. HanGenix' unique technology goes beyond just monitoring compliance through the use of "patient protection zones," which provide a reminder to care givers prior to breaking compliance protocol and thus improving hand-hygiene compliance rates. The ultrasound platform allows for easy implementation, requiring no infrastructure investment, no IT integration, and no power consumption. As a result, healthcare facilities can achieve a quick payback on their investment while driving a very robust ROI. Learn more about HanGenix and meet Jeff at the Summit, by completing your RSVP here. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1624456538148-OMLZ2FHRBJJNWQQJVTH2/JK+Pic.png Summit 14 Gallery B - HanGenix: Protecting Lives and Preventing Costs Introducing Jeff Kline, Chief Executive Officer, HanGenix Solutions, joining the Summit from Atlanta, Georgia HanGenix Solutions is a high-tech organization bringing together a novel, patent-protected technology, robust software and analytics, process improvement and change management practices to monitor and improve hand hygiene compliance. HanGenix’ mission is to save thousands of lives while driving millions of dollars out of the healthcare system by helping healthcare facilities improve hand-hygiene compliance. By creating an "Alliance for Compliance," HanGenix is bringing together the best people, process, data, and technology to help organizations improve patient care, drive higher quality, and improve financial performance by reducing unnecessary infections. HanGenix' unique technology goes beyond just monitoring compliance through the use of "patient protection zones," which provide a reminder to care givers prior to breaking compliance protocol and thus improving hand-hygiene compliance rates. The ultrasound platform allows for easy implementation, requiring no infrastructure investment, no IT integration, and no power consumption. As a result, healthcare facilities can achieve a quick payback on their investment while driving a very robust ROI. Learn more about HanGenix and meet Jeff at the Summit, by completing your RSVP here. https://cavendishglobal.com/summit-15-gallery-b daily 0.75 2021-07-19 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1625757788049-OM13AYFS4OKC1CIT66E9/1598497206474.jpg Summit 15 Gallery B - Clarity Telehealth: Bridging the gap between surgery and mental health. Introducing Merritt Widen, Chairman and Chief Executive Officer, Clarity Telehealth, based in San Rafael, Calif. Clarity Telehealth was founded by an All-Star team consisting of pioneers in behavioral Telehealth, eminent psychiatrist-executives, experienced healthcare industry leaders and world renowned surgeons to address a critical treatment gap in behavioral healthcare. Over 8 million people undergo major life-changing surgeries in the US each year, and very few have access to the mental health support they need to recover. Such procedures as open heart surgery, neurosurgery, amputation, mastectomy, bariatric and spinal surgeries are highly associated with depression, anxiety, PTSD, and even psychosis brought on by the understandable stress. Untreated mental health issues result in patient non-compliance to treatment plans, higher mortality risk, lower patient satisfaction and poorer surgical outcomes. Clarity develops mental health support programs for specific surgical procedures and patient populations. Services are delivered in the patient’s home by Clarity clinicians, efficiently and stress free, through our comprehensively supported Telehealth system. Clarity’s mission is to change the way surgery interfaces with mental health in the years to come. Clarity CEO, Merritt Widen, has been involved with entrepreneurial ventures for over 35 years. An alumnus of the University of Chicago, Stanford and the Harvard Business School, Merritt started Great Lakes Partners, an options and commodities trading house, soon after graduation. It eventually had memberships on the CBOE, Chicago Merc, Amex, Philadelphia Stock Exchange and Kansas City Board of Trade. Merritt launched a boutique investment bank, Heartland Financial Corp. in 1990, which specialized in working with start ups and as court appointed investment bankers/managers for companies in reorganization. As CEO, he worked with companies across a wide spectrum of industries, from high tech to truck parts, medical devices to spring water. His international experience includes working with companies in the UK, Mexico, Russia and Romania. Merritt founded Forefront TeleCare in 2009 which he led for over a decade and is now a national leader in providing behavioral care via Telehealth to seniors in 40 states. He is considered a pioneer and thought leader in the behavioral Telehealth industry. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1625757788049-OM13AYFS4OKC1CIT66E9/1598497206474.jpg Summit 15 Gallery B - Clarity Telehealth: Bridging the gap between surgery and mental health. Introducing Merritt Widen, Chairman and Chief Executive Officer, Clarity Telehealth, based in San Rafael, Calif. Clarity Telehealth was founded by an All-Star team consisting of pioneers in behavioral Telehealth, eminent psychiatrist-executives, experienced healthcare industry leaders and world renowned surgeons to address a critical treatment gap in behavioral healthcare. Over 8 million people undergo major life-changing surgeries in the US each year, and very few have access to the mental health support they need to recover. Such procedures as open heart surgery, neurosurgery, amputation, mastectomy, bariatric and spinal surgeries are highly associated with depression, anxiety, PTSD, and even psychosis brought on by the understandable stress. Untreated mental health issues result in patient non-compliance to treatment plans, higher mortality risk, lower patient satisfaction and poorer surgical outcomes. Clarity develops mental health support programs for specific surgical procedures and patient populations. Services are delivered in the patient’s home by Clarity clinicians, efficiently and stress free, through our comprehensively supported Telehealth system. Clarity’s mission is to change the way surgery interfaces with mental health in the years to come. Clarity CEO, Merritt Widen, has been involved with entrepreneurial ventures for over 35 years. An alumnus of the University of Chicago, Stanford and the Harvard Business School, Merritt started Great Lakes Partners, an options and commodities trading house, soon after graduation. It eventually had memberships on the CBOE, Chicago Merc, Amex, Philadelphia Stock Exchange and Kansas City Board of Trade. Merritt launched a boutique investment bank, Heartland Financial Corp. in 1990, which specialized in working with start ups and as court appointed investment bankers/managers for companies in reorganization. As CEO, he worked with companies across a wide spectrum of industries, from high tech to truck parts, medical devices to spring water. His international experience includes working with companies in the UK, Mexico, Russia and Romania. Merritt founded Forefront TeleCare in 2009 which he led for over a decade and is now a national leader in providing behavioral care via Telehealth to seniors in 40 states. He is considered a pioneer and thought leader in the behavioral Telehealth industry. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1626102112761-6YS91D5W54P58VH93LWZ/SJ.png Summit 15 Gallery B Joining Merritt Widen is Steven P. James, MD, MBA, a distinguished fellow of the American Board of Psychiatry and Neurology, lifetime fellow of the American Board of Sleep Medicine, and published author of books, scientific journals and presenter at international medical congresses for over three decades. He is a co-founder and Chief Medical Officer of Clarity Telehealth and is passionate about enhancing patient access to psychiatric treatment and the continuing advances in neurosciences. Prior to Clarity, he worked within the pharmaceutical industry for over twenty-five years building high performance teams and held both clinical research and Medical Affairs leadership roles in several companies including Eli Lilly & Co., Allergan, Shire, Merck-Serono and Elan Pharmaceuticals. During his tenure in industry, he championed innovative approaches to improving patient diagnosis, recruitment, and clinical outcomes in multiple therapeutic areas including psychiatry, obesity and pain. A graduate of the University of Kentucky College of Medicine, he completed his internship and residency in psychiatry at Weill Cornell Medicine, New York-Presbyterian Hospital and Stanford University School of Medicine. After completion of his training, he was a research fellow at the National Institute of Mental Health (NIMH) followed by assistant professor of psychiatry at the University of Pennsylvania School of Medicine before embarking on his career in industry. He has a Master of Business Administration (MBA) from the University of California, Irvine with a special emphasis in strategic planning. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1626465368981-9T47PI78UMUXVXVS7NIO/Hausfeld_Jeffrey-Headshot.jpg Summit 15 Gallery B - BioFactura, Inc.: Innovation in Biomanufacturing Introducing Jeffrey Hausfeld, MD, MBA, Chairman of the Board and Chief Medical Officer, BioFactura, Inc., and Chairman and Co-Founder of SoPE (Society of Physician Entrepreneurs) based in Frederick, MD BioFactura is a clinical-stage biopharmaceutical company that develops high-value biosimilar (generic biologics) and biodefense drugs using its patented StableFast™ Biomanufacturing Platform, the optimal system for bringing these medicines to market with faster, lower cost, superior-quality manufacture. Dr. Jeffrey Hausfeld has served on the national board and committees of specialty medical societies since he began his practice in Otolaryngology/Facial Plastic Surgery in 1982. He is an Associate Clinical Professor of Surgery at George Washington University School of Health Sciences and an alumnus of the Yale University School of Medicine. Dr. Hausfeld is widely published in the medical literature, is the pioneer of innovative laser surgery techniques, is the author of a lay oriented medical book on snoring and sleep apnea, and has appeared on numerous local and national television and radio shows as a medical expert. He has also served as a health care consultant, spokesperson, and executive coach for multi-national pharmaceutical companies, health care firms, as well as the U.S. military. Dr. Hausfeld stepped down from his clinical duties after receiving a Masters in Business Administration from Johns Hopkins University. Dr. Hausfeld is presently developing assisted living facilities specializing in Alzheimer’s and dementia care. He serves as a consultant to several healthcare/life science startups in diagnostics, devices, biotech and Health IT. He also serves on the Investment Advisory Board of the Center for Innovation Technology’s Life Science Gap Fund. The fund supports promising healthcare and life sciences ventures in the Commonwealth of Virginia. Dr. Hausfeld is the Chairman and Founder of the Society of Physician Entrepreneurs, a global network focused on educating healthcare and life science professionals in Bioentrepreneurship and Innovation. Dr. Hausfeld is orchestrating the Series C Financing of BioFactura and acted as the lead investor in previous rounds. He serves as Chairman of the Board of BioFactura as well as their Chief Medical Officer as the company develops its Biosimilar platform as well as its novel Bio-defense therapeutics. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1626711962455-32JTDLSM4NYV6KTM9ODJ/Darryl+Sampey+Headshot.jpg Summit 15 Gallery B Joining Jeffrey Hausfeld is Darryl Sampey, PhD, who co-founded BioFactura in 2004 and has guided the venture over the past 15 years from start-up through incubator stages to become a significant biopharmaceutical product development and clinical manufacturing company. As President and CEO, Dr. Sampey manages all strategic and scientific endeavors of the Company. Before BioFactura, he led both process development and manufacturing teams at Human Genome Sciences, Inc. (HGS) honing his skills developing and scaling up new biologics processes and control strategies. During his tenure with HGS, Dr. Sampey played key roles in the start-up, commissioning, and validation of the company’s first cGMP manufacturing facility and associated development laboratories. Prior to his work at HGS, Dr. Sampey gained industrial experience in the commercial research laboratory designing and optimizing fermentation and product recovery processes for novel vaccines at North American Vaccine, Inc. His work in vaccine research has since progressed to internationally-approved vaccines for whooping cough in infants and meningitis in adults. Darryl Sampey began his career in biotechnology at the University of Maryland graduating first in his class with a Bachelor of Science in Chemical Engineering, Magna Cum Laude, and, subsequently earned a Ph.D. in Bioengineering. https://cavendishglobal.com/summit-16-gallery-a daily 0.75 2021-09-07 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1631036555528-ZB1KKQHH9DQVOFAZZZJ1/Weild+Photo.png Summit 16 Gallery A - David Weild IV Chairman and CEO, Weild & Co., and former NASDAQ Vice Chairman David is considered the world’s foremost expert in how stock market structure impacts capital formation, job formation, upward mobility and economic growth. He previously headed investment banking and equity capital markets at Prudential Securities (then, a top ten underwriter), and served as President of PrudentialFinancial.com. Broadly known as “Father of the JOBS Act” (the Act that led to securities crowdfunding, generally solicited private placements, new forms of IPOs in order to broaden access to capital), the studies that Weild co-authored uncovered that it was modern electronic market structure that led to a decline in small IPO activity and equity capital formation broadly which in turn undermines rates of innovation, economic growth, upward mobility and more inclusive capitalism. His work informed the capital markets aspects of the FAST Act and he worked closely on a new form of stock exchange to better support entrepreneurs that was included in The JOBS and Investor Confidence Act of 2018 - that passed the House 406-4 and was supported by the Trump Administration but failed to pass the Senate when President Trump shut down the Government and the legislation was stalled by pushing it into the 2019 Congress. Weild is a sought-after expert who has spoken at the White House (“My Brother’s Keeper, I Have A Dream Summit” and US Office of Science and Technology Policy), the US Congress, US Securities and Exchange Commission (SEC), the European Commission, the Organization of Economic Cooperation and Development (OECD), the Federation of European Securities Exchanges (FESE), the G-20, the Budapest Economic Forum, The National Black Chamber of Commerce, The Rainbow Push Coalition, The Kingonomics Conference for the 50th Anniversary of Martin Luther King’s March on Washington (where he first met Congressman John Lewis), among others. David is an advisor to OHUB (Opportunity Hub) in Atlanta, whose chairman and founder, Bishop Rodney Sampson, is the author of Kingonomics. Weild works with Mr. Sampson on Diversity Equity Inclusion Solutions or “DEIS” one of which is a corporate certification program that was developed and launched, in partnership with UNC at Chapel Hill, Duke University and Stanford University. In 2016, sensing a need to support the vast array of human capital that could be harnessed in support of financing the growth economy, Weild & Co. launched services to license, onboard and support professionals in what has been called “LPL Financial of investment banking.” Weild & Co.’s twin objectives are to be the first full-service, variable cost model, major bracket investment bank and the largest driver of job growth and social impact of any securities firm in the world. David has priced over 500 IPOs and 500 follow-on offerings and pioneered the use of form S-3 shelf registrations to help issuers mitigate market risk. This led to entire new categories of financings for less-than-investment-grade issuers including overnight equity offerings, registered directs, accelerated book builds and equity lines of credit. David holds an MBA from the Stern School of Business and a BA in Biology from Wesleyan University where he completed graduate work in molecular genetics and was the European Correspondent for GEN. He studied on exchange at The Sorbonne, Ecole des Haute Etudes Commerciales and The Stockholm School of Economics. He is Chairman Emeritus of Tuesday’s Children, the noted 9/11 charity that also provides support to US military families of the fallen, first responders and set up the Resiliency Center of Newtown. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1631036555528-ZB1KKQHH9DQVOFAZZZJ1/Weild+Photo.png Summit 16 Gallery A - David Weild IV Chairman and CEO, Weild & Co., and former NASDAQ Vice Chairman David is considered the world’s foremost expert in how stock market structure impacts capital formation, job formation, upward mobility and economic growth. He previously headed investment banking and equity capital markets at Prudential Securities (then, a top ten underwriter), and served as President of PrudentialFinancial.com. Broadly known as “Father of the JOBS Act” (the Act that led to securities crowdfunding, generally solicited private placements, new forms of IPOs in order to broaden access to capital), the studies that Weild co-authored uncovered that it was modern electronic market structure that led to a decline in small IPO activity and equity capital formation broadly which in turn undermines rates of innovation, economic growth, upward mobility and more inclusive capitalism. His work informed the capital markets aspects of the FAST Act and he worked closely on a new form of stock exchange to better support entrepreneurs that was included in The JOBS and Investor Confidence Act of 2018 - that passed the House 406-4 and was supported by the Trump Administration but failed to pass the Senate when President Trump shut down the Government and the legislation was stalled by pushing it into the 2019 Congress. Weild is a sought-after expert who has spoken at the White House (“My Brother’s Keeper, I Have A Dream Summit” and US Office of Science and Technology Policy), the US Congress, US Securities and Exchange Commission (SEC), the European Commission, the Organization of Economic Cooperation and Development (OECD), the Federation of European Securities Exchanges (FESE), the G-20, the Budapest Economic Forum, The National Black Chamber of Commerce, The Rainbow Push Coalition, The Kingonomics Conference for the 50th Anniversary of Martin Luther King’s March on Washington (where he first met Congressman John Lewis), among others. David is an advisor to OHUB (Opportunity Hub) in Atlanta, whose chairman and founder, Bishop Rodney Sampson, is the author of Kingonomics. Weild works with Mr. Sampson on Diversity Equity Inclusion Solutions or “DEIS” one of which is a corporate certification program that was developed and launched, in partnership with UNC at Chapel Hill, Duke University and Stanford University. In 2016, sensing a need to support the vast array of human capital that could be harnessed in support of financing the growth economy, Weild & Co. launched services to license, onboard and support professionals in what has been called “LPL Financial of investment banking.” Weild & Co.’s twin objectives are to be the first full-service, variable cost model, major bracket investment bank and the largest driver of job growth and social impact of any securities firm in the world. David has priced over 500 IPOs and 500 follow-on offerings and pioneered the use of form S-3 shelf registrations to help issuers mitigate market risk. This led to entire new categories of financings for less-than-investment-grade issuers including overnight equity offerings, registered directs, accelerated book builds and equity lines of credit. David holds an MBA from the Stern School of Business and a BA in Biology from Wesleyan University where he completed graduate work in molecular genetics and was the European Correspondent for GEN. He studied on exchange at The Sorbonne, Ecole des Haute Etudes Commerciales and The Stockholm School of Economics. He is Chairman Emeritus of Tuesday’s Children, the noted 9/11 charity that also provides support to US military families of the fallen, first responders and set up the Resiliency Center of Newtown. https://cavendishglobal.com/summit-16-gallery-b daily 0.75 2021-09-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1632321901649-CH3T2ZH9E5HQ4WQE06Z4/gitte-pederson.png Summit 16 Gallery B - DNA is Not Your Fate: Introducing OneRNA Introducing Gitte Pedersen, Co-Founder and Chief Executive Officer, Genomic Expression, based in Boston, Mass. Gitte Pedersen founded Genomic Expression with her brother when their parents got diagnosed with cancer. Prior to Genomic Expression, she operated Proximity Ventures and advised companies and Danish Ministry of Foreign Affairs brining in +$1B deals to Danish Biotech companies. She worked at Novo Nordisk in a number of management positions and brought multiple product to market worldwide. She has a master in Chemical Engineering and a bachelor in International Trade. Genomic Expression is a commercial-stage RNA Platform For Next Generation Cures. By analyzing RNA, we can detect disease, monitor health and design next generation cures. Focus on women cancer and infectious disease. Regulatory approvals obtained. Recurring customers, partnered with handful of clinical sites including Rutgers cancer center and US National Cancer Institute. Top 10 of the XTC, presented for Richard Branson at Necker island, won the Lyfebulb and the EUTop50 award, and presented at the UN and the European Parliament, semi-finals of XPRIZE. Meet Gitte and learn more about Genomic Expression’s groundbreaking work by completing your RSVP. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1632321901649-CH3T2ZH9E5HQ4WQE06Z4/gitte-pederson.png Summit 16 Gallery B - DNA is Not Your Fate: Introducing OneRNA Introducing Gitte Pedersen, Co-Founder and Chief Executive Officer, Genomic Expression, based in Boston, Mass. Gitte Pedersen founded Genomic Expression with her brother when their parents got diagnosed with cancer. Prior to Genomic Expression, she operated Proximity Ventures and advised companies and Danish Ministry of Foreign Affairs brining in +$1B deals to Danish Biotech companies. She worked at Novo Nordisk in a number of management positions and brought multiple product to market worldwide. She has a master in Chemical Engineering and a bachelor in International Trade. Genomic Expression is a commercial-stage RNA Platform For Next Generation Cures. By analyzing RNA, we can detect disease, monitor health and design next generation cures. Focus on women cancer and infectious disease. Regulatory approvals obtained. Recurring customers, partnered with handful of clinical sites including Rutgers cancer center and US National Cancer Institute. Top 10 of the XTC, presented for Richard Branson at Necker island, won the Lyfebulb and the EUTop50 award, and presented at the UN and the European Parliament, semi-finals of XPRIZE. Meet Gitte and learn more about Genomic Expression’s groundbreaking work by completing your RSVP. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1631113736775-L261B5SGH69YS8H3OXNV/cg-headshot-peara-tim.jpg Summit 16 Gallery B - Separating Pain from Addiction Introducing Tim Peara, President, Bridge Therapeutics Bridge Therapeutics (“Safe alternatives to Opioids”) is a quick-to-sales biopharma company disrupting the $35B+ markets for pain and addiction. Bridge is tackling a root cause of the Opioid crisis by providing strong pain relief with low risk of addiction or overdose. Proven ingredients and best-in-class delivery technology should allow Bridge to obtain FDA approval quickly while erecting economic barriers to entry around therapies. Bridge’s team is relevant, capable and experienced, guiding it to become a multi-billion-dollar company. Bridge Therapeutics CEO Tim Peara brings deep experience in business development and finance, building departments for large companies as well as developing projects and technology companies, both in the USA and abroad. For 20 years Tim has developed technology start-ups (Greenfuel Technologies) and energy projects (Koch, GE) preceded by 14 years on Wall Street as an investment strategist (Prudential, Lehman). He earned a BA from Wesleyan University, Connecticut and an MBA from the University of Chicago’s Booth School of Business. Meet Tim and learn more about Bridge Therapeutics’ groundbreaking work by completing your RSVP. https://cavendishglobal.com/summit-17-gallery-a daily 0.75 2023-12-06 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1633727725507-UNC7AFHFCVYLK0CWW0Z4/charlie.jpg Summit 17 Gallery A - Charles "Charlie" Mills Chief Executive Officer, Medline Industries Charlie Mills is the CEO of Medline, the largest privately-held manufacturer and distributor of health care supplies in the United States, headquartered in Northfield, Illinois. Medline’s worldwide revenues were $17.5 billion in 2020. Charlie joined Medline in 1986, has held various positions, and was named CEO in 1997. Prior to joining Medline, he was in sales with IBM from 1984-1986. Charlie received his B.S. degree in Mechanical Engineering and his MBA from Cornell University. Medline is a healthcare company: manufacturer, distributor, and solutions provider focused on improving the overall operating performance of healthcare. Medline works with both the country’s largest healthcare systems and independent facilities across the continuum of care to provide the clinical and supply chain resources required for long-term financial viability in delivering high-quality care. With the size of one of the country’s largest companies and the agility of a family-owned business, Medline is able to invest in its customers for the long-term and rapidly respond with customized solutions. Headquartered in Northfield, Illinois, Medline has 28,000+ employees worldwide and does business in more than 110 countries. Learn more about Medline at http://www.medline.com. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1633727725507-UNC7AFHFCVYLK0CWW0Z4/charlie.jpg Summit 17 Gallery A - Charles "Charlie" Mills Chief Executive Officer, Medline Industries Charlie Mills is the CEO of Medline, the largest privately-held manufacturer and distributor of health care supplies in the United States, headquartered in Northfield, Illinois. Medline’s worldwide revenues were $17.5 billion in 2020. Charlie joined Medline in 1986, has held various positions, and was named CEO in 1997. Prior to joining Medline, he was in sales with IBM from 1984-1986. Charlie received his B.S. degree in Mechanical Engineering and his MBA from Cornell University. Medline is a healthcare company: manufacturer, distributor, and solutions provider focused on improving the overall operating performance of healthcare. Medline works with both the country’s largest healthcare systems and independent facilities across the continuum of care to provide the clinical and supply chain resources required for long-term financial viability in delivering high-quality care. With the size of one of the country’s largest companies and the agility of a family-owned business, Medline is able to invest in its customers for the long-term and rapidly respond with customized solutions. Headquartered in Northfield, Illinois, Medline has 28,000+ employees worldwide and does business in more than 110 countries. Learn more about Medline at http://www.medline.com. https://cavendishglobal.com/summit-17-gallery-b daily 0.75 2021-10-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1634833052584-9V2VUHBUBA4DSQM3D620/IMG_0611.jpg Summit 17 Gallery B - Fernando Volante Chief Executive Officer and Co-Founder Fernando has 16+ years of experience in the Residential Real Estate Industry. He managed an investing company that bought and sold more than 56 residential buildings. Startup minded with successful launches in LATAM ranging from an FX Forex brokerage firm to a retail home goods store. He has a law degree from Universidad Católica Andres Bello and a Master in Business Administration from the Universidad Metropolitana in Caracas, Venezuela. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1634833052584-9V2VUHBUBA4DSQM3D620/IMG_0611.jpg Summit 17 Gallery B - Fernando Volante Chief Executive Officer and Co-Founder Fernando has 16+ years of experience in the Residential Real Estate Industry. He managed an investing company that bought and sold more than 56 residential buildings. Startup minded with successful launches in LATAM ranging from an FX Forex brokerage firm to a retail home goods store. He has a law degree from Universidad Católica Andres Bello and a Master in Business Administration from the Universidad Metropolitana in Caracas, Venezuela. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1634833138329-YAOJUHBUYVGF48CSB0O3/IMG_1876.jpg Summit 17 Gallery B - Martin Fernandez Feo, DDS, MSD COO, CPO and Co-Founder Dr Martin Fernandez-Feo is a private practice periodontist and dental implant specialist with 16+ years of clinical experience. He is also a Master of Science in oral biology and a former clinical assistant professor at Boston University Henry Goldman School of Dental Medicine. https://cavendishglobal.com/summit-17-gallery-c daily 0.75 2021-10-22 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1634929244178-79VFQT2D3D2H1WJFJUKD/cliff+01.jpg Summit 17 Gallery C - Clifford L. Hendrick Chief Executive Officer and Director Mr. Hendrick has been with Cetya for 8 years, serving as an advisor to Cetya for one year prior to becoming its CEO in July 2014. Prior to Cetya, Mr. Hendrick spent over 20 years working for Genzyme Corporation, most recently as the Vice President and General Manager of Early Development for the Oncology business. Mr. Hendrick worked for Integrated Genetics for six years prior to its merger with Genzyme in 1989, and in research for the Life Sciences division of Millipore Corporation for 11 years before joining Integrated Genetics and the biotechnology industry in 1983. Mr. Hendrick holds a B.S. in Life Sciences from the Massachusetts Institute of Technology and a M.B.A. from Northeastern University. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1634929244178-79VFQT2D3D2H1WJFJUKD/cliff+01.jpg Summit 17 Gallery C - Clifford L. Hendrick Chief Executive Officer and Director Mr. Hendrick has been with Cetya for 8 years, serving as an advisor to Cetya for one year prior to becoming its CEO in July 2014. Prior to Cetya, Mr. Hendrick spent over 20 years working for Genzyme Corporation, most recently as the Vice President and General Manager of Early Development for the Oncology business. Mr. Hendrick worked for Integrated Genetics for six years prior to its merger with Genzyme in 1989, and in research for the Life Sciences division of Millipore Corporation for 11 years before joining Integrated Genetics and the biotechnology industry in 1983. Mr. Hendrick holds a B.S. in Life Sciences from the Massachusetts Institute of Technology and a M.B.A. from Northeastern University. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1634929449856-RSLRE4DBHTMTOTFDX6K6/LouJ-16-crop2.jpg Summit 17 Gallery C - Louis Junker, PhD Chief Scientific Officer Dr. Junker has worked for 30 years developing and commercializing therapeutic products for Biotechnology and Pharmaceutical companies. He served as an advisor to Cetya in 2013, VP Preclinical Development since 2014, and CSO since 2019. He was previously Consultant to Amgen, AstraZeneca, Ampio Pharmaceuticals, KBI BioPharma, and Novartis among other companies. Dr Junker was Founder and COO of Coragen Biologics from 2001 to 2004, and Director of Process Development and Engineering at Sulzer Biologics from 1996 to 2001. Dr Junker was a Postdoctoral Fellow and junior Faculty member at University of Colorado Health Sciences Center from 1986 to 1989, holds a Ph.D. from the Department of Nutritional Sciences, Purdue University (1986) and a B.S. in Biology and Chemistry from Western Michigan University (1980). Dr. Junker is a “Chemistry, Manufacturing and Controls” (CMC) expert and has extensive experience developing products from pre-clinical to post-marketed phases. He has managed in house and outsourced development and manufacturing activities including scale-up, transfer, validation and commercialization of processes for large and small molecule drug products. Deep understanding of cellular biochemistry, purification of proteins, small molecule drug development, formulation of drug products and analytical method development. Supported “Greenfield” and smaller facility design projects, managed capital projects for Clients including the schedule, budget, and diverse teams needed to implement Program requirements. Supported IND, NDA and BLA submissions as CMC expert with working knowledge of current FDA and European regulations for the approval of drug and biologic products. https://cavendishglobal.com/summit-18-gallery-a daily 0.75 2021-11-04 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1636039210120-7R02P8MUBYG5JXSUCQCS/Ron-Diamond.png Summit 18 Gallery A - Ronald S. Diamond Chairman and CEO, Diamond Wealth; Chicago Chair, TIGER 21; and Member of the Advisory Board, Stanford Family Office Initiative Mr. Diamond is a Member of the Advisory Board of the Stanford Family Office Initiative and served as former Chairman of the Advisory Board at Stanford University for the Disruptive Technology and Digital Cities Program. In addition, Mr. Diamond guest lectures at Stanford’s Graduate Business School, Graduate Engineering School, and the Entrepreneur program. He serves on the Advisory Board of 10 privately held companies and acts as Chairman for 4 of them. Mr. Diamond is also the Chair of two TIGER 21 chapters in Chicago. A frequent speaker at Family Office and Alternative Investment Conferences, Mr. Diamond has spoken at over 100 conferences across the globe. Mr. Diamond is also the Founder of Family Office World — (www.familyofficeworldpodcast.com) a podcast whose mission is to educate the market about Family Offices. Earlier in his career, Mr. Diamond founded Pinnacle Capital — a $250 million hedge fund that outperformed the S&P index 10 out of 10 years — before ultimately selling his company to an international investment firm. Previously, Mr. Diamond served as a Senior Managing Director at Bear Stearns. He began his career as an analyst at Drexel Burnham Lambert. Deeply committed to giving back, Mr. Diamond is an active philanthropist and civic leader. He is Chairman of the Advisory Board for the World Peace Initiative launched at Stanford University. He also serves as the Chairman of the Advisory Board of JSC and currently sits on the Board at the JCC and JUF. Mr. Diamond studied at Northwestern University, graduating Magna Cum Laude and earning his degree in Economics. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1636039210120-7R02P8MUBYG5JXSUCQCS/Ron-Diamond.png Summit 18 Gallery A - Ronald S. Diamond Chairman and CEO, Diamond Wealth; Chicago Chair, TIGER 21; and Member of the Advisory Board, Stanford Family Office Initiative Mr. Diamond is a Member of the Advisory Board of the Stanford Family Office Initiative and served as former Chairman of the Advisory Board at Stanford University for the Disruptive Technology and Digital Cities Program. In addition, Mr. Diamond guest lectures at Stanford’s Graduate Business School, Graduate Engineering School, and the Entrepreneur program. He serves on the Advisory Board of 10 privately held companies and acts as Chairman for 4 of them. Mr. Diamond is also the Chair of two TIGER 21 chapters in Chicago. A frequent speaker at Family Office and Alternative Investment Conferences, Mr. Diamond has spoken at over 100 conferences across the globe. Mr. Diamond is also the Founder of Family Office World — (www.familyofficeworldpodcast.com) a podcast whose mission is to educate the market about Family Offices. Earlier in his career, Mr. Diamond founded Pinnacle Capital — a $250 million hedge fund that outperformed the S&P index 10 out of 10 years — before ultimately selling his company to an international investment firm. Previously, Mr. Diamond served as a Senior Managing Director at Bear Stearns. He began his career as an analyst at Drexel Burnham Lambert. Deeply committed to giving back, Mr. Diamond is an active philanthropist and civic leader. He is Chairman of the Advisory Board for the World Peace Initiative launched at Stanford University. He also serves as the Chairman of the Advisory Board of JSC and currently sits on the Board at the JCC and JUF. Mr. Diamond studied at Northwestern University, graduating Magna Cum Laude and earning his degree in Economics. https://cavendishglobal.com/new-gallery-2 daily 0.75 2021-12-13 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1636999438925-PXW94VYARMSKB3GIVVH5/Adam+Cohen+-+Headshot.jpg Summit 18 Gallery B - Bellesoma: Establishing a New Standard of Care and Improving Quality of Life for Breast Reconstruction & Aesthetic Breast Surgery Patients Introducing Adam Cohen, Co-Founder, President and CEO, Bellesoma Bellesoma is transforming the field of women’s breast health through its software-guided surgical platform that is improving quality of life outcomes, not only in surgical aesthetics, but also in pioneering procedures in breast reconstructive surgery, with a direction towards women who have undergone lumpectomies and mastectomies after being diagnosed with breast cancer. Bellesoma is currently available in the market and desires to scale it’s operations to make their surgical solution available to women around the globe. Adam Cohen, the CEO, co-founded Bellesoma after experiencing his wife’s personal journey with breast surgery. He has had a rewarding career as a serial entrepreneur. He achieved his first successful exit within 5-years from company he started immediately after receiving his undergraduate degree from the University of Illinois - Gies School of Business. From there he took an industrial supply company from $125M to $225M in sales with an equity exit followed by a successful turnaround of financial services company as President. Adam also holds an MBA from Northwestern University – Kellogg School of Management. Adam currently lives in Chicago, IL with his wife and two teenage sons. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1636999438925-PXW94VYARMSKB3GIVVH5/Adam+Cohen+-+Headshot.jpg Summit 18 Gallery B - Bellesoma: Establishing a New Standard of Care and Improving Quality of Life for Breast Reconstruction & Aesthetic Breast Surgery Patients Introducing Adam Cohen, Co-Founder, President and CEO, Bellesoma Bellesoma is transforming the field of women’s breast health through its software-guided surgical platform that is improving quality of life outcomes, not only in surgical aesthetics, but also in pioneering procedures in breast reconstructive surgery, with a direction towards women who have undergone lumpectomies and mastectomies after being diagnosed with breast cancer. Bellesoma is currently available in the market and desires to scale it’s operations to make their surgical solution available to women around the globe. Adam Cohen, the CEO, co-founded Bellesoma after experiencing his wife’s personal journey with breast surgery. He has had a rewarding career as a serial entrepreneur. He achieved his first successful exit within 5-years from company he started immediately after receiving his undergraduate degree from the University of Illinois - Gies School of Business. From there he took an industrial supply company from $125M to $225M in sales with an equity exit followed by a successful turnaround of financial services company as President. Adam also holds an MBA from Northwestern University – Kellogg School of Management. Adam currently lives in Chicago, IL with his wife and two teenage sons. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1637076360298-GZQVTYP6NBXX03B6DCGK/Paul+Denslow+Headshot+Nov+2021.jpeg Summit 18 Gallery B - Shoreline Biome: The time of the Microbiome is Finally Here Introducing Paul Denslow, Chief Executive Officer, Shoreline Biome Shoreline Biome have developed a breakthrough, patented microbiome assay, and proprietary data driven analysis platform. The technology can identify ALL of the bacteria in a sample, at the strain level – the level required for ACTION. With it being high throughput and low cost, the Microbiome can finally be unlocked for personalized patient care and precision research alike. With the technology already commercialized, and clients including NASA and an array of pharma companies, Shoreline Biome will play an exciting and central role in the Microbiome revolution. Paul Denslow is an experienced bio-tech investor, syndicate-lead and consultant, who knows how to spot opportunities in the market place and deliver them effectively and efficiently. He is a strong believer in the power of platforms and big data to drive enhanced health outcomes. Paul joined Shoreline Biome because of the Company’s potential to do exactly this, and because of the outstanding team. Originally from the UK, Paul has worked in Asia, Europe and the US, holding senior roles at HSBC and Standard Chartered, with over 15 years of experience in banking, including running a large and successful regional financial markets business. He is an avid sailor, with 7 Newport to Bermuda Races and a leg of an around-the-world the round yacht race (from Singapore to Cape Town) to his name. He received his BSc. from the University of Bath. Learn more about Shoreline Biome by visiting https://shorelinebiome.com/ https://cavendishglobal.com/summit-19-gallery daily 0.75 2021-12-15 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1639599865595-WB2QVVAB9SIT5Y541WUW/IMG_20211210_131208__01.jpg Summit 19 Gallery - Robert Granier Founder and Chief Executive Officer Robert Granier is a founder and the Chief Executive Officer of General Fluidics Corporation, where he brings over 25 years of experience developing and has commercializing new products. Over his career he has managed over $200 million in technology research and development and commercialized more than a dozen new products including three R&D 100 award winners. Prior to General Fluidics, he was the Director of the Center for Technology Development at the Massachusetts General Hospitals, a collaborative innovation program between the hospital, Harvard University and the Massachusetts Institute of Technology. Mr. Granier earned a master's degree in management from Harvard University and bachelor's degree in environmental engineering from Louisiana state University. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1639599865595-WB2QVVAB9SIT5Y541WUW/IMG_20211210_131208__01.jpg Summit 19 Gallery - Robert Granier Founder and Chief Executive Officer Robert Granier is a founder and the Chief Executive Officer of General Fluidics Corporation, where he brings over 25 years of experience developing and has commercializing new products. Over his career he has managed over $200 million in technology research and development and commercialized more than a dozen new products including three R&D 100 award winners. Prior to General Fluidics, he was the Director of the Center for Technology Development at the Massachusetts General Hospitals, a collaborative innovation program between the hospital, Harvard University and the Massachusetts Institute of Technology. Mr. Granier earned a master's degree in management from Harvard University and bachelor's degree in environmental engineering from Louisiana state University. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1639600042339-TIEQC5U9IJY36AK3L590/bobw.png Summit 19 Gallery - Robert (Bob) S. Warren Chief Operations Officer and Chief Financial Officer Mr. Warren is the COO & CFO at General Fluidics. He joins GF after a career as a venture investor, corporate attorney, operating executive, entrepreneur and CPA. Most recently he was a partner at ID Fund, a late-stage venture capital group. He was previously a corporate partner in the Life Sciences Practice Group at Foley Hoag, and has been lead counsel on dozens of M&A transactions, representing both strategic and private equity buyers and company sellers. He has extensive experience counseling public and private companies on complex corporate transactions, including mergers and acquisitions, financing transactions and strategic relationships. Mr. Warren also previously served as COO & CFO to an advanced clinical-stage biopharmaceutical company out of MGH. In the late 1990s Mr. Warren served as Controller for a software localization start-up sold in mid-2000. He is also a CPA. https://cavendishglobal.com/summit-19-gallery-b daily 0.75 2021-12-15 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1639599504227-VQNBW6R7H0LR4DM1H1DK/katz.png Summit 19 Gallery B - Bob H. Katz, MS, MB Chief Executive Officer and President Mr. Katz is an accomplished life science executive with broad, multi-disciplinary background in early-stage technology development and clinical applications. Bob was previously President, CEO & Director of ContraMed, LLC a clinical stage Women’s Health start-up developing novel intrauterine contraceptive products in the drug/device combination category. He was responsible for driving OUS human pilot studies, managing product development for two assets, directing contract manufacturing and clinical & regulatory consultants. Bob successfully raised funds for the design and successful execution of two Phase 2 (IND) US multicenter clinical studies and a successful follow-on Phase 3 US multicenter study for the lead asset. Strong positive outcomes from these studies led to the acquisition of ContraMed by Sebela Pharmaceuticals, a privately held specialty pharma based in Dublin, Ireland. Prior to ContraMed, Bob held C-level positions in a number of successful venture-backed start-ups whose products are in worldwide commercial and clinical use. He has undergraduate degrees in Engineering and Business from Rutgers University, a Master’s degree in Biomedical Engineering from Boston University and an MBA. He is a named inventor on over 25 patents and author of several clinical papers https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1639599504227-VQNBW6R7H0LR4DM1H1DK/katz.png Summit 19 Gallery B - Bob H. Katz, MS, MB Chief Executive Officer and President Mr. Katz is an accomplished life science executive with broad, multi-disciplinary background in early-stage technology development and clinical applications. Bob was previously President, CEO & Director of ContraMed, LLC a clinical stage Women’s Health start-up developing novel intrauterine contraceptive products in the drug/device combination category. He was responsible for driving OUS human pilot studies, managing product development for two assets, directing contract manufacturing and clinical & regulatory consultants. Bob successfully raised funds for the design and successful execution of two Phase 2 (IND) US multicenter clinical studies and a successful follow-on Phase 3 US multicenter study for the lead asset. Strong positive outcomes from these studies led to the acquisition of ContraMed by Sebela Pharmaceuticals, a privately held specialty pharma based in Dublin, Ireland. Prior to ContraMed, Bob held C-level positions in a number of successful venture-backed start-ups whose products are in worldwide commercial and clinical use. He has undergraduate degrees in Engineering and Business from Rutgers University, a Master’s degree in Biomedical Engineering from Boston University and an MBA. He is a named inventor on over 25 patents and author of several clinical papers https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1639599566164-FLNXHSCLSXMX7XNTUQQC/franklin.png Summit 19 Gallery B - Alan Franklin, MD, PhD Founder and Chief Medical Officer Dr. Alan Franklin is a graduate of Northwestern University (Bachelor of Science in Biomedical Engineering), the Medical College of Ohio/University of Toledo (MD) and Vanderbilt University (PhD Molecular Physiology). His thesis focused upon the molecular biology and cell type specific gene expression in the insulin producing cells of the pancreatic islet. Dr. Franklin fulfilled ophthalmology residency at Saint Louis University where he was chief resident in 1996-1997, and then completed his clinical training at University of Iowa Hospitals and Clinics for vitreoretinal diseases and surgery. His research work on an anti-vascular agent as a candidate to treat retinal diseases such as diabetic retinopathy and age-related macular degeneration was awarded the best research project by an ophthalmic physician in training at the 1999 Association of University Professors in Ophthalmology meeting. Dr. Franklin is a member of the Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Society of Retina Specialists and the European Society of Retina Specialists. https://cavendishglobal.com/previous-events/2014-oxford-uk daily 0.75 2015-02-23 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1424185310191-WPO0KMMBQULABZOALR9O/909C9957.MOV.22_16_12_13.Still001.jpg Previous - Oxford, UK https://cavendishglobal.com/previous-events/2015-la-jolla-ca daily 0.75 2017-08-03 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1424787182635-JEG4H4BKQBPNFLXSW8PW/impact-forum.jpg Previous - La Jolla, CA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423936625570-OA2TKAELFTWPHNDX90M4/J.-Craig-Venter-Institute.png Previous - La Jolla, CA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1426263487958-UQZJSRK60F7FHZ217843/Scripps_Logo_Large.jpg Previous - La Jolla, CA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423936625755-AFIUCUC7JTCVAKTWSCUU/UCSD_logo.png Previous - La Jolla, CA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1424785877653-MDRZW7NS104YBC5O05JV/SanfordConsortium_Lab_Logo.png Previous - La Jolla, CA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1426263136924-TNC3YBI1DM9NYJE7WJL9/SBI-color-logo.jpg Previous - La Jolla, CA https://cavendishglobal.com/previous-events/2014-united-nations-ny-usa daily 0.75 2016-11-02 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423939280052-VM53NKQJGK11QYH8TXVB/UN+Troops+Accused+of+Raping+Haitian+Man.jpg Previous - United Nations, NY, USA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423939278206-HJOLGLHJKLMNVWNYVTYM/logo.png Previous - United Nations, NY, USA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423939279534-TB07WY7SAY4O5SZLYATJ/3c64c7007fcd4e7bb5542dfa3f73b05doriginal.jpg Previous - United Nations, NY, USA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423939280006-UHBTPANSKJ57WFVQEZZX/RU_logo%28294%29.jpg Previous - United Nations, NY, USA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1423938522949-XVHGAS0P7X16Q8M5JY7H/20140505_3693.jpg Previous - United Nations, NY, USA https://cavendishglobal.com/join daily 0.75 2021-10-04 https://cavendishglobal.com/innovation-partner-services daily 0.75 2020-02-26 https://cavendishglobal.com/ip-registration-request daily 0.75 2015-08-31 https://cavendishglobal.com/resources/cavendish-iq daily 0.75 2021-10-04 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484778397721-S6MEROYCABWVYMORI1A1/IQ_Logo2.png Cavendish IQ https://cavendishglobal.com/host daily 0.75 2021-10-04 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519495135633-8CF5PRIIPCBSFTKBUEZ8/cg_phoenix.jpg Apply to be a Host https://cavendishglobal.com/regconf daily 0.75 2020-03-04 https://cavendishglobal.com/digital-profile-form daily 0.75 2015-08-21 https://cavendishglobal.com/previous-events/2015-cleveland-clinic daily 0.75 2017-08-01 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1434028805714-3OF8FN8DYJ0HIBOFSFTZ/cleveland-clinic- Previous - Cleveland Clinic https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1501604411533-SKDL99OJ148FXSF4Z99Z/image-asset.png Previous - Cleveland Clinic https://cavendishglobal.com/cleveland-clinic-invitation-request-confirmation daily 0.75 2018-02-28 https://cavendishglobal.com/oxford-video daily 0.75 2015-08-21 https://cavendishglobal.com/fhku34q79qyiufhqhb4jh3g2jhbeq98397rhiuh daily 0.75 2015-10-24 https://cavendishglobal.com/presentation-guidelines daily 0.75 2018-07-03 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1441117768985-EEK3SNBI2I33EAMZ1R1E/bannerforweb%3F.jpg Presentation Guidelines https://cavendishglobal.com/cleveland-forum daily 0.75 2015-09-17 https://cavendishglobal.com/previous-events/chopra-event daily 0.75 2017-08-02 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1452726873497-7C09RVEUW96M4B3O5G6M/image-asset.jpeg Previous - Carlsbad Chopra Summit https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1452726666871-T34V45K24QKXA31CBQAD/image-asset.jpeg Previous - Carlsbad Chopra Summit https://cavendishglobal.com/previous-events/nyu-reynolds-event daily 0.75 2016-01-04 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1445528579974-47ELBFNVX46LWRGCPYKL/image-asset.jpeg Previous - NYU Reynolds Summit https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1446221980571-72PKMR52MPK5P5QKBEUG/image-asset.png Previous - NYU Reynolds Summit https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1445528603435-GSMEWUDGDDEGKURJJY20/image-asset.jpeg Previous - NYU Reynolds Summit https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1445528106325-U02OUYEEKJ4CHLKDZM8Y/image-asset.jpeg Previous - NYU Reynolds Summit https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1446222584871-Z832L05FTWAZO8CVS8LE/image-asset.png Previous - NYU Reynolds Summit https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1445528222317-ZYROCPPC81QVS3U4YJHT/image-asset.png Previous - NYU Reynolds Summit https://cavendishglobal.com/previous-events/2016-palm-beach daily 0.75 2017-08-02 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1449770301590-Y290WW5VIWH4WFBUH5E5/Breakers.JPG Previous - Palm Beach - The Breakers, Palm Beach https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1449770312085-1HQ8ST8CUPWTNAIJ9U9X/Breakers+pool.jpg Previous - Palm Beach - Poolside at The Breakers https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1481217610289-WULIAVXT6IG7R0FE3IUZ/_DM21341.JPG Previous - Palm Beach - McLaren Automotive offered community members the 'ultimate driving experience' https://cavendishglobal.com/invitation-request daily 0.75 2020-05-06 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519325475429-HH8IOZM50R2SDSIM7MRM/8J5A5054.JPG Invitation Request https://cavendishglobal.com/focus-areas/education daily 0.75 2018-03-15 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1521129191362-MIARFN1SEPRTJ2W4MIG7/cg_education_banner.jpeg Education https://cavendishglobal.com/focus-areas/global-sustainability daily 0.75 2016-04-13 https://cavendishglobal.com/focus-areas/health daily 0.75 2018-03-15 https://cavendishglobal.com/focus-areas/inclusive-entrepreneurship daily 0.75 2018-02-28 https://cavendishglobal.com/previous-events/2016-boca-grande daily 0.75 2017-08-02 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1458248478470-BNDE2THTKGFVMGXCHOKD/image-asset.jpeg Previous - Boca Grande Education Summit https://cavendishglobal.com/playlist-for-ips daily 0.75 2016-03-24 https://cavendishglobal.com/2016-san-diego daily 0.75 2017-08-01 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460488425976-ZDPMBDIKAGHR6HKRT8DF/image-asset.jpeg Previous - San Diego - June 2016 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460487545738-GCAFIRN6W0ZO573A7J27/booth-31.jpg Previous - San Diego - June 2016 - La Jolla and Torrey Pines https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460487594111-B1SRH1MODRV09USCPSYB/bg-fs-legendary-services.jpg Previous - San Diego - June 2016 - The Lodge at Torrey Pines https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1460487654009-DTO73FVU7OA78Q4FM9JI/room-image1%402x1.jpg Previous - San Diego - June 2016 - Illumina Theater, The Alexandria at Torrey Pines https://cavendishglobal.com/2016-phoenix daily 0.75 2017-08-01 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1466691850577-1EP7CDMRL1LXIIIDC3XI/image-asset.png Previous - Phoenix, AZ - September 2016 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1472163144493-TA973KB6YXCH8QH3E8ZH/phoenix.jpeg Previous - Phoenix, AZ - September 2016 https://cavendishglobal.com/impact-investor-member-application daily 0.75 2016-07-26 https://cavendishglobal.com/la-jolla-video daily 0.75 2016-10-18 https://cavendishglobal.com/2017-san-diego daily 0.75 2017-08-01 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678415367-C2AWBM5FABM64U28TF20/entrance.jpeg Previous - San Diego, CA - February 2017 - Fairmont Grand Del Mar, Main Entrance https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678437555-F9WME4PW9FZISF5HF46F/479139_high.jpg Previous - San Diego, CA - February 2017 - Aria Lawn at the Fairmont Grand Del Mar https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484755665651-OA2QUZSFHEYMIWMWW15A/1380228209GCS_7739.JPG Previous - San Diego, CA - February 2017 - <i>USS Midway</i> On Monday night, Cavendish hosted cocktails, dinner and entertainment aboard the famed ship in the beautiful San Diego Bay https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678458404-XZIAL5VYIWXUVGRGNCTB/479257_high.jpg Previous - San Diego, CA - February 2017 - Manchester Salon https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678489905-SNYUKS0ZSYIC1L2NZFFS/479264_high.jpg Previous - San Diego, CA - February 2017 - The ultimate venue for Innovation Partner presentations https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678466314-0R6HZRSKGLV9T4HUD9TK/479259_high.jpg Previous - San Diego, CA - February 2017 - Forum attendees gathered for special cocktail receptions at the end of the day https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484678480447-OXZ9NGKZ6NMND8T5UR6F/479042_high.jpg Previous - San Diego, CA - February 2017 - Fairmont Grand Del Mar https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1485444714484-WMDTXYXVEUF9JXEKST6C/jonathan+sackier_1x1.jpg Previous - San Diego, CA - February 2017 - Jonathan Sackier, MD Managing Partner and Chief Medical Officer, Cavendish Global https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1485444531025-R2R0W2EVXI7K3AQ0DV0A/0304ec1.jpg Previous - San Diego, CA - February 2017 - Evonne Fearnot MED Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1485444048146-BYVJZBPKX1AZHGD2R73X/image001.jpg Previous - San Diego, CA - February 2017 - Scott Cunningham Partner, Covington & Burling LLP https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1485444122081-S7ADVU87N7UM0QKUYFPU/Ackerman_Wade_300.jpg Previous - San Diego, CA - February 2017 - Wade Ackerman Covington & Burling LLP https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1485444494142-R2PFZN1JHD2K3B07M0NU/2c75068.jpg Previous - San Diego, CA - February 2017 - Paul Fearis CEO, Clinvue https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1485206818552-6E08Z2JAYR0TW4C7IJME/GDM-B.JPG Previous - San Diego, CA - February 2017 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1485206578107-L3339JG2C8DV64S6QJ3M/Logo+PBIG_Full_CMYK.jpg Previous - San Diego, CA - February 2017 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1484669104976-F8VV1EV6VGILRHQ31N7Z/sdbanner.png Previous - San Diego, CA - February 2017 https://cavendishglobal.com/san-diego-videos daily 0.75 2017-03-01 https://cavendishglobal.com/2017-dc daily 0.75 2017-08-01 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1491415019241-EQTN8I04IF02ZUOL3RWH/unspecified-1.png Previous - Washington, DC - May 2017 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490116753654-BVQHQEYV50UH74LY6U6I/RonaldReagan.jpg Previous - Washington, DC - May 2017 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490278863660-98R236N4FAPWWHLWJG9E/Willard_Logo.jpg Previous - Washington, DC - May 2017 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1492706067557-BSMX5BC86HEFUD3YIAF5/CIF_Logo_Transparent.png Previous - Washington, DC - May 2017 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490219930244-03CVQ2WQYBECXD6OULZQ/IMG_3269-2.jpg Previous - Washington, DC - May 2017 - Forum attendees will stay at the historic Willard InterContinental https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490219905696-CZ1WAX624Y1GM6CO5QS0/Meeting_Room_Willard.jpg Previous - Washington, DC - May 2017 - Rehearsals and Cavendish Advisors will be hosted at the Willard InterContinental https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490219911773-R1NMQTIL43NZ879AT30N/Round+Robin+Bar_1.jpg Previous - Washington, DC - May 2017 - Round Robin Bar at the Willard InterContinental — it is said the term "lobbying" was first coined here https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490219935692-DYUYN96EC7WQ7T4QRP8T/Rounds4.jpg Previous - Washington, DC - May 2017 - The Forum will convene at the Ronald Reagan Building for presentations, keynotes, panels and more https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1490219331976-NE3WUZTX0HZ172EDSCK8/dc_impact_investing_forum.jpg Previous - Washington, DC - May 2017 https://cavendishglobal.com/2017-chicago daily 0.75 2018-02-25 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1499112429302-BXQAQYKS3V0BV53L2RXT/banner.jpg Previous - Chicago, IL - July 2017 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1499467636682-XXG6C5RJP8DSDVD3R7CT/sean_o_sullivan.png Previous - Chicago, IL - July 2017 - Sean O'Sullivan, SOSV https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1498752160025-RD245XVNHGX7HF3FQ4ES/DrJoanneSmith+c+Robin+Subar.jpg Previous - Chicago, IL - July 2017 - Joanne C. Smith, MD, Shirley Ryan AbilityLab https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497895644333-2ZRC5TXDMIV89IRY8UWU/EricLefkofsky_HeadshotMedia.jpg Previous - Chicago, IL - July 2017 - Eric Lefkofsky, Tempus https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1499095927497-I69Z075VZZXSBOQQS82B/me_lab.jpg Previous - Chicago, IL - July 2017 - Ramille N. Shah, PhD, Northwestern University https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1499467834513-NEG8OX9BTSRH6DQXKI0M/76969.jpg Previous - Chicago, IL - July 2017 - Gene E. Robinson, PhD, University of Illinois https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497895615373-7KVFGF3O3J2IOJPETGAA/AnnaSnider_cropped.jpg Previous - Chicago, IL - July 2017 - Anna K. Snider, Bank of America Head of Due Diligence for the CIO, Global Wealth & Investment Management, a division of Bank of America https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1499794118634-A1SUDZG3AR98TSXAFA4G/25235b1.jpg Previous - Chicago, IL - July 2017 - Michael Wallach, Levy Family Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1499794021771-67L7Q2HFFNVO3BUTEM53/AAEAAQAAAAAAAAwVAAAAJDExYjFhYmMxLTIxZDctNGZkMC05YTFlLTU4OWU0NjcwYzViOQ.jpg Previous - Chicago, IL - July 2017 - Caren Yanis, Philanthropic Advisor https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1499794350911-G6CHIT9TMPGLCGRL9ZZE/Screenshot+2017-07-11+13.31.12.png Previous - Chicago, IL - July 2017 - Bruce Werner, Kona Advisors https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1497978552360-1KLE0YLN5W3CWFSKF1XZ/chicagobanner.png Previous - Chicago, IL - July 2017 https://cavendishglobal.com/washington-dc-videos daily 0.75 2017-06-20 https://cavendishglobal.com/communitystoryplaylist daily 0.75 2017-08-29 https://cavendishglobal.com/2017-nyc daily 0.75 2018-02-24 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519507214467-694DAG58SS8SM4OHXA20/milamber_logo.jpg Previous - New York, NY https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505754198897-TIEL15HPZT4CZYLFIJMB/dave2_400x400.jpg Previous - New York, NY - David Brancaccio, Marketplace Morning Report David Brancaccio Host and Senior Editor, American Public Radio's Marketplace Morning Report David Brancaccio, host and senior editor of public radio’s Marketplace Morning Report, will discuss the challenge of measuring economic success and the debate over growth versus well-being. The Marketplace Morning Report is the business program with the largest audience in America. He is the former host of the television program NOW on PBS, and co-producer of the documentary film Fixing the Future. He is also the host of the Esquire Classic podcast. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505754072168-59WUJF147Y57JS8ZI1DR/Greg-Shell.jpg Previous - New York, NY - Greg Shell, Bain Capital Double Impact Greg Shell Managing Director, Bain Capital Double Impact Mr. Shell joined Bain Capital Double Impact as a managing director in 2016. Prior to joining, Mr. Shell served as a Lead Portfolio Manager of a concentrated Global Equity product at GMO. Previously, Mr. Shell was a Senior Equity Analyst at Columbia Management Group and a Consultant at Bain & Company in its Strategy and Private Equity practice areas. Mr. Shell earned his MBA from Harvard Business School and received a Bachelor of Science from MIT. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505317952978-HKN643WVMEDPYU3XCPX5/Johannes_Fruehauf.jpg Previous - New York, NY - Johannes Fruehauf, LabCentral Johannes Fruehauf Co-Founder and President, LabCentral and BioLabs, General Partner at BioInnovation Capital Johannes Fruehauf is a founder and the president and executive director of LabCentral. He is responsible for all aspects of LabCentral’s operation. Johannes is a physician and successful biotech entrepreneur. Prior to LabCentral, he founded Cambridge Biolabs, a contract research facility serving startup and virtual companies in Kendall Square. He is also a co-founder of ViThera Pharmaceuticals, Deltix and Cequent Pharmaceuticals, and an advisor or board member to numerous life sciences companies and non-profits. Johannes earned his medical degree at the University of Frankfurt and his PhD at the University of Heidelberg (Germany). https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505317982742-JDHYYH9FJNCOZVCQC8BC/Marcia_Nelson.jpg Previous - New York, NY - Marcia Nelson, The Alberleen Group Marcia Nelson Managing Director, Family Office Solutions, The Alberleen Group Marcia Nelson is Managing Director of Alberleen Family Office Solutions and is responsible for client marketing and development of Alberleen’s network of family offices and private investors. Ms. Nelson has a 20 year track record of working with family offices and their advisors, collaborating with other families, and creating thought leadership around impact investing and philanthropic giving. She started her career working for an ultra-high-net-worth philanthropic family and subsequently managed business development and relationship management in the areas of estate planning, finance, and accounting at firms including FMV Opinions, Marcum, and Anchin, Block & Anchin. Ms. Nelson is passionate about women’s issues and founded Deals and Divas, an educational and networking organization focusing on engaging and supporting women entrepreneurs. She serves on the board of The Association for Corporate Growth -ACG- NY where she chairs programming and is a member of the Family Office Committee. In 2017, she was the recipient of the Lou Halstead Women of Leadership Award, given by ACG-NY. Ms. Nelson has been involved with several charitable organizations, including volunteering with Literacy Volunteers of America and as a board member of Turtle Bay Music School in NYC. She also served on the Board of Women in the Boardroom, a national organization that prepares women to serve on corporate boards. Ms. Nelson earned her BA from Southern Utah State College and her MBA in finance and tax from Fordham University. She is a Utah native and is very active in the Mormon Church. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505318145649-WD1VPQPFR4ODUMXNYQ5Y/FabianBolin_KampenMotCancer_small.png Previous - New York, NY - Fabian Bolin, WarOnCancer.com Fabian Bolin Former Investment Banker, Actor, Screenwriter, CEO and Co-Founder, WarOnCancer.com Fabian Bolin is the CEO and co-founder of WarOnCancer.com, an empowering social platform for everyone affected by cancer - patients, survivors and their loved ones. The focus lies on mental health and recovery through storytelling, connection and financial support. WarOnCancer.com aims to play an integral part in modernizing mental healthcare and is already collaborating with both Karolinska Institute and Uppsala University Hospital (Sweden) in order to incorporate the service as a tool for healthcare professionals while at the same time becoming a useful data provider for both healthcare, pharmaceutical companies and research institutions. Fabian is currently undergoing treatment for acute lymphoblastic leukemia and has been selected into the management team for the department of Hematology, Oncology and Endocrine tumors at Uppsala University Hospital. Events in Fabian's own life are what led him to embark on what he now feels is his purpouse in life: helping everyone affected with cancer. Following business studies at Stockholm School of Economics in 2011, Fabian went on to pursue a career in investment banking at Citigroup in London. After two years of working as a bonds trader, Fabian resigned to follow his passion to work in the film industry. In 2013, Fabian graduated from a one-year method acting course at Brian Timoney Actors’ Studio in London and has since appeared in various productions in London and the US. After being diagnosed with leukemia in 2015 at 28 years of age, Fabian began documenting his cancer battle on a blog, which quickly gained global attention. His first post, shared over 13,000 times on Facebook has led to over 100,000 messages, e-mails and letter of support to date. He later won the award “Journalist of the Year 2015” for his blog by CancerRehabFonden. By recognizing the power and potential of storytelling and combining it with a strong urge to empower others affected, the idea of #WarOnCancer was born. A movement to unite the world. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505318270868-NB07LIYKH4011JSNCJN8/Jolyne_Caruso.jpg Previous - New York, NY - Jolyne Caruso, CEO, The Alberleen Group Jolyne Caruso CEO, The Alberleen Group Ms. Caruso is Founder and CEO of The Alberleen Group. She has over 30 years of Wall Street experience in both global capital markets and asset management businesses at major Wall Street firms. Previously, she worked as global head of Absolute Return Strategies at Lehman Brothers and served on the management committee of the firm. Prior to Lehman, Ms. Caruso was co-founder and president of Andor Capital Management, a $7.0 billion technology-focused equity hedge fund. From 1992 to 2001, she was managing director and head of equities Americas at JP Morgan and was chairman of JP Morgan Securities. She began her career at Bear Stearns in institutional equities. Ms. Caruso holds a B.A. with honors from Barnard College, Columbia University, and is chair of Barnard’s Board of Trustees. She is a director of The Center for Clean Air Policy (CCAP), serves on the fund advisory board of Golden Seeds, and is an advisor to both Columbia University’s Entrepreneurship Program and Massey Quick, a private wealth management firm. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505332990287-FDG2Q8E9LAK9A3QHTAN2/James_Rosebush_031417.jpg Previous - New York, NY - James Rosebush, Intersection Impact Fund The Honorable James Rosebush Founder and Managing Partner, Intersection Impact Fund, Reagan White House Official, and Best-Selling Author, True Reagan Mr. Rosebush is a pioneer in the field of impact philanthropy and investing. Beginning in the early 1970s, he became an advocate of employing robust investment-like management practices to measure the effectiveness of charitable giving. He also became a proponent of using program-related investment funds (PRIs), as well as corporate social responsibility (CSR) programs to make a positive impact in the community. Mr. Rosebush held leadership roles in private and corporate foundations at a time when the Sullivan Principles were being applied to management practices and board governance. In response to this new movement, he was involved in the creation of collaborative industry impact groups such as Grantmakers in Health, which sought to increase the effectiveness of every contributive dollar in the field of health. His philanthropic work has included helping to found four schools including the first school without walls, a school for youthful offenders, and the Challenger Memorial Center for Space Science Education. He integrated corporate engagement with public investment in K-12 education, seeking measurable, documentable, advances in competency. This was the focus of his work as the CEO of the Fairfax Education Foundation—the first public school education foundation in the US-- and as founder and CEO of Technology Transforming Education Compact, Inc.—an industry-led effort to turn around the public schools in our Nation’s Capital. Mr. Rosebush was appointed to create and manage the first White House office focused on impact philanthropy and investing for President Reagan. This initiative became the president’s favorite domestic policy program and was a pattern for successive administrations. As a senior advisor to the President, he was an advocate for the integration of corporate, investment, and philanthropic initiatives to be combined and focused on societal issues for maximum impact. He also became the longest servicing Chief of Staff to the First Lady and managed her philanthropic program as well as establishing the Nancy Reagan Foundation. Following his White House years, he has been an advisor to many investment firms, family offices, and philanthropies. Among these are: Tudor Investment Corporation, JP Morgan, Bankers, Trust, Alex. Brown and Sons, Columbia Capital, The Carlyle Group, Stargazer Funds, Hillview Capital, CapitalSource, The American Stock Exchange, and Bessemer Trust, as well as, The Martin Luther King Memorial Foundation, The Museum of the International Red Cross, The Urban Monuments Foundation, The Impact Incubator at Children’s Hospital Los Angeles, World Healers Network. He is a designated philanthropy advisor to Fidelity Investments and UBS. In addition to serving on various boards, Mr. Rosebush has taught corporate social responsibility in the McDonough School of Business at Georgetown University; the history of philanthropy at The George Washington University; and a course entitled Crisis in the Classroom at Principia College, his undergraduate alma mater. His graduate degree is in public affairs from Boston University. Among numerous awards he was selected as was a Woodrow Wilson Scholar at Princeton University and was nominated by President Reagan to serve as Ambassador to UNESCO. His most recent book, a best seller, is TRUE REAGAN, What Made Ronald Reagan Great and Why It Matters. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505318496906-0L5Y3QL84J50AOSRRKMX/David_Deming.jpg Previous - New York, NY - David H. Deming, The Alberleen Group David H. Deming Managing Partner, The Alberleen Group David Deming has over thirty years in investment banking. He has focused on the healthcare industry for over 15 years, including 12 years as the leader of JP Morgan’s Healthcare Investment Banking Group. His experience includes mergers & acquisitions advice, strategic partnerships, capital raising and general financial advice for pharmaceutical, biotech, medical device companies and service companies. Some of Mr. Deming’s former client assignments were for Johnson & Johnson, Baxter International, Gilead Sciences, Scios Pharmaceuticals, CV Therapeutics, Celgene Corporation and Tenet Healthcare. Mr. Deming also has significant experience working with Japanese clients including Chugai Pharmaceutical Co., Eisai Co., Fujisawa Pharmaceutical Co., and Mitsubishi Tanabe Pharma. Mr. Deming founded TAG Healthcare Advisors in 2013. Prior to this role, he was the CEO of a start-up pension management business, SmartNest LLC, which was successfully sold in 2010. He previous spent over 27 years at JP Morgan Chase and JP Morgan where he conducted M&A across industries before joining the healthcare investment banking effort. Mr. Deming served as head of the global healthcare investment banking team for 12 years. Mr. Deming graduated from Hobart College with a BA in Economics with Highest Honors. Mr. Deming is a member of the Board of Directors of the following companies: Celularity, Cutanea Life Sciences, IRX Therapeutics and Sorrento Therapeutics. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505330181970-3WDX5ZQV3CB7V2DTAGRM/BROOKS+steve.jpg Previous - New York, NY - Steven S. Brooks, MD, Brooks Medtech Steven S. Brooks, MD, MBA, FACC Principal, Brooks Medtech Steven Brooks is a multi-faceted health care consultant, publisher, cardiologist and clinical trialist. Steve’s interests include regulatory strategy, scientific and medical due diligence, and medical technology commercialization. Currently, Steve is a Senior Analyst with Popper and Company, an Expert Consultant with NDA Partners, as well as a principal in Brooks Medtech, LLC. In these consulting roles Steve is active in developing thought leadership, content and consultation on multiple interconnected strategic areas. Client services included Market entry strategy, market segmentation, combined market, regulatory and reimbursement strategy, clinical trial design, and evidence development. By leveraging a large network of contacts in academia, government, including the FDA and CMS, and industry, nuanced guidance is developed for diverse client needs. Steve is a Product Development Contributor to StepWise Medical, a medical device accelerator formed as a collaboration of medical device experts, engineers and commercialization partners. It manages the critical steps in the development of medical devices: from innovation to acquisition. In addition, Steve serves as Chief Medical Officer of Global Interconnect, a US-Asia design, engineering, and manufacturing firm with a primary focus in electrosurgical devices. Steve provides thought leadership and assists in the design process for innovative device designs. Previously, Steve served from 2015 to 2016 as the Vice President of Regulatory Affairs and Health Economics for Ablative Solutions, Inc., a medical device manufacture with a catheter based product which performs renal denervation for the treatment of hypertension. The product is CE marked, and enrolling a post-market study in Europe. In September 2016 ASI’s 100 patient Phase 2b IND was approved by FDA and will begin enrollment. Steve facilitated the regulatory strategy including the Request For Designation which determined its status to be regulated as a drug, and led the Pre-IND and IND process for the company, with contributions to the clinical development and clinical trial design. In addition, Steve led reimbursement interests, setting up a meeting with CMS and determining reimbursement of the IND clinical trial, and efforts to obtain reimbursement of the IND trial by CMS. An Orphan Drug Designation application was submitted for a secondary indication. Prior to joining Ablative Solutions, Steve was the Chief Innovation Officer at Sage Growth Partners (SGP), a healthcare consulting firm with expertise in healthcare. At Sage, Steve developed the Medtech Practice and managed the Canton Health Ventures incubator, managing incubator tenants, as well as launching ISOSight Medical, Inc, a line-of-sight ultrasound device company which is based off of intellectual property licensed from the University of Pittsburgh. Previously Steve served as a medical officer for the Food and Drug Administration in the Peripheral Interventional Devices Branch and Interventional Cardiology Devices Branches. In this role he performed medical device review of cardiac and vascular-related products throughout the full product lifecycle. From the pre-submission stage, he worked collaboratively with engineers, chemists, veterinarians, statisticians to assist in design testing and risk mitigation, as well as planning pre-clinical and clinical testing programs. A large role involved clinical trial design, review of clinical trial data, and assessment of the total data submission for the purposes of product clearance and approval. Steve worked collaboratively with the Office of Compliance for consideration of Health Risk Assessments and product recalls. Prior to joining the FDA in 2007, Steve was an Interventional Cardiologist, triple boarded in Internal Medicine, General Cardiology and Interventional Cardiology. Steve completed an MBA at the Johns Hopkins Carey School of Business in the Business of Medicine Program, and has continued to interact with the program as an adjunct faculty member lecturing on drug and device regulation and business strategy and consulting with students on their projects in the “Discovery to Market” course and the graduate and undergraduate programs as an advisor to the Johns Hopkins Centre for Bioengineering Innovation & Design (CBID). He is also a grant reviewer for the Maryland State TEDCO program for multiple funds and a medical executive in the mdPACE commercialization program. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505399831630-WV0LA1210JXJCK23R89V/Andrew_Smith.jpg Previous - New York, NY - Andrew Smith, Houlihan Capital Andrew Smith President, Houlihan Capital https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1507906251942-1BDM7RSEV5JRXV1QGPO2/David_Weild_Photograph.jpg Previous - New York, NY - David Weild, Weild & Co. David Weild IV Chairman and CEO, Weild & Co., former Vice Chairman, NASDAQ https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505317833979-N1PQ81OTL3AIKPQKL2NE/Peter_Samuelson.jpg Previous - New York, NY - Peter Samuelson, First Star Peter Samuelson Producer, Philanthropist, and co-founder, First Star https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1506459415270-OP5C2PSOG327W648EGNQ/JHAF_SQ.jpg Previous - New York, NY https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1505317596327-NRU1FUOHD8PJ7V5FOT47/AdobeStock_60595305+copy.jpeg Previous - New York, NY https://cavendishglobal.com/2018-san-diego daily 0.75 2018-05-11 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519506054036-09FXAVAVIYMUM532F1RL/SanfordConsortium_Lab_Logo_1bf9d940fb1ff48286f566a9c579463f.png Previous - San Diego, CA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519506088894-SJYLEEZIXBDHWCA8MXW4/estancia_2.jpg Previous - San Diego, CA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1510334892790-80K43MX9NQ66CPLPZRRD/AdobeStock_78560912.jpeg Previous - San Diego, CA https://cavendishglobal.com/speakers daily 0.75 2018-05-11 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511030389788-FK46E4PGXOLS6H2OJXVK/rsmith_web.jpg Our Speakers Robin L. Smith, MD Chairman and President Stem For Life Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511109912635-41T2CUH3WYL1T22QE8NU/scagan_web.jpg Our Speakers Sherry Cagan President and Founder Stand4Lyme Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511038023240-NRL8559UB6H5SXTKB923/pdolan_web.jpg Our Speakers Paul Dolan Co-Owner and CEO Cleveland Indians (MLB) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511108311391-HYETX3A4WUUQ9WHD97T6/rharrington_web.jpg Our Speakers Ronald Harrington Philanthropist and Entrepreneur Harrington Discovery Institute at University Hospitals (Cleveland) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511208882224-05PTIR19F07WM1X4MM59/jjewett_web.jpg Our Speakers Jack Jewett President and CEO Flinn Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511034281302-OC43UEO51MION5YTHI8H/bdidato_web.jpg Our Speakers Barry Didato Chief Investment Officer and Executive Vice President The Innovation Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511208868857-9XIGKLCM50XDG3LOF3UK/emoskowitz_web.jpg Our Speakers Eva Moskowitz CEO Success Academy Charter Schools https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511026930240-HT1826P4JM7OUPD1W9JO/mstevens_web.png Our Speakers Melissa Stevens Executive Director, Center for Strategic Philanthropy Milken Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511025549638-4DL6OYWESB36Y8EKWPSN/argivens_web.jpg Our Speakers Alexandra Reeve Givens Trustee The Christopher and Dana Reeve Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511030801313-YJCB8IVXDNLZM955U33Q/swestly_web.jpg Our Speakers Steve Westly Founder and Managing Partner, The Westly Group, and former California State Controller and CFO https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511209185298-U1B71B9K8IAXDCS5I13U/rramoni_web.jpg Our Speakers Rachel Ramoni, DMD, ScD Chief Research and Development Officer US Department of Veterans Affairs https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511033743303-RW3A60EA20J8RZK4GHN0/Eric_Reiman.png Our Speakers Eric M. Reiman, MD Executive Director, Banner Alzheimer's Institute, and CEO, Banner Research https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511109923896-SQJQPCHSBTWCHRQ07FEU/mtenenbaum_web.jpg Our Speakers Marty Tenenbaum, PhD Founder and Chairman Cancer Commons https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511208843487-V5P2ZHZMHAGP2NG38FAX/dweild_web.jpg Our Speakers David Weild IV CEO, Weild & Co., and former Vice Chairman, NASDAQ https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511025700087-YAXKNC1TOJQTIAAE68GY/jfruehauf_web.jpg Our Speakers Johannes Fruehauf Co-Founder and President LabCentral https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511209462728-BAZ0F84A44OJ1KFPJ36H/mfitzpatrick_web.jpg Our Speakers Michael Fitzpatrick World-renown musician, Prince Charles Award for Outstanding Musicianship recipient, and founder and Chairman, Earth's Call https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511038178654-Z6MZE047XSRENOM7ANP9/jgallagher_web.jpg Our Speakers Jeffrey Gallagher CEO Virginia Biotechnology Association (VirginiaBio) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511110174525-GGZS8UV7HMZDZVLPEUVW/srowe_web.jpg Our Speakers Stanton J. Rowe Chief Scientific Officer and Corporate Vice President Edwards Lifesciences https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511023566984-OCB233KRXDLL5B2VEPN0/bernardi_web.jpg Our Speakers Linda Bernardi Chief Innovation Officer, Cloud and Internet of Things (IoT) IBM https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511110180838-0OG0WJ3JVPTFTYV6P16G/lcagan_web.jpg Our Speakers Laird Cagan Managing Director and Co-Founder Cagan McAfee Capital Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511023152558-U9VJBE823OQJ1S8G6302/shell_web.jpg Our Speakers Greg Shell Managing Director Bain Capital (Double Impact) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511031174052-QWXP7M9D9BJB3NYJF9NK/dchopra_web.jpg Our Speakers Deepak Chopra, MD American Author and Advocate Founder, The Chopra Foundation, and Co-Founder, The Chopra Center for Wellbeing https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511109407296-U4U3MMAC8LFBLFJDB8VC/dcosgrove_web.jpg Our Speakers Delos "Toby" Cosgrove, MD President and CEO Cleveland Clinic https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511024753553-5FR4SQH7DGJ9X6A45DWX/gsimon_web.jpg Our Speakers Gregory C. Simon President, Biden Cancer Initiative The Biden Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511111712355-QHORWQNP0GUZRVU270W1/mgriofa_web.jpg Our Speakers Marc O'Griofa, MD Physician, Scientist, and Engineer https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511209489902-GOHFLO2E1HJTTPC9EAAP/sharborth_web.jpg Our Speakers Susie Harborth Managing Director and Co-Founder, BioLabs San Diego General Partner and CFO, BioInnovation Capital https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511027421517-VOGCPSSII06J3DBW9NWF/fbolin_web.jpg Our Speakers Fabian Bolin Actor, Screenwriter, and CEO WarOnCancer.com https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511204534164-3VPN6F33XZSUTPOP9WU5/dawallach_web.jpg Our Speakers D.A. Wallach American recording artist, songwriter, essayist, and investor in health and biotechnology https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511035288381-CGYMZZ7Y379VBRUNOUO4/kbingham_web.jpg Our Speakers Kate Bingham Managing Partner SV Health Investors https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511110168163-R7ZSHT6IGRIAEBI60GVJ/dpanzirer_web.png Our Speakers David Panzirer Trustee Leona M. and Harry B. Helmsley Charitable Trust https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511023760967-QHZ198PIHCFRBEGCF55Z/fishburne_web.jpg Our Speakers Lindy Fishburne Senior Vice President, Investments, Thiel Foundation Managing Partner, Breakout Labs https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511109426735-T5SVD5RTCOU4PUNPMJCT/mkhan_web.jpg Our Speakers Mehmood Khan, MD Vice Chairman and Chief Scientific Officer, Global Research and Development PepsiCo https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511110169305-1494XY5I6AHM8LVX2H8B/tgraham_web.jpg Our Speakers Thomas Graham, MD Chief Innovation Officer Cleveland Clinic https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511209218127-V5AADZS81TBE4R4W93V4/rflores_web.jpg Our Speakers Rubén Flores, PhD Director of Commercialization UCSD https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511023995877-VYZIYUWW3WGYM5BJSF1H/jsmith_web.jpg Our Speakers Joanne Smith, MD President and CEO Shirley Ryan AbilityLab (Chicago) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511035170891-U4CEG25Y2QI1QOG13TL0/jsanti_web.jpg Our Speakers Jenny Santi Author, Advisor, and Director and Head of Philanthropy Services (Southeast Asia), UBS https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511204517200-QQ5DG7EYVWHR6B0X4YZK/lthrall_web.jpg Our Speakers Laura S. Thrall President and CEO CureSearch https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511205002774-0Y4TLLOGCCA4Q71EII84/pwilderotter_web.jpg Our Speakers Peter Wilderotter President and CEO Christopher and Dana Reeve Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511204230071-172TQQ8ZBM7P5147Z7ND/jrosebush_web.jpg Our Speakers James Rosebush CEO, GrowthStrategy, Bestselling Author, and Reagan White House Official https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511209208908-J52SHU097ID9FOPXMZDL/iblech_web.jpg Our Speakers Isaac Blech Investor 21st Century Investors Group https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511204988728-3WEBUVQV8KWQFK26BAKX/elefkofsky_web.jpg Our Speakers Eric Lefkofsky CEO, Tempus, and co-founder and Chairman, Groupon https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511111705741-1Z8NR9X63LDFA9PDJCLM/jdoty_web.jpg Our Speakers James R. Doty, MD Director and Founder, Center for Compassion and Altruism Research and Education Stanford University https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511205011394-EYOBE5G1HZO6CI46PDEW/tfulmer_web.jpg Our Speakers Terry Fulmer, PhD President The John A. Hartford Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511035494195-2WO1CKU4X5TMPIF5DGL1/dsanford_web.jpg Our Speakers T. Denny Sanford Chairman and CEO United National Corporation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511111701197-2VRMKOMOSMFATUONIANB/ijacobs_web.jpg Our Speakers Irwin Jacobs Co-Founder and former Chairman Qualcomm https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511204240026-JPGSHCO92F5OE4AH1U73/jyoung_web.jpg Our Speakers Jack Young Managing Director Qualcomm Ventures and Qualcomm Life https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511111000282-6ZNSI8NKUBS45N3YIFW2/dbrancaccio_web.jpg Our Speakers David Brancaccio Host and Senior Editor, Marketplace Morning Report American Public Media https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511109418816-BG86TSWT5SER9009RSPY/amwanza_web.jpg Our Speakers Angela Kaya Mwanza Senior Vice President, Wealth Management UBS https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511209473206-UYFOXOYSR6S4A8897LYP/sobrien_web.jpg Our Speakers Soledad O'Brien American Broadcast Journalist and Executive Producer https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511033868742-65F18L7JUZW8ANDQPL50/msummar_web.jpg Our Speakers Marshall L. Summar, MD Director, Rare Disease Institute Children's National Medical Center https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511037798988-KOCWFE06WSSZ04VICOMJ/pitbull_web.jpg Our Speakers Armando Christian Perez ("Pitbull") American Musician and Record Producer, and founder, SLAM (Sports Leadership and Management Academy) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511030267516-BADOIJ23UY0VNOPIM873/dbrooks_web.jpg Our Speakers Deborah W. Brooks Co-Founder and Executive Vice President The Michael J. Fox Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511026521475-YPH2I4VAS81WUQSCLB9R/jcventer_web.jpg Our Speakers J. Craig Venter, PhD Founder, Chairman, and CEO The J. Craig Venter Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511024358515-9UY1JVBIYKYG7CS18Y9O/dducey_web.jpg Our Speakers Governor Doug Ducey 23rd Governor State of Arizona (US) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511037878883-G1D5F7X3NLPLOQX7VJ4S/chovet_web.jpg Our Speakers Charlotte Hovet, MD Global Medical Director, Healthcare and Life Sciences Dell, Inc. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511204505042-WCFS3LUOXBGTDQGNWXN1/gbrodbar_web.jpg Our Speakers Gabriel Brodbar Executive Director NYU Reynolds Program in Social Entrepreneurship https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511026305178-J5C04IK4S84F4VSGKLHB/bnewhouse_web.jpg Our Speakers Barbara Newhouse President and CEO The ALS Association https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511108178940-URQTRMTTKGFR2O2O0YTD/mfield_web.jpg Our Speakers Marshall Field V President The Field Corporation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511208857828-LOYZZ7VAKRP9S0N0FE91/jgreenwood_web.jpg Our Speakers James C. Greenwood President and CEO Biotechnology Innovation Organization (BIO) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511033997963-U2E2KBZGJS095J6VXEI5/dfletcher_web.jpg Our Speakers Deborah Fletcher Senior Vice President, Client Partner Sudler & Hennessey https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511109917017-0UDW9566CCJFKC8OR5M8/azolezzi_web.jpg Our Speakers Anthony Zolezzi Operating Partner Pegasus Capital Advisors LP https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511204250688-WW4W2894DNVDU1H6ZXC7/psamuelson_web.jpg Our Speakers Peter Samuelson Co-Founder and President First Star https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511023409346-4T6TR6H3C13AJPGOP6S8/mcauliffe_web.jpg Our Speakers Governor Terry McAuliffe 72nd Governor State of Virginia (US) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511024162822-BZG71JA73MD5VEXI0DFQ/mwilliams_web.jpg Our Speakers Montel Williams American Television Personality   https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511204527819-GLDO5VL4D43UJKP6DP41/jzehner_web.jpg Our Speakers Jacki Zehner President The Jacquelyn and Gregory Zehner Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511029647430-96873GYW3Q0HI25J0BBG/kjafa_web.jpg Our Speakers Dr. Krishna Jafa Deputy Director, Integrated Delivery The Bill & Melinda Gates Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511108081963-WOT3MKD4TITG45A1WJ11/joates_web.jpg Our Speakers John Oates American Musician https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511025899325-GAYFYJPEQ8EJMG2L2XL0/lsmarr_web.jpg Our Speakers Larry Smarr, PhD Founding Director California Institute for Telecommunications and Information Technology (Calit2) https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511022224930-KIWDUWUPLR33ODC22Q3Y/osullivan_web.jpg Our Speakers Sean O'Sullivan Founder and Managing Partner SOSV https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511029910178-BVBMGLJQK65L8066B9XQ/jlsigler_web.jpg Our Speakers Jamie-Lynn Sigler American Actress https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511107980172-2RUM5BM0JZU87P9N1L52/cyanis_web.jpg Our Speakers Caren Yanis Principal, Croland Consulting, former President, Crown Family Philanthropies, and former Executive Director, Oprah Winfrey Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511204219084-P8TSLNFJNGVQRK2M9LHV/tpham_web.jpg Our Speakers Tiffany Pham Founder and CEO Mogul https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511030100810-JPN18NRP9N1CXAY4MPZO/mburnham_web.jpg Our Speakers Malin Burnham Chairman The Sanford Burnham Medical Research Institute https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511209453720-U8DSCQZ8Y59Z3ISTXF6L/dcoleman_web.jpg Our Speakers David Coleman President and CEO The College Board https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511035405741-J4YEPZHSUSNZK8GPCXB1/fgupton_web.jpg Our Speakers B. Frank Gupton, PhD Chair, Chemical and Life Science Engineering, and Director, Institute for Engineering in Medicine Virginia Commonwealth University https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511031019195-QX1R5AJ8M2ONT6U3TDEG/sparazynski_web.jpg Our Speakers Scott Parazynski, MD Physician, Author, and former NASA Astronaut https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511209196931-UXS33C59SVXGI854S3Y3/jmetzl_web.jpg Our Speakers Jamie Metzl American writer, Partner at Cranemere, and Senior Fellow, Atlantic Council https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511109412264-XGGWH4SVTJLCE84YKBEH/rferrari_web.jpg Our Speakers Ronald L. Ferarri Principal Bessemer Trust https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511109930457-OBQIV8BOWP3K03H9ABWD/rhenderson_web.jpg Our Speakers Rain Henderson CEO, Clinton Health Matters Initiative (CHMI) Clinton Foundation https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511204994256-1XZJHEDCPPWYTY111VAG/rknight_web.jpg Our Speakers Rob Knight, PhD Principal Investigator, Knight Lab (UCSD), and co-founder, American Gut Project https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519493928389-HNQFM5APBA10XLRI6TCK/cg_podium.jpg Our Speakers https://cavendishglobal.com/partners daily 0.75 2019-05-30 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511118762126-IZB8OGK8RAKAO8BP9PVW/whiteoak_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511115280013-K9GT6R2TBOFSD68LLN8T/mclaren_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511118406256-Y6V2UJI3WZEL6HBCZ8CH/sanford_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511118414304-30EER3113MGDWK74C7W0/matter_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511114987555-3JK0EFWSPPRF6PX6F86T/scripps_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511116081161-BYDX5C8Y8D0ZB4J0DM0A/jcvi_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511114134931-ST4P9UFX8K69UNO9GB12/hartford_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511114047111-JTL52JJ58MMOB5Q3WU2X/merrill_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511114768518-UWPV38RU4SL76O602JAL/morganlewis_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511114757520-SNRIA32F8EB25UJMYOSG/ucsd_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511115926518-RIFBMUXI4VQ6KLC0QT88/proskauer_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511116816054-BRL56DHUC3WNUQNFLPL5/nyas_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511114365058-BWHU0NW0P8J9FNTM4SDB/vabio_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511115915452-2NPEBALFZYBHT73W5VFO/chopra_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511115503892-GEGTFUDE8JSWX0QHENW5/northwestern_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511118742658-YYOX10OB44QU8DFL2JMI/nyur_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511114977877-HOH7FSGYWI3IGEX3JZIG/rockefeller_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1559221871866-61NPBO7IQP3HAWMC3SOT/CG_web_logo_envestnet.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511118263968-7H4Y3PQ7USOQBZS68TSW/uiuc_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511114519341-TR08XS7920XXISAS7Q2A/cleveland_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511116798987-N5QMZCOAQROJBIEPGSKF/rmglobal_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511118733273-TWS90BT8N6ZBXAFZY8GE/m4all_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511118271198-QEYEJ5QAL1JI2HOGGP9B/phelps_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511116780404-MH658GNJ3WGN5P8OWAM6/biocom_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511115395776-JLQ0IKIHKUIDGU5KUESK/poloclub_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511115273136-KTTBFMRFPVX0EVM9UAGK/vcu_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511116324776-Y8HGC0ODFXK7OZV5LELN/oxford_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511116809187-8AHYW9CAT95UHL3AT966/azbio_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511118753223-QXTLX7N939DVBFZR1EUU/propel_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511116070898-2WHR5QHUU31HKIW9HIKV/milamber_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511116302966-XY0WYMQS1BP8NE3OB6OI/pepsico_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1511116314744-TRD60FMPQRBT2Q0BHEFM/ibio_logo.jpg Our Partners https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519494387145-BYKAV4DYGAZBUWMQVTYW/Corpus_Christi_College_New_Court%2C_Cambridge%2C_UK_-_Diliff.jpg Our Partners https://cavendishglobal.com/testimonials daily 0.75 2020-04-23 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1536597016705-KJE1KY47EXBPAKCF3Y30/Turner_Logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519842295416-PNEKUYH2L9MIJELU692Y/infiniti-blue_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519842494379-Q76HXYBH619K5HHZJC4Y/corvida_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519850590909-N3QTG24Q13N05XVM8TQJ/cavidi_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519850653352-EIOIWOB9OYYUIUFU19KN/kalos_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519850252062-ZSRWFPEFKY9JGIY8K7L6/bostonmicrofluidics_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519844590785-B9Z6QH076XSLD2HV0NVE/prolung_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519850737551-G3WF3SYQG2DH893X0HKU/myomo_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1587658392667-CT99I9LCNKMTSOWGO57F/CG_Web_LifeWaveBiomedical.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519844473665-GVKKJKZENLZSXJ99QA2G/mitogenetics_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519849483792-WXMXVL7BJXPNCR05XLYI/easton_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519845352568-RM7LFOCXRTY4XUO8GSPA/interprise_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519849536794-3G9XP8VH8OBN9JUE4TC4/CircleLogo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519849669412-W4D4IKP6LGDNK0DPNDGJ/cdr_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519850151007-2ZR7OR8CXH8I94RG018H/tibercreek_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519850799575-N9IDLSU8CFDHYE8CDRIB/petlife_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519844322114-1NQK7ZMI527I3E663T4N/teloregen_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519850372775-Y0L1DASLVKTKU61F6895/rxi_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519850019597-SH21R3UD4W2J4ORC0T86/weallife_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519849935084-B4C0VSTW9R62IHP4TGAL/firststar_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1523645903639-LFOOI1V1548RQJB2F5GY/cellphire_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519844754219-AZV6SA9I2V9C702DUBI9/oxfordcap_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519850465146-HN0S1QIKGN2VWFZQ0JOE/ii_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519843668972-V8KH5NWG5CI8ZR2EEBYD/cannakids_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519842606140-EMGXASKESJ71OREY66SB/reva_logo.jpg Cavendish Stories https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1519338094053-OVT0AMDWUC7VU9EVQC5N/8J5A5245.JPG Cavendish Stories https://cavendishglobal.com/2018-boca-grande daily 0.75 2018-05-11 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1516382273615-454OBJSAY4NUCDWCN56S/DSC_0089.JPG Previous - BOCA GRANDE, FL https://cavendishglobal.com/contact daily 0.75 2019-12-19 https://cavendishglobal.com/members/impact-investor daily 0.75 2018-05-02 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1524241579890-UTQ7K78JND3A9X071N4S/CG_InvestorHeader.jpg Impact Investors https://cavendishglobal.com/members/strategic-partner daily 0.75 2018-05-18 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1524257724972-P90SBJHME75J3JNFA7LV/CG_StrategicHeader.jpg Strategic Partners https://cavendishglobal.com/selection daily 0.75 2018-07-10 https://cavendishglobal.com/2018-chicago daily 0.75 2018-07-24 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529335300440-CLFHRJNS2OR471GMBCHQ/MATTER-Logo-POS%5B1%5D.png Previous - Chicago, IL https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1524844824217-1K28XHWQIYWE3L8QJS4H/CG_Web_CH18_1.jpg Previous - Chicago, IL Attendees convened at the University Club of Chicago for two days of powerful presentations, networking and social programming. https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1529335287249-SJQJSMN7M2XFH7JPIVN8/SRALab_Logo.png Previous - Chicago, IL https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1524845514975-0PLGHP6A1QS7PGUKBSG0/RLieber.png Previous - Chicago, IL https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1524259548366-TEXAOS1LVG9OEW0P3FTV/SRALab_Banner.jpg Previous - Chicago, IL https://cavendishglobal.com/2018-seattle daily 0.75 2019-02-19 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1536248941675-7NQJIYQE0RZ6NWCMN743/logo-ihme-blk-135.png Recent - Seattle, WA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1534265022036-GJB9VV3OMR4IK8EP90MO/SEA1_Web_EnvestnetLogo.jpg Recent - Seattle, WA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1536248993294-CG4XROFPREJWEBUUVF2H/Intellectual-Ventures-logo.jpg Recent - Seattle, WA https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1531494791252-RSSJUGG2BUY17HSILAO4/CG_Web_SEA1_Banner.jpg Recent - Seattle, WA https://cavendishglobal.com/2019-sfo daily 0.75 2019-04-30 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1535557369053-WZJUYYEZRQNILRN587N7/CG_Web_SFO1_Banner.jpg Previous - San Francisco, CA https://cavendishglobal.com/2019-nyc daily 0.75 2019-04-10 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1550757711647-3V2HOG8Y3FD729B4XH0V/platinum-banner-6.jpg Recent - New York, NY https://cavendishglobal.com/2019-phoenix daily 0.75 2019-10-15 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558105917680-7WASQF7HYNHZDHPZ7X28/CG_Web_PHX2_AZBIO_Banner.jpg Previous - Phoenix, AZ https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1553106497651-ZOT8FH96HF9O4C42SEMV/skyline.jpg Previous - Phoenix, AZ https://cavendishglobal.com/2019-chicago daily 0.75 2019-05-30 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558470786296-G1LWSM06PC2SAQHVMKE1/HT_Logo.jpg Recent - Chicago, IL https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1558471091937-26IKNP8SSIMJ203N5UKL/SRA_Envestnet.jpg Recent - Chicago, IL https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1553105434756-0084AUFBM9KUT4A1436A/IMG_1936.jpg Recent - Chicago, IL https://cavendishglobal.com/2020-sfo daily 0.75 2020-03-13 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1571068280718-FM100LWQML1BX4ND71EC/pillar.jpg Recent - San Francisco, CA https://cavendishglobal.com/2021-chicago daily 0.75 2020-04-03 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1583938342354-KW0SSHVC9YYK8J4LBJC5/CG_Web_CH4_Thanks.jpg Upcoming - Chicago https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1583941310888-3T08HYMXTJ2NQUYA9X5L/CG_Web_City_Chicago_2.jpg Upcoming - Chicago https://cavendishglobal.com/summit-survey daily 0.75 2021-04-22 https://cavendishglobal.com/summit-series/rsvp daily 0.75 2021-12-13 https://cavendishglobal.com/summit-series daily 0.75 2023-12-06 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1587566447696-W83E2PCBVU9PODAFPS6H/8J5A6753.JPG Summit Series https://cavendishglobal.com/summit-series/1 daily 0.75 2021-03-08 https://cavendishglobal.com/summit-series/2 daily 0.75 2021-03-08 https://cavendishglobal.com/summit-series/3 daily 0.75 2021-03-08 https://cavendishglobal.com/summit-series/4 daily 0.75 2021-03-08 https://cavendishglobal.com/ttcc daily 0.75 2020-07-20 https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1434028805714-3OF8FN8DYJ0HIBOFSFTZ/cleveland-clinic- 2015 - Cleveland https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588876975437-9BLT3U3RZ4Z9EB4I2XMF/jp_bw.jpg 2015 - Cleveland - James Patrick, Executive Vice President, Envestnet EVP, Envestnet https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588876978448-GBM98CU2ZQLA7LUHAP5V/jp_bw.jpg 2015 - Cleveland https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588876982005-B96WEBHMHXJBAT1X1QDR/jp_bw.jpg 2015 - Cleveland https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588876985289-25ERAC6EK0ML4TI2GTSU/jp_bw.jpg 2015 - Cleveland https://images.squarespace-cdn.com/content/v1/54dcd925e4b05c8b9b528c85/1588887128944-OXGRCETEK74PEXIOFNPH/CG_WEB_FS_CLE1_Banner.jpg 2015 - Cleveland https://cavendishglobal.com/summit-series/5 daily 0.75 2021-03-08 https://cavendishglobal.com/summit-series/6 daily 0.75 2021-03-08 https://cavendishglobal.com/summit-series/7 daily 0.75 2021-03-08 https://cavendishglobal.com/summit-series/8 daily 0.75 2021-03-08 https://cavendishglobal.com/summit-series/9 daily 0.75 2021-03-08 https://cavendishglobal.com/summit-series/10 daily 0.75 2021-03-08 https://cavendishglobal.com/summit-series/11 daily 0.75 2021-05-22 https://cavendishglobal.com/privacy daily 0.75 2021-03-09 https://cavendishglobal.com/summit-series/12 daily 0.75 2021-05-22 https://cavendishglobal.com/summit-series/13 daily 0.75 2021-07-08 https://cavendishglobal.com/summit-series/14 daily 0.75 2021-07-08 https://cavendishglobal.com/summit-series/15 daily 0.75 2021-07-16 https://cavendishglobal.com/summit-series/16 daily 0.75 2021-10-29 https://cavendishglobal.com/summit-series/17 daily 0.75 2023-12-06 https://cavendishglobal.com/summit-series/18 daily 0.75 2021-12-13 https://cavendishglobal.com/summit-series/19 daily 0.75 2021-12-15